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1 Summary
Many modified nucleotides are known to be present in tRNAs which have different functions
and effects in translation and other cellular processes. Inosine at the wobble position (position
34) in tRNAs has an important role in translation because it increases the base pairing
possibilities between mRNA and tRNA.
In bacteria only tRNAArg2 contains I34. The deamination at this position is catalyzed by
tadA (tRNA-specific adenosine deaminase A) which is the first and so far only bacterial
deaminase that acts on RNA. This study presents evidence that bacteria encode only one
polypeptide that is sufficient for tRNA:adenosine 34 deaminase activity. tadA is encoded by an
essential gene thus underscoring the important role of I34 also in bacteria. tadA selectively binds
to tRNAArg2, whereas eukaroytic tRNAs are not bound or deaminated by tadA, except when they
contain the anticodon loop of tRNAArg. A minisubstrate consisting of the anticodon arm of
tRNAArg2 is a substrate for tadA, providing further evidence that important recognition elements
are located in this region of the tRNA. Mutational analysis has shown that the sequence UAGC
at positions 33 to 36 and a stem-loop structure are sufficient for inosine formation. Thus, the
anticodon is the major determinant for tadA acitivity. However, inosine formation is less
efficient with the minimal minisubstrate compared to wild-type minisubstrate, suggesting that
additional sequences or structures might be required for efficiency.
Recombinant human Tad2 and human Tad3 are sufficient to reconstitute tRNA:adenosine
34 deaminase activity. The complex deaminates eukaryotic tRNAs from humans, B. mori and S.
cerevisiae and also tRNAArg2 from E. coli. a-hTad2 antibodies deplete the tRNA:adenosine 34
activity from HeLa cell extracts by depleting both subunits, indicating that they form a stable
complex. This is further supported by the result that recombinant hTad2 localizes to the nucleus
and transports hTad3 into the nucleus. hTad2 and hTad3  cannot be exchanged in vitro with
subunits from other organisms, however this is not due to lack of interaction since hTad2 and
hTad3 interact with Tad2 and Tad3 proteins from S. cerevisiae and E. coli. Interestingly, the
Arg2 minisubstrate is not deaminated by the human tRNA:adenosine 34 deaminase although this
enzyme is known to modify full-length tRNAArg2. This result indicates that tRNA binding is
different for prokaryotic and eukaryotic Tad2 and Tad3 proteins.
The analysis of bacterial and human tRNA:adenosine 34 deaminases extended our
knowledge on how these enzymes work and how they are evolutionarily related.
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Type Organism Transcript Cis-acting elements/ Mechanism Functional/
(Genome) Trans-acting factors physiological
consequences
Insertion/deletion type editing
U insertion/ kinetoplastids mRNA(mt) anchoring coupled creation of
deletion sequence/guide cleavage/ligation reading frames
RNAs, TUTase,
RNA ligase, endo-
nuclease, other factors
C insertion Physarum mRNAs, rRNAs, ? ? production of
(also U, AA, polycephalum tRNAs (mt) functional
CU, GU, GC) RNAs
G insertion paramyxovirus P mRNA (v) slippery pseudotemplated creation of addi-
sequence/viral transcription tional downstream
reading frames
A insertion Ebola virus GP mRNA (v) slippery sequence/ pseudotemplated shift from syn-
viral polymerase transcription thesis of secreted
to structural GP
3’ terminal vertebrates mRNAs (mt) flanking tRNA endonuclease, ?
A addition structure/endo- TATase
nuclease, TATase
Conversion type editing
C to U land plants mRNAs, tRNAs flanking sequence (?) ? restoration of
rRNA ? (mt) evolutionary
cons.
mRNAs (cp) sequences
Physarum cox1 mRNAs ? ? removing
polycephalum (mt) frameshifts
marsupials tRNAs (mt) ? ? correction tRNA
identity switch
mammals mRNAs (n): mooring sequence, C-deamination creation of a stop
apoB, NF1 efficiency element, codon
AU-rich region/C-deaminase
(APOBEC1), auxiliary
factors
U to C land plants mRNAs (mt, cp) flanking sequence U-amination creation of
reading
frames
mammals WT1 mRNA, ? ? WT1: abolishment
of transcriptional
tRNAs (n) repressor activity
A to I mammals pre-mRNAs (n): dsRNA structure ds-dependent alteration of
GluR, 5-HT2CR ADAR1, ADAR2 A-deamination receptor 
ADAR2 determinants
cephalopod Kv2 K+ channel ? temperature- silent amino acid
(squid) mRNA (n) dependent substitutions and
changes in 
channel gating
Drosophila Ca2+ channel a1 dADAR (?) ? ?
melanogaster subunit (Dmca1A)
4f-rnp
human hepatitis antigenomic RNA dsRNA structure dsRNA-dependent switch from repli
delta virus (v) ADAR1, ADAR2? cation to packaging
A-deamination
HIV TAR element in ? ? ?
mRNA (v)
eukaryotes, anticodon of Tad1p/ADAT1 enlargement of
prokaryotes tRNAs Tad2p/3p-complex coding capacities
U to A humans a-galactosidase ? base-replacement ?
mRNA (n) (?)
C to A, U to G, Acanthamoeba tRNAs (mt) internal guide base-replacement correction of mis-
U to A, A to G castellani primitive pairing in the
fungi (chytridiomycetes) acceptor stem
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RNA editing has been defined as co- or post-transcriptional processes that alter the information
of primary transcripts other than splicing, capping or 3’-end formation. The term RNA editing
describes the mechanisms by which the sequence content of primary transcripts can be changed
and can alter the informational content of a mRNA and subsequently also of the protein sequence
translated from this mRNA. RNA editing was found in many eukaryotic organisms and variety
was also observed for the substrates which include mRNA, tRNA and rRNA. RNA editing can
be divided into two types: it either involves the insertion or deletion of nucleotides or their
modification.
2.1 Insertion-deletion RNA editing
The term RNA editing was first coined by Benne et al. (1986) to describe the insertion of
uridines into the cytochrome oxidase subunit II mRNA in kinetoplasts of Trypanosoma brucei.
In various trypanosomatids 12 of 18 mitochondrial mRNAs undergo U insertions and deletions
at precise sites usually within open reading frames (Feagin et al., 1988b; Shaw et al., 1989; Shaw
et al., 1988). The extent of editing was shown to vary from the insertion of a few nucleotides to
extensive insertion-deletion of uridine residues in which over 50% of the final mRNA product is
the result of RNA editing (Feagin et al., 1988a; Shaw et al., 1988). This process creates initiation
and termination codons, corrects frameshifts and builds entire reading frames from ’cryptic’
genes.
Trypanosomatids have a single mitochondrion (kinetoplast) which contains a network of
thousands of DNA minicircles and maxicircles (Shapiro and Englund, 1995; Simpson, 1987).
The maxicircles  encode ribosomal RNAs and some of the proteins involved in the mitochondrial
respiratory chain. Minicircles and also maxicircles encode small RNA molecules (50-70 nt) that
were named guide RNAs (gRNAs; Blum et al., 1990). gRNAs contain the sequence information
that is needed for both the number of U’s and the sites of insertion and deletion (Blum et al.,
1990). The 5’ region of gRNAs (anchor) is complementary to sequences just downstream of the
Table I  Different types of site-specific editing and their functional consequences (table adapted from Smith et
al. (1997) and A. Gerber, thesis, 1999)
Abbreviations: apoB-apolipoprotein B; cox1-cytochrome c oxidase subunit 1; cp-chloroplast; ds-double stranded;
GP-glycoprotein; mt-mitochondria; n-nuclear; TATase-terminal adenylyltransferase; TUTase-terminal
uridylyltransferase; v-viral; WT1-Wilms’ tumor susceptibility gene 1
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editing site in the mRNA and thus provides site-specificity. The central portion of the gRNA
contains the editing information of the number of U insertions or deletions and is complementary
to the mature edited mRNA. The 3’ region of the gRNA has an oligo(U) tail that is added
posttranscriptionally. The function of this tail is not known. Editing generally proceeds from 3’
to 5’ which is due to the creation of new anchor sequences by already edited mRNA sequences
(Abraham et al., 1988; Maslov and Simpson, 1992).
Uridine insertion-deletion editing is catalyzed by an enzyme cascade (Fig. 2.1; Blum et
al., 1990; Kable et al., 1996; Seiwert et al., 1996; reviewed by Estevez and Simpson, 1999). The
gRNA first hybridizes downstream of the first editing site via the anchor and directs an
endonuclease to cleave at the first unpaired nucleotide. U’s are added by a terminal uridylyl
transferase (TUTase) or removed by an exonuclease. The edited mRNA can then basepair with
the 5’ region of the gRNA and thereby extend the duplex. The two mRNA fragments are joined
by a RNA ligase.
Figure 2.1  Model for U-insertion RNA editing
(from Alfonzo et al., 1997).
The mRNA is represented by a thick line and the
cognate gRNA by a thin line. Shown are the different
catalytic steps of U-insertion editing. See chapter 2.1
for details about the proteins involved in the catalysis
of insertion editing.
The development of in vitro editing systems lead to the identification of several proteins
involved in insertion-deletion editing. A number of factors were found to bind to gRNAs, among
them gBP21 (Koller et al., 1997), TBRGG1 (Vanhamme et al., 1998), RBP16 (Hayman and
Read, 1999) and glutamate dehydrogenase (GDH; Bringaud et al., 1997). gBP21 has a high
affinity for gRNAs and antibodies against gBP21 depleted in vitro editing activity (Lambert et
al., 1999). However, a T. brucei strain with a knock-out of both gBP21 alleles was still able to
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edit and had a normal gRNA pool, but levels of mitochondrial transcripts were reduced (Lambert
et al., 1999). Recently, gBP21 was found to accelerate the rate of gRNA-pre-mRNA anchor
formation by stimulating base-pairing between gRNA and mRNA (Muller et al., 2001).
TBRGG1 belongs to the RGG protein family and was found to bind strongly to synthetic
oligo(U) (Vanhamme et al., 1998). The protein co-migrated with in vitro editing activity in
glycerol gradients, but no direct association with gRNAs or the editing machinery was shown.
Because mitochondrial rRNAs are polyuridylated in Trypanosomes, TBRGG1 could be involved
in rRNA metabolism. RBP16 binds different gRNAs via the oligo(U) tail (Hayman and Read,
1999). Antibodies against RBP16 immunoprecipitated gRNAs and rRNAs, probably due to the
oligo(U) tail. As in the case of TBRGG1 this suggested a role in mitochondrial rRNA
metabolism. GDH was shown to bind to the oligo(U) tail of gRNAs (Bringaud et al., 1997). This
binding probably involves the NADP(H) binding site of the enzyme because binding to gRNAs
could be competed with NADP(H). A T. brucei GDH knock out strain is viable and showed no
differences in abundance of edited mRNAs (Estevez et al., 1999b). GDH also binds UTP and
this suggested a regulatory link between mitochondrial metabolism and RNA editing (Bringaud
et al., 1997).
Insertion-deletion editing seems to be catalyzed by a large RNP (protein-gRNA complex;
reviewed by Madison-Antenucci et al., 2002). In T. brucei and L. tarentolae three different
complexes have been described which sedimented at 10S, 20S and 35-40S (Corell et al., 1996;
Peris et al., 1997; Pollard et al., 1992; Rusche et al., 1997). The isolation of different editing
complexes could be explained by a dynamic assembly-disassembly of the components that are
required for editing (reviewed by Madison-Antenucci et al., 2002). The complex purified by
Rusche et al. (1997) was composed of eight major polypeptides, three of which appeared to be
RNA ligases. The complex contained the four ’core’ activities gRNA-directed endonuclease,
TUTase, 3’ U-specific exonuclease, RNA ligase and was able to catalyze a complete editing
reaction in vitro. A monoclonal antibody against the 35-40S complex was used to clone a gene
coding for REAP-1 (RNA-editing-associated protein 1; Madison-Antenucci et al., 1998). In vitro
U-insertion editing was inhibited by this antibody. Madison-Antenucci and Hajduk (2001)
showed that REAP-1 is a RNA-binding protein which binds to poly(G) and single-stranded G-
rich RNAs. Pre-edited RNAs were shown to be the preferred substrate and this suggested a role
for REAP-1 in bringing these RNAs into the editing complex.
In T. brucei mitochondrial extracts three different riboendonuclease activities have been
described (Piller et al., 1997; Salavati et al., 2002), one of these having the predicted features of
a RNA editing riboendonuclease: cleavage of the mRNA immediately 5’ of a mRNA-gRNA
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duplex and site-specificity for the gRNA-directed editing site. A riboendonuclease termed
MAR1 was isolated from L. tarentolae (Alfonzo et al., 1998). MAR1 cleaved a pre-edited
mRNA in the absence of gRNA and did not distinguish between pre-edited and fully edited
substrates, indicating that this protein is not involved in RNA editing. However, additional
factors that confer gRNA-dependance could be absent in the purified MAR1 fraction. Cruz-
Reyes et al. (1998) showed the existence of differences in adenosine nucleotide requirements for
cleavage at U-deletion or U-insertion sites in T. brucei. Cleavage at U-deletion sites required
high concentrations of ATP and ADP, whereas cleavage at U-insertion sites occured in the
absence of these nucleotides and was even inhibited by high concentrations. However, the
physiological relevance of this phenomenon remains to be explained. Cleavage at U-insertion
and U-deletion sites could also be catalyzed by two different endonuclease with different
specificity. After cleavage U residues are added to the 3’-OH of the 5’ cleavage fragment by a
TUTase or U’s are removed by a 3’ to 5’ riboexonuclease. Recently, a TUTase was purified and
the gene cloned from L. tarentolae (Aphasizhev et al., 2002). The enzyme was specific for the 3’
U-addition. Antibodies against the TUTase co-precipitated a portion of the RNA editing ligases
and ~40% of the gRNAs. Inhibition of TUTase by RNAi decreased RNA editing and affected
parasite viability. Three 3’-5’ exonuclease activities were detected in mitochondrial extract from
L. tarentolae. One of these enzmyes was purified and was specific for 3’-terminal U’s
(Aphasizhev and Simpson, 2001). This exonuclease digested RNA in a distributive manner, was
specific for single-stranded 3’-oligo(U) and was blocked by a terminal dU. After the removal or
addition of U’s the edited mRNA fragments are ligated by RNA ligases. The editing complex
purified by Rusche et al. (1997) contained three putative RNA ligases whereas Panigrahi et al.
(2001b) identified two novel proteins named TbMP52 and TbMP48 by purifying the editing
complex. Antibodies against the ligase TbMP52 immunoprecipitated in vitro RNA editing
activity (Panigrahi et al., 2001a). TbMP52 encodes an essential RNA ligase and knock out
experiments showed that mRNAs were not edited in a deletion strain leading to death of the
bloodstream form of the parasite (Schnaufer et al., 2001). Huang et al. (2001) showed that
TbMP52 is needed to ligate RNAs in U-deletion editing. Probably the second ligase TbMP48
seals RNAs in U-insertion. Finally, the gRNA-mRNA duplex has to unwind to allow the next
gRNA to hybridize or to bind to the ribosome. Unwinding may occur due to weak G:U base
pairs in the duplex (Maslov and Simpson, 1992) or by a RNA helicase (Missel and Goringer,
1994).
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2.2 C to U editing
2.2.1 Apolipoprotein B editing
The first example of RNA editing discovered in mammals was the tissue-specific editing of
apolipoprotein B (apoB) mRNA. Thereby, a single cytidine is converted to uridine which results
in the change of a glutamine codon (CAA) to a stop codon (UAA). RNA editing generates two
forms of apoB: apoB100 is synthesized in the liver and represents the major protein component
of very low density lipoproteins (VLDL) and their maturation products intermediate density
lipoproteins (IDL) and low density lipoproteins (LDL). The C-terminus of apoB100 interacts
with the LDL receptor and thereby removes LDL from the circulation. LDL transports two-thirds
of the plasma cholesterol in humans and high levels of LDL cholesterol is one of the main risk
factors for coronary heart disease. apoB48 which is identical to the N-terminal 48% of apoB100
is synthesized in the small intestine and is required for synthesis and secretion of chylomicrons.
These particles transport fats from the intestine to the liver and to adipose tissue (reviewed by
Anant and Davidson, 2001; Chester et al., 2000; Innerarity et al., 1996; Keegan et al., 2001).
apoB100 and apoB48 are both synthesized from the same 14 kb mRNA which encodes 4536
amino acids (Chang et al., 1998). C to U editing at position 6666 is a nuclear event and occurs
with high site-specificity on spliced apoB mRNA (Lau et al., 1994a). The establishment of an in
vitro system was crucial to identify the trans-acting factor and the cis-acting sequence elements
around the editing site (Driscoll et al., 1989). cis-acting elements encompass 26 nt consisting of a
tripartite motif which includes a 11 nt ’mooring’ sequence located 4-5 nt downstream of the
edited C, a ’spacer’ element of 2-8 nt located between the mooring sequence and the edited C
and an enhancer region upstream of the editing site (Backus and Smith, 1992; Davies et al.,
1989; Driscoll et al., 1993; Innerarity et al., 1996; Shah et al., 1991; Smith and Sowden, 1996).
More distal sequences were also postulated to play a role in apoB editing (Hersberger and
Innerarity, 1998). apoB mRNA was suggested to form a stem-loop structure at the editing site
with the edited C in the loop (Richardson et al., 1998).
ApoB C to U editing is catalyzed by a protein complex (Fig. 2.2). The catalytic subunit
was initially cloned from rat small intestine (Teng et al., 1993) and was named APOBEC1 for
apoB mRNA editing catalytic polypeptide 1 (Davidson et al., 1995). APOBEC1 belongs to a
family of cytidine deaminases (CDAs) and it contains the motifs that are characteristic of
cytidine deaminases. A deaminase domain with three Zn2+-binding residues and a glutamic acid
that is thought to mediate proton transfer during catalysis is very similar to the deaminase
domain of E. coli cytidine deaminase (ECCDA; Navaratnam et al., 1995). Two phenylalanine
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residues in the active site that are not found in ECCDA are involved in apoB mRNA binding
(Anant et al., 1995; Navaratnam et al., 1995). Furthermore, APOBEC1 contains a putative
nuclear localization signal (NLS) at the N-terminus, a RNA-binding domain and a leucine-rich
domain in the C-terminus which could be involved in dimerization (Lau et al., 1994b).
APOBEC1 forms a complex with the auxiliary factor ACF (APOBEC1 complementation factor,
also known as ASF, APOBEC1 stimulating factor) that is the minimun requirement for in vitro
apoB editing (Lellek et al., 2000; Mehta et al., 2000). ACF has three RNA-recognition motifs
(RRMs) at the N-terminus and a putative double-stranded RNA binding domain at the C-
terminus which might bind the stem that is formed between the mooring sequence and the 3’-
efficiency element (Fig. 2.2; Hersberger et al., 1999). ACF binds apoB mRNA and interaction
with APOBEC1 might recruit the complex to the editing site (Mehta et al., 2000).
Figure 2.2 Molecular model of the minimal apoB mRNA editing complex (from Anant and Davidson, 2001).
The apoB mRNA from nt 6609-6744 was modeled with the mfold program. The model predicts a three branch,
stem-loop structure with the edited C (asterisk) within a loop. APOBEC1 binding sites are marked with arrows.
APOBEC1 is predicted to form a homodimer (the second APOBEC1 is not shown ), ACF is predicted to bind to the
loop containing the edited C as well as the other two loops based on the presence of single- and double-stranded
RNA binding domains. Other proteins that might regulate apoB mRNA editing are predicted to bind to the minimal
complex and form a holoenzyme.
In humans and rabbits APOBEC1 is expressed exclusively in the small intestine (Teng et
al., 1993), whereas in rodents it is also expressed in the liver and in tissues that do not express
apoB including spleen, kidney, gonads and brain (Greeve et al., 1993). Due to the broader
expression of apoB48 rodents have low LDL levels (Greeve et al., 1993). To determine the
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phenotypic effects of apoB mRNA editing, apobec-/- and APOBEC1-overexpressing mice were
generated. apobec-/- mice were healthy and had little changes in lipoprotein concentration
(Hirano et al., 1996; Morrison et al., 1996; Nakamuta et al., 1996). However, mice are probably
not the perfect model system to address the effects of apoB editing because apoB100 levels are
naturally low in rodents. APOBEC1-overexpressing mice had reduced LDL concentrations, but
had dysplasia and developed hepatocellular carcinomas, probably due to aberrant editing of
mRNAs that are normally not edited (Yamanaka et al., 1995; Yamanaka et al., 1997). One such
mRNA is Nat1 (novel APOBEC1 target 1) which encodes a eIF4G homologue. Editing of Nat1
mRNA was suggested to interfere with its repressor function which could allow the expression
of tumorigenic genes (Yamanaka et al., 1997; reviewed by Chester et al., 2000; Keegan et al.,
2001). Furthermore, editing of additional cytidines in the apoB mRNA were found in the
APOBEC1-overexpressing mice (Sowden et al., 1998). Homology to the apoB mRNA mooring
sequence was found in the human neurofibromatosis type 1 (NF1) mRNA (Mukhopadhyay et al.,
2002; Skuse et al., 1996). The appropriately spaced C in this mRNA is indeed deaminated
leading to a truncated protein which probably no longer acts as a tumor suppressor.
A human APOBEC1-related protein has been identified which is expressed exclusively in
the heart and skeletal muscle (Liao et al., 1999). However, this protein named APOBEC2 cannot
edit or bind apoB mRNA and has no cytidine deaminase activity. Jarmuz et al. (2002) identified
a cluster of APOBEC1-related genes on chromosome 22. These APOBEC3A to 3G proteins bind
zinc, RNA and form homodimers similar to APOBEC1. Expression in a variety of tumor cell
lines suggested a role in growth or cell cycle control, however the function of these proteins is
not known. Another APOBEC1-related protein is phorbolin-1 which is highly expressed in
psoratic lesions. Phorbolin-1 has no cytidine deaminase activity and does not edit apoB mRNA
(Madsen et al., 1999). Candidate proteins that might contribute to apoB editing were identified
by APOBEC1-binding, RNA affinity and UV cross-linking (Anant et al., 2001b; Greeve et al.,
1998; Harris et al., 1993; Lau et al., 1990; Lau et al., 1997; Mehta and Driscoll, 1998;
Navaratnam et al., 1993b; Richardson et al., 1998; Schock et al., 1996). One of those is GRY-
RBP (glycine-arginine-tyrosine-rich RNA-binding protein) which is 50% homologous to ACF
(Blanc et al., 2001). GRY-RBP inhibits apoB mRNA editing by binding ACF thereby inhibiting
its interaction with apoB mRNA. The role of the other factors is unclear. They might contribute
to specificity or could modulate the editing reaction. Site-specificity might also be achieved by
structural elements of the apoB mRNA which could direct the enzymatic machinery to the
correct site (reviewed by Davidson, 2002).
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2.2.2 Activation-induced cytidine deaminase (AID)
AID was identified from germinal center B cells in a subtractive screen for genes involved in
class switch recombination (CSR) and somatic hypermutation (SHM), two essential processes
for antibody maturation (Muramatsu et al., 1999). AID is homologous to APOBEC1 and has
cytidine deaminase activity, but does not edit apoB mRNA in vitro (Muramatsu et al., 1999). aid-
/- mice did not undergo CSR, had enlarged germinal centers indicative of a hyper-IgM phenotype
and were also defective in SHM (Muramatsu et al., 2000). In agreement with these results, 18
patients with the hyper-IgM syndrome HIGM2 all had mutations in the coding sequence of hAID
( Revy et al., 2000; reviewed in Longacre and Storb, 2000). HIGM2 is characterized by defective
CSR and SHM and by abnormal germinal centers. Recently, it was shown that AID could induce
SHM in hybridoma cells that represent a late stage of B-cell differentiation (Martin et al., 2002).
Most of the mutations involved G/C nucleotides, suggesting that AID might be a DNA-specific
cytidine deaminase (Martin et al., 2002). Okazaki Im et al. (2002) showed that ectopic
expression of AID was sufficient to induce CSR in a synthetic switch substrate in a murine
fibroblast cell line. Therefore, all components for CSR except AID are expressed constitutively
and ubiquitously. AID is also involved in gene conversion of immunoglobulins, another antibody
maturation process (Arakawa et al., 2002). How AID is involved in the three maturation steps
remains a mystery. It is unknown whether AID really is a cytidine deaminase acting either on
mRNA or DNA. This hypothesis is based solely on its homology with APOBEC1, but so far no
substrate has been identified.
2.3 A to I editing in pre-mRNAs
Adenosine to inosine deamination has been observed in tRNAs, viral transcripts and mRNAs
from numerous eukaryotic species (Bass, 1993; Rueter and Emeson, 1998). The extent of editing
varies between transcripts, some RNAs contain only a single editing site whereas in others up to
50% of the As are modified (Rueter and Emeson, 1998). This ‚’hypermutation type’ of editing
has been observed in RNAs encoding the matrix protein of measles virus (Bass et al., 1989;
Cattaneo, 1994) and in RNAs of other viruses (Hajjar and Linial, 1995; Kumar and Carmichael,
1997; Murphy et al., 1991; O'Hara et al., 1984). Non-viral examples are the Drosophila 4f-rnp
gene which encodes a RNA-binding protein of unknown function (Petschek et al., 1996) and
transcripts encoding a voltage-dependent potassium channel from the squid Loligo peali (Patton
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et al., 1997). Because I pase pairs with C during reverse transcription, A to I deaminations are
identified as A to G changes when comparing genomic and cDNA sequences. I is read as G by
the translational machinery (Basilio et al., 1962), therefore A to I editing in pre-mRNAs can
change codons and their amino acid specificity in the mature mRNAs.
Analyses of editing sites in mammals and viruses showed that the substrate RNAs formed
double-stranded (ds) structures with bulges and loops (Egebjerg et al., 1994; Higuchi et al.,
1993; Rueter et al., 1999). The dsRNA is usually formed between exonic and intronic sequences
named ECS (editing site complementary sequence, Fig. 2.4; Burns et al., 1997; Herb et al., 1996;
Higuchi et al., 1993; Lomeli et al., 1994; Rueter et al., 1999). Mutations disrupting the base
pairing lead to a decrease or complete loss of editing while compensatory mutations that restored
base pairing also restored editing (Higuchi et al., 1993; Rueter et al., 1995). The structure of the
pre-mRNA rather than its primary sequence was suggested to determine editing sites (Bass,
1997). A 5’-neighbour preference of A, U and C and a disfavour for A close to the 3’-end of a
duplex region have been identified (Polson and Bass, 1994).
Pre-mRNAs coding for subunits of the glutamate-gated ion channels (GluRs) expressed
in the mammalian brain were the first physiological substrates identified that undergo site-
specific A to I editing (reviewed in Seeburg, 1996; Seeburg et al., 1998). The major excitatory
neurotransmitter in the central nervous system (CNS) L-glutamate activates the three distinct
receptor families NMDA (N-methyl-D-aspartate), AMPA (a-amino-3-hydroxy-5-methyl-4-
isoxazolpropionic acid) and kainate receptors. The pentameric receptors are assembled from 18
sequence-related subunits, five of which undergo pre-mRNA editing at up to three sites
(Seeburg, 1996; Seeburg et al., 1998). A physiologically important editing event occurs at the
Q/R site of the AMPA receptor subunit GluR-B (Higuchi et al., 1993; Sommer et al., 1991). The
arginine residue resulting from editing is located in a pore forming domain and is responsible for
the reduced permeability to Ca2+ ions of AMPA receptors containing this subunit. Another site
that is edited in the GluR-B pre-mRNA is the R/G site. Other pre-mRNAs in the CNS that are
selectively edited are serotonin receptor 5HT2C pre-mRNA (Burns et al., 1997), voltage-gated
calcium and sodium channels (Hanrahan et al., 2000; Smith et al., 1996) and a glutamate-gated
chloride channel in Drosophila (Semenov and Pak, 1999). Serotonin receptors transmit signals
via G-proteins and subsequent stimulation of phospholipase C, thereby also regulating synaptic
transmission. Pre-mRNAs coding for the serotonin receptor 5-HT2C are edited at four sites. The
fully edited receptor has a 10-15 fold reduction in the efficacy of receptor G-protein interaction
(Burns et al., 1997). In a screen for novel small non-coding RNAs, a brain-specific C/D box
snoRNA was identified that has complementarity to the serotonin receptor 5-HT2C mRNA
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covering two of the four editing sites (Cavaille et al., 2000). Interestingly, the mRNA nucleotide
potentially targeted for methylation by this snoRNA is one of the four edited adenosines.
Therefore, it was suggested that editing and alternative splicing of serotonin receptor 5-HT2C
mRNA could be regulated by the binding of the snoRNA. A to I editing in the antigenomic RNA
of the Hepatitis Delta Virus (HDV) changes a stop codon (UAG) to a tryptophan codon (UIG),
thereby controlling the production of two protein variants, each of which has an important role
during the viral life cycle (Polson et al., 1996; Polson et al., 1998). The shorter (unedited) form
of the protein is needed for replication whereas the longer (edited) form promotes packaging of
the viral genome.
** *o
** *o
** *o
ADAR1
RED2
ADAR2
1254
701
746
identity: 33%
similarity: 56%
R-enriched
domain
RG-
enriched
domain
Za Zb NLS
Figure 2.3  Protein domain structure of mammalian adenosine deaminases acting on RNA (ADARs).
The enzymes contain a deaminase domain (green) with three Zn2+-chelating residues (asterisks) and a glutamate
mediating proton transfer during catalysis (circle), two or three dsRNA binding domains (dsRBDs; blue) and a
bipartite nuclear localization signal (NLS; red). The size of the proteins is indicated at the C-terminus by the number
of amino acids. The amino acid relationship is shown as percentage identity and similarity (adapted from (Gerber
and Keller, 2001).
Pre-mRNA editing is catalyzed by adenosine deaminases acting on RNA (ADARs; Bass
et al., 1997). In humans, three members of this family have been identified: ADAR1, ADAR2
and RED2/ADAR3. ADAR1 and ADAR2 are ubiquitously expressed (Wagner et al., 1990) and
can convert A to I in long dsRNAs and at specific sites in pre-mRNAs (reviewed in Gerber and
Keller, 2001; Keegan et al., 2001; Keller et al., 1999; Maas and Rich, 2000b). Ubiquitous
expression goes along with the observation that I is found in mRNAs of all tissues with highest
level in brain mRNAs (Paul and Bass, 1998). ADARs do not require cofactors to deaminate A to
I. The enzyme binds to the pre-mRNA substrate via its dsRNA binding domains (RBDs, Fig.
2.4) which contribute to the identification of the editing site (Yi-Brunozzi et al., 2001). However,
the main deteminant for substrate specificity of ADARs is found within the deaminase domain.
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Protein chimaeras between ADAR1 and ADAR2 where the deaminase domain was exchanged
showed that this domain has an important role in defining substrate specificity (Wong et al.,
2001). Several isoforms of the ADAR1 and ADAR2 have been described which also vary in
their editing activity (Gerber et al., 1997; Lai et al., 1997; Liu et al., 1997). ADAR1 and ADAR2
have distinct but overlapping substrate specificity and do not need cofactors in contrast to
APOBEC1. ADAR2 edits the Q/R site in GluR-B pre-mRNA, whereas ADAR1 edits the intronic
hotspot 1 site. Both enzymes deaminate A to I at the R/G site (reviewed in Keller et al., 1999;
Maas and Rich, 2000b). ADAR2 can edit its own pre-mRNA, thereby generating an alternative
splice site (Rueter et al., 1999). The edited mRNA includes a 47 nt cassette that changes the
reading frame leading to a 82 amino acid protein. Instead translation starts at the second
methionine and generates an enzyme that is catalytically active in vitro. However, only low
amounts of this ADAR2 isoform are detectable, probably due to instability of the protein or
inefficient translation initiation. ADAR2 pre-mRNA self-editing could serve as a negative
autoregulatory mechanism which prevents ADAR2 overexpression and avoids editing at aberrant
sites. RED2/ADAR3 is expressed only in the brain and so far no substrate has been identified
(Chen et al., 2000; Melcher et al., 1996). D. melanogaster has a single ADAR protein (Palladino
et al., 2000a), whereas  C. elegans encodes two ADARs (Hough et al., 1999). ADARs have a
common domain organization: one to three dsRNA binding domains (dsRBDs) are followed by a
C-terminal catalytic deaminase domain with three conserved deaminase motifs (Fig. 2.3). The
extended N-terminal region of ADAR1 contains two Z-DNA binding domains the function of
which is not known (Schade et al., 1999). Recently, the nuclear localizatin signals (NLS) of
human and Xenopus ADAR1 were mapped. In Xenopus ADAR1 a short basic region upstream of
the dsRBDs was sufficient for nuclear import whereas the homologous sequence in human
ADAR1 does not display NLS activity (Eckmann et al., 2001). In human ADAR1 the NLS
overlaps with the third dsRBD, however nuclear import does not depend on RNA binding,
showing a dual function for this domain.
Figure 2.4  Schematic representation of the substrate recognition by ADARs (from Gerber and Keller, 2001).
ADARs recognize double-stranded RNA that is formed between the editing site and the ECS (editing site
complementary sequence, shown as white box) that is often located in a downstream intron. The enzyme binds to
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the pre-mRNA through its double-stranded RNA binding domain (shown in red) and deaminate a specific adenosine
to inosine by the deaminase domain (green).
ADAR1 and ADAR2 genes were knocked out in mice and a null mutant of the
Drosophila ADAR has been characterized. Surprisingly, flies are viable without ADAR and they
developed normally (Palladino et al., 2000b). However, the mutant flies showed strong
behavioural deficits including locomotion and mating defects and tremors that increase in
severity with age. Large lesions in the brain and a disorganized retina were observed, however
the flies had an almost normal lifespan. Heterozygous mice for ADAR2 were normal,
homozygotes had a normal embryonic development but died from postnatal day P0 to P20
(Higuchi et al., 2000). The adar2-/- phenotype could be rescued with a GluR-B allele that already
encoded the edited position at the Q/R site and was thus independent of editing. This experiment
showed that the Q/R site is the physiologically most important ADAR2 editing site. ADAR1+/-
mice died before embryonic day 14 and had defects in erythropoiesis (Wang et al., 2000). A
heterozygous embryonic lethal phenotype is very rare, therefore a dominant-negative effect of
the truncated ADAR1 cannot be excluded. In addition, viable ADAR1+/- mice could be generated
by another group, but the homozygotes died during embryonic development (reviewed in
Keegan et al., 2001). The differences between these results might be due to the different
constructs that were used to generate the transgenic mice.
RNA editing generates diversity in proteins that are encoded by a single locus. RNA
editing was also suggested to be involved in several diseases either by the lack of or aberrant
editing. Sodhi et al. (2001) showed that schizophrenia patients have reduced editing of the
serotonin 5-HT2C receptor transcripts. Another study showed elevated levels of editing in people
who have committed suicide (Niswender et al., 2001). Underediting of GluR-B mRNA,
alterations in serotonin receptor 5-HT2C mRNA editing and alternative splicing were found in
malignant human brain tumors (Maas et al., 2001). These results suggested a role for RNA
editing in tumor progression and might explain the occurrence of epileptic seizures in association
with malignant gliomas. Alterations in the level of editing at the Q/R site in GluR-B pre-mRNA
was reported in patients with Alzheimer disease, Huntington disease and schizophrenia
(Akbarian et al., 1995). A to G and C to U changes have been found in HIV-1 (human
immunodeficiency virus 1) transcripts of chronically infected cells (Bourara et al., 2000),
however it is not clear whether these changes are the result of RNA editing or error-prone
reverse transcription (Berkhout et al., 2001). More research will be required to elucidate whether
RNA editing is indeed involved in all these diseases.
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2.4 Modifications in tRNAs
2.4.1 General aspects
tRNAs are transcribed into long RNA units that are enzymatically trimmed to yield a functional
tRNA (Deutscher, 1984). In bacteria, polycistronic as well as monocistronic precursors are
present whereas in eukaryotes the majority of the primary transcripts are monocistronic. In both
eukaryotes and bacteria, modifications occur at different stages during the processing of the
precursor tRNA. In bacteria, several modifications occur in polycistronic precursors. Some
modified nucleotides inhibit the RNAse P reaction which generates the mature 5’ end of the
tRNA suggesting that this cleavage step occurs early in the tRNA maturation process and
precedes modification (Schaefer et al., 1973). Thus, on one hand, results show that modification
can occur on a molecule of mature size and that some endonucleolytic steps may take place
before modifications. On the other hand, when available, precursor molecules may be used as
substrate for the modifying enzymes. Therefore, tRNA modification is a function of the
processing stage, the concentration of the substrate and the amount and activity of the tRNA-
modifying enzyme.
The function of a modification in a tRNA may depend on its position and is not
necessarily conserved for a given modified nucleotide. The occurrence of a modification does
not necessarily correspond to a necessity in terms of biological functions, because to be modified
or not is determined by the specificity of the modifying enzyme and therefore the modification
my occur in more tRNAs than are really essential. Modifications in the anticodon arm affect
translational efficiency and specificity indirectly by modulating anticodon arm conformation
which can affect the tRNA:mRNA complex structure and stability. These modulations can
increase translational efficiency and prevent frameshifting. Structural alterations far from the
anticodon are known to change the structure of the anticodon and thereby also influence the
decoding ability of the tRNA. However, it has been difficult to obtain results demonstrating a
function of modified nucleosides outside the anticodon region. Several modified nucleotides are
present in the same subset of tRNAs in all organisms, suggesting that their occurrence was an
early evolutionary event. Most if not all tRNA-modifying enzymes are position specific and
some modifications are catalyzed in several steps requiring several enzymes. Usually, enzymes
have evolved to recognize one specific substrate and to disregard other molecules similar to the
substrate.
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Escherichia coli encodes 86 tRNA genes which represent 40 different tRNA species. If
the average size of a gene is assumed to be 1 kb, the synthesis of all tRNA-modifying enzymes
in E. coli requires 1% of the bacterial genome. Assuming the average size of the a tRNA gene in
E. coli to be 150 nucleotides with mature tRNAs 75-95 nucleotides in length, the genetic
information devoted to the synthesis of the primary tRNA transcripts is about 12 kb, which
represents about 0.25% of the genome of E. coli. Thus, in bacteria, at least four times more
genetic information is devoted to the synthesis of the tRNA-modifying enzymes than to the
synthesis of their substrates.
Almost 30 different modified nucleotides have been identified in E. coli tRNAs which are
almost exclusively found in single-stranded regions of the tRNA (Fig. 2.5). All tRNA species
contain Y55, m5U54 and the unmodified U33 and modifications at positions 34 and 37 are frequent.
Some modified nucleotides (Y, s4U, D) are found in more than one position of the tRNA and in
several cases a certain modification is found in only one tRNA species (Fig. 2.5). The function of
a particular modification does not have to be essential for all the tRNA species it is part of, but
depends on the position in the tRNA and on the tRNA species (table II). A great variety of
modified nucleotides is observed at positions 34 (wobble position) and 37. Modifications at the
wobble position can directly affect translation by altering the pattern of hydrogen bond donors
and acceptors. Many modifications also affect wobbling by altering nucleoside conformation.
Certain of these modifications increase wobbling, while others restrict it. Specific modifications
can therefore be either determinants or antideterminants for the translation of specific codons.
Position 37 is virtually always a purine and is usually modified. These modified bases may
stabilize cognate anticodon:codon interaction, primarily through increased base stacking (Jukes,
1973; Nishimura, 1972). Increased stability of the codon:anticodon pairing is associated with
increased translational efficiency and in some cases with enhanced reading frame maintenance.
Modifications may also prevent base 37 from pairing with the message (Pieczenik, 1980). In no
cytoplasmic tRNA is an unmodified A or U present at position 34 and a pattern can be seen for
modifications at this position. tRNAs with a certain modified nucleotide read certain codons and
some modifications restrict wobbling whereas others extend wobbling (see chapter 2.4.3).
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8
13
16
21
17
18
20A
20
9
32
34
37
38
39
46
40
54
47
55
65s4U (2)
s4U (26)
D (16)
Y (1, E)
Gm (12)
D (26) D (1, C)
acp3U (8)
D (14)
m5U (40)
Y (2)
Y(40)
Y (5)
m7G (22)
Y (3)
D (14)
m2A (6)
m6A (1, V)
i6A (1, Sec)
ms2i6A (8)
m1G (7)
t6A (7)
m6t6A (1, T)
A (10)
Y (11)
U* (1, G)
cmo5U (4)
mcmo5U (?)
mnm5U (1, R)
mnm5Um (1, L)
mnm5s2U (3)
mnm5Se2U
ac4C (1, M)
k2C (1, I)
I (1, R)
Q (5)
G (12)
C (9)
U (1, Sec)
Y (3)
Um (4)
Cm (5)
s2C (4)
Figure 2.5  Location of modified nucleotides in tRNAs from E. coli (adapted from Björk, 1996).
Shaded positions are those at which modified nucleotides are present. Figures within parentheses show the number
of tRNAs having the indicated modified nucleotide. If this modification is found in only one tRNA, the amino acid
specificity of that tRNA is also shown (one-letter code; Sec denotes selenocysteine). U* indicates an unidentified
modification.
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Table II  Modifications in tRNAs from E. coli
Abbreviations to the left of the nucleoside symbol denote modifications of the base, whereas a symbol to the right of
the nucleoside symbol denotes modification of the ribose. An index and an exponent indicate the number and the
position of the substitution, respectively.
Modification Name Function
m2A 2-methyladenosine
m6A N6-methyladenosine may strengthen base-pairing between pos. 36 of
anticodon and first position of codon, may
prevent A36 from base-pairing other than U
i6A N6-isopentenyladenosine
ms2i6A 2-methylthio-N6-pentenyladenosine decodes UNN  codons, stabilization of
anticodon:codon interactions, effectively
compensating for the weak A:U base pair
t6A N6-threonylcarbamoyladenosine  modification may stabilize U:A base pair at
the first codon position, positive determinant for
IleRS
m6t6A N6-methyl-N6-threonylcarbamoyladenosine  may prevent misreading at the first position
with a U:G base pair
s2C 2-thiocytidine may increase efficiency of codon:anticodon
formation
ac4C N4-acetylcytidine reduces reading of AUG codons, decreases
misreading of noncognate AUA codons
k2C lysidine prevents misacylation, changes base-pairing
abilitiy of C to recognize only A
Cm 2’-O-methylcytidine pos. 32: restricts nucleotide flexibility
pos. 34: restricted wobbling with tRNAMet
D dihydrouridine establishing correct conformation for
aminoacylation?
Gm 2’-O-methylguanosine ?
m1G 1-methylguanosine methyl group  prohibits base pairing with
Watson-Crick geometry, might prevent out-of-
phase reading with shifted or expanded
anticodon
methyl group may increase base stacking
m7G 7-methylguanosine ?
I inosine increase codon:anticodon pairing possibilities
Q queuosine minor effects on decoding of U and C
s4U 4-thiouridine pos. 8: acts as sensor for near-UV light and
protects cells from such stress, prevents
expression of SOS response and thus reduces
mutagenesis
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expression of SOS response and thus reduces
mutagenesis
Y pseudouridine different functions depending on the position of
Y in the tRNA:
pos. 32: ?
pos. 34, 35: increases translational efficiency
by stabilizing anticodon:codon pairing
pos. 38-40: increases translational efficiency,
especially at pos. 38
Um 2’-O-methyluridine ?
cmo5U uridine 5-oxyacetic acid enhance wobbling, tRNAs read A, G and U
mcmo5U uridine 5-oxyacetic acid methyl ester
mnm5U 5-methylaminomethyluridine
mnm5Um 5-methylaminomethyl-2-O-methyluridine restricts wobbling, tRNAs read A > G
mnm5s2U 5-methylaminomethyl-2-thiouridine
mnm5Se2U 5-methylaminomethyl-2-selenouridine
acp3U 3-(3-amino-3-carboxypropyl)-uridine ?
m5U ribosylthymine stabilizes tRNA structure, decreases errors and
increases A-site binding
U* unknown modification ?
2.4.2 Role of modified nucleotides in aminoacylation
Amino acids are attached to tRNAs by aminoacyl-tRNA synthetases. Each of the 20 aminoacyl-
tRNA synthetases in a cell must distinguish its own set of isoacceptor tRNAs from the many
noncognate tRNAs to catalyze the covalent attachment of the correct amino acid to the 3’ end of
only these species. Ultimately, the fate of the cell rests on this interaction, as there are no
subsequent proof-reading steps in protein synthesis whereby the amino acid is matched against
the anticodon to ensure that the proper amino acid is inserted in response to a given codon. The
research of the last 25 years on tRNA recognition allows to summarize a few general recognition
patterns. Major identity elements for aminoacyl-tRNA synthetases are nucleotides in the
anticodon and in the distal part of the acceptor arm. However, the relative importance of these
two widely spaced tRNA domains varies greatly among different tRNA species. In E. coli
tRNAMet the anticodon contains the major recognition elements (Schulman and Pelka, 1988;
Stern and Schulman, 1977) whereas in E. coli tRNAAla the acceptor arm alone constitutes the
recognition site for alanyl-tRNA synthetase (AlaRS; Hou and Schimmel, 1988; McClain and
Foss, 1988). Between these two extremes lie the majority of tRNAs which harbor nucleotides
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important for their identities in both these tRNA domains. The delineation of the entire set of
identity elements for a given tRNA proved to be difficult because many regions of the tRNA
playing no role in recognition could serve to block aminoacylation by competing aminoacyl-
tRNA synthetases. Thus, the number of potential identity elements is very large, perhaps most of
the nucleotides in a tRNA.
Most modified nucleotides in tRNA may not be essential for the aminoacylation reaction
(Björk, 1992). However, nucleotides in the anticodon are important identity determinants for
many aminoacyl-tRNA synthetases. In vitro transcription of tRNAs allowed a direct comparison
between native and unmodified tRNA. Such comparisons of the kinetics of the aminoacylation
reactions with cognate and noncognate aminoacyl-tRNA ligases revealed that of 14 different
unmodified tRNAs, all except three E. coli tRNAIle1, tRNAGlu and tRNALys accept the cognate
amino acid (Sylvers et al., 1993; Tamura et al., 1992). Thus, modified nucleotides are not a
prerequisite for most aminoacylation reactions in vitro. However, in all cases but one (E. coli
tRNAAsp) the cognate interactions with the unmodified species have kinetic characteristics that
are different from those of the fully modified species. It was shown that modifications at
positions 8, 26, 32, 38, 39, 40, 46, 47, 54 and 55 play no significant role in aminoacylation of the
tRNA.
Two isoleucine isoacceptors tRNAIle1 and tRNAIle2 (minor species) are present in E. coli.
These tRNAs contain G34 and k2C34 as the wobble nucleotide, respectively (Muramatsu et al.,
1988b; Yarus and Barrell, 1971). Although these two nucleotides are quite different, isoleucyl-
tRNA synthetase (IleRS) recognizes both species. When k2C34 is replaced with C34, the tRNAIle2
anticodon is changed to the tRNAMet anticodon CAU (Fig. 2.6). Such a mutant tRNA is
efficiently misacylated with methionine (Muramatsu et al., 1988a). The k2C34 modification acts
thus as a positive identity element for IleRS and as an antideterminant for MetRS preventing
deleterious misacylation. S. cerevisiae also has two isoleucine acceptors, a major tRNAIle with
the anticodon IAU and a minor tRNAIle with the anticodon Y A Y (Pixa et al, 1984;
Szweykowska-Kulinska, 1994). Both nucleotides at the wobble position, I and Y, contribute
significantly to the efficiency of aminoacylation (reviewed in Pallank et al., 1995).
Chemical modification of mnm5s2U34 present in tRNAGln, tRNAGlu and tRNALys
significantly reduced amino acid acceptance of these tRNAs (Kern and Lapointe, 1979;
Saneyoshi and Nishimura, 1971; Seno et al., 1974). Several studies showed that the mnm5 group,
but not the s2 group is a positive determinant for LysRS, GluRS and GlnRS from E. coli
(reviewed in Björk, 1995). This was confirmed by the crystallographic structure of the GlnRS-
tRNAGln complex which showed a direct interaction between mnm5s2U34 and the aminoacyl-
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tRNA ligase (Rould et al., 1989). Unmodified tRNALys which lacked all modifications, among
them mnm5s2U34, had a 140-fold lower lysine acceptance activity compared with native tRNALys
(Tamura et al., 1992) and is thus one of the few exceptions where aminoacylation depends on
modified nucleotides.
2.4.3 Modified nucleotides in translation
Cellular physiology is fundamentally dependent on the functions of our translational apparatus
and these functions are dependent on modified nucleotides. Modifications at position 34 are
frequent, some have obvious effect on the decoding spectrum by altering the array of H-bonding
groups. In other cases, modifications alter the relative affinities for codons by altering anticodon
loop structure. In addition, message sequences near codons (codon context) can also affect
decoding efficiency and accuracy. Aminoacylated tRNAs also undergo conformational changes
during ribosomal selection and those changes can depend on tRNA sequences far from the
anticodon. Codon choice is highly correlated with the relative abundance of the corresponding
tRNAs (Ikemura, 1985). In S. cerevisiae, genes expressed at high levels strongly prefer
synonymous codons that are transcribed by major isoacceptor tRNAs (Bennetzen and Hall,
1982).
Position 34 (wobble position)
Uridine at the wobble position is almost always modified and the nature of the modification is
correlated with the base(s) read. Crick (1966) predicted that U should only read A and G.
However, tRNAs with unmodified U occur in mitochondria and Mycoplasma and those tRNAs
read codons ending with all four bases (Andachi et al., 1989; Osawa et al., 1992; Sibler et al.,
1986). This might be due to a limited number of tRNA species in these organelles and organisms
and a translational system that has been greatly reduced. Codon family boxes that encode two
different amino acids have to be read by tRNAs with a modified U at position 34 to avoid
translational errors (Fig. 2.6). The A- and G-ending codons of the split codon boxes are
frequently read by tRNAs with xm5U34 modifications (mnm5U34, mcm5U34, mnm5Um34,
mnm5s2U34, mnm5Se2U34, Um34). Because these modifications should not read pyrimidine-ending
codons, they contribute to restricted wobbling. However, there is evidence that these tRNAs
might also be inefficient in reading G-ending codons because in many cases a tRNA with C34 is
present and xm5s2U34 was shown to prefer A-ending codons over G-ending codons in vitro (Agris
et al., 1973; Lustig et al., 1981). Furthermore, E. coli tRNAArg4 decodes AGA better than AGG in
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vivo (Spanjaard et al., 1990). Interestingly, lysine and glutamate have single tRNAs to decode
their respective codons in E. coli (Fig. 2.6). In these cases greater tRNA:mRNA stability of
xm5U34:A is correlated with codon usage. Highly expressed gene strongly prefer the A-ending
over the G-ending codon (Dalphin et al., 1997). In a minor tRNAIle from yeast pseudouridine is
present at position 34. This tRNA reads the codon AUA and probably does not frequently read
the AUG methionine codon. Thus, Y34 restricts wobbling. Restricted wobbling can also be
achieved with unmodified U34. It was shown that reading of GGN glycine codons by a tRNA
with unmodified U34 depended on the presence of C32. When C32 was mutated, the decoding was
strongly restricted to A>G>>U and C (Lustig et al., 1993).
Amino acids that are encoded by family boxes are decoded by at least two tRNAs. One of
the tRNAs has G34 and should read codons ending in C and U. In eukaryotes, A- and G-ending
codons are read by tRNAs that have xm5U34 and C34, respectively. Inosine 34-containing tRNAs
are common in eukaryotes and read codons ending in C and U and in S. cerevisiae also A-ending
codons (Percudani, 2001). Bacteria use tRNA with a xo5U34 modification (cmo5U34, mcmo5U34)
to read codons within family boxes but not in split boxes (reviewed in Yokoyama and
Nishimura, 1995). Because tRNAs with xo5U34 decoded triplets ending in A, G and U (Ishikura
et al., 1971), the xo5 adduct facilitates wobbling. By enhanced wobbling, the xo5U34
modifications might increase translational efficiency.
Several tRNAs contain modified C34. Cm34 allows the reading of G-ending codons, but
some tRNAs with this nucleotide can also recognize A-ending codons. However, there are cases
for which Cm:A decoding would result in translational errors (Fig. 2.6). In many eukaryotes and
archaea  tRNAMet has Cm34. These tRNAs should only read AUG because AUA is an isoleucine
codon. Because the apparent decoding specificity of Cm appears to vary among genetic systems
and tRNAs, other unknown features of tRNAs must strongly contribute to specificity. The
isoleucine codon group is unique in that it includes three (AUU, AUC and AUA) of the four
codons in a family box, but it does not include the AUG methionine codon (Fig. 2.6). In
eukaryotes, the isoleucine codons AUC and AUU are read by the inosine-containing tRNA
whereas AUA is read by the tRNA with the complementary anticodon UAU. In bacteria,
organelles and certain archaea, the isoleucine codons are read by two tRNAs. One contains G34
for reading AUU and AUC and the other contains C34 modified with lysidine (or a derivative) to
read AUA. Apparently, the k2C34 modification switches base pairing specificity from G to A.
Isoleucine codons might not be read with tRNAs containing a modified U34 because the
repertoire of modifications might not include nucleotides that can prevent the decoding of AUG
by isoleucine tRNAs.
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Figure 2.6  The universal genetic code
Many bacteria and eukaryotes use tRNAs with Q34 to read NAY codons (Sprinzl et al.,
1998). This modification does not directly affect the base pairing of G, though it might slightly
alter the relative affinities of the base for C and U. An E. coli mutant lacking Q34 in tRNAs for
Tyr, His, Asn and Asp did not show a major growth defect suggesting that codons read with Q34
could also be read with G34 (Noguchi et al., 1982). Because the NAY codons all occur within
split boxes, it is important that these tRNAs do not read A- and G-ending codons (Fig. 2.6). It is
not clear whether Q34 prevents such misreading.
The elongator tRNAMet is the only tRNA in E. coli that contains ac4C34. This suggests a
unique function of the acetyl group in this tRNA. Upon removal of the ac4 group by bisulfite, the
tRNA gained the ability to misread the isoleucine codon AUA and also became more efficient in
recognizing the cognate codon AUG (Stern and Schulman, 1978). Thus, ac4 decreases the
efficiency to read both the complementary AUG codon and the noncomplementary AUA codon.
Cm34 occurs in most eukaryotic and prokaryotic tRNATrp and UUG-reading tRNALeu species. E.
coli tRNALeu5 with the anticodon CmAA recognizes the Leu codons ending in A and G, but not
Introduction
24
in U and C. The recognition of A-ending codons is much weaker than that of G-ending codons
(reviewed in Yokoyama and Nishimura, 1995). The modified cytidines Cm and ac4C have the
common feature of conformational rigidity and an unusual stability of the C3’-endo form of the
ribose.
Inosine at position 34 occurs in eukaryotes and bacteria and a detailed discussion about
the function of I34 in translation can be found in chapter 5.
Position 37
The nucleotide at position 37 is highly correlated with the base at position 36 (Yarus, 1982). The
anticodon plus the nearby sequence features (the extended anticodon) contains more coding
information than the anticodon alone and can perform more efficiently and accurately at the
ribosome. Position 37 is virtually always a purine and is usually modified (Fig. 2.5). tRNAs
reading codons starting with U or A have ms2i6A or ms2io6A and t6A or m6t6A at position 37,
respectively. The weak A36:U or U36:A interactions between position 36 of the anticodon and the
first position of the codon might be stabilized by these hypermodifications and prevent first-
position errors. If this is true, codons starting with C or G, which results in a strong G:C base
pairing, would not require any stabilizing modification at position 37. Indeed, unmodified A or
methylated G is found in this position of such tRNA subsets (reviewed in Björk, 1996).
Modifications at position 37 may prevent the tRNA from base pairing with the mRNA and also
from pairing across the anticodon loop. There is a strong correlation between potential Watson-
Crick base pairing within the anticodon loop of primary transcripts and base modifications that
would inhibit such pairing (Dao et al., 1994). It has been shown that a suppressor tRNATrp with
C32 and G38 had an extraordinarily low translational efficiency which could be relieved by
mutations at either position that disrupted the putative base pair across the anticodon loop (Yarus
et al., 1986). The many roles associated with modifications at position 37 might explain the
variety that is observed for modified nucleotides 3’ to the anticodon (Fig. 2.5).
The miaA protein catalyzes the first step in the synthesis of ms2i6A37, the 6-
isopentenylation. Since this adduct is required for subsequent modification steps, miaA mutants
have completely unmodified A37. In general ms2i6A37-deficient tRNAs were inefficient in
translation. Elongation rates were decreased and the average translational cycle was slowed
about fourfold in vivo (Ericson and Bjork, 1986). Furthermore, lack of ms2i6A37 also induced an
increase in codon context sensitivity (Bouadloun et al., 1986) and increased frameshifting about
two-fold (Schwartz and Curran, 1997).
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When a guanosine is present at position 37, it is always converted to m1G, suggesting that
an unmodified G is detrimental for the tRNA. m1G37 is found in tRNAs that read CUN (leucine),
CCN (proline) and CGN (arginine) codons of bacteria. The modification is predicted to have two
effects on decoding. First, the methyl adduct at the N1 position of G prohibits base pairing with
Watson-Crick geometry. This might prevent out-of-frame reading with a shifted or expanded
anticodon (Pieczenik, 1980). Second, because the 1-methyl group increases base hydrophobicity,
it may increase base stacking (Nishimura, 1972) which could increase decoding efficiency. Björk
et al. (1989) isolated a S. typhimurium mutant of the tRNA(m1G37)methyltransferase trmD
(trmD3) that was defective in the methylation of G37. This mutant grew 30% more slowly than
wild-type cells and the chain elongation rate was reduced. Three proline tRNAs that normally
contained m1G37 were found to frequently shift frame when C's were present successively in the
message. However, not all codons read by m1G37-containing tRNAs were equally affected by the
loss of the methylation. The leu attenuator which is sensitive to the rates of translation of four
consecutive leucine codons by m1G37-containing tRNAs is not deattenuated by the trmD3
mutation (Li and Bjork, 1995). This result suggested that the m1G group affects anticodon arm
structure and decoding function, but effect are highly dependent on the broader tRNA sequence
and on the codon. The presence of m1G37 affects the cognate anticodon-codon interaction by
increasing the aminoacyl-tRNA selection and the polypeptide chain elongation rate.
Modifications at other positions in the tRNA
Pseudouridines are found at positions 38, 39 and 40 (Fig. 2.5). Almost half of the tRNAs in E.
coli contain one or more of these modifications. NMR analyses showed that Y39 increased the
stability of the anticodon arm of E. coli tRNAPhe (Davis and Poulter, 1991). Generally,
pseudouridines at the 3’ side of the anticodon increase translational efficiency, maybe due to
stabilization of the anticodon region. Mutations in hisT fail to perform pseudouridylation at
positions 38-40. The histidine leader mRNA contains seven consecutive histidine codons that
were read inefficiently by tRNAHis lacking Y 38 and Y39 which resulted in a derepressed his
operon (Johnston et al., 1980). The growth rate of the hisT mutant was reduced by 30% in
minimal medium as was the polypeptide chain elongation (Palmer et al., 1983). Comparison of
the effect of Y deficiency of two amber suppressors which have Y at position 39 alone or at both
positions 38 and 39, respectively, suggested that the Y at position 38 (in the anticodon loop)
exerted in a codon-context independent manner a stronger influence on the activity of the tRNA
than Y in position 39 (Bossi and Roth, 1980; Hagervall et al., 1990). Y has a strong impact on
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the activity of the tRNA, and although Y in the stem increases the activity, this effect is less than
the effect exerted by Y in the loop.
Base 32 is always a pyrimidine and it is frequently modified (Fig. 2.5). Structurally, all
modifications occuring at this position are predicted to restrict nucleotide flexibility. There is
evidence that base identity at position 32 is important for translational efficiency. In E. coli s2C32
is present in tRNAArg2. In vitro translation of MS2 RNA with cell-free extracts from E. coli
resulted in the viral synthetase and the coat protein but also in several other polypeptides that
were the result of +1 or –1 frameshifting (Baumann et al., 1985). The addition of native tRNAArg2
in 15-fold excess inhibited the –1 frameshifting whereas the addition of tRNAArg2(C34) did not,
suggesting that tRNAArg2(s2C34) efficiently competed with the frameshifting tRNA at the
frameshifting site. Mutation of Cm32 in an amber suppressor reduced suppression efficiency
more than 10-fold (Yarus et al., 1986). Position 32 can also affect the decoding range of tRNAs.
An E. coli tRNAGly variant with unmodified U34 translated all four GGN codons if base 32 was
cytosine (Boren et al., 1993). When C32 was changed to U32 only GGA was efficiently decoded.
The molecular mechanisms for this effect is unknown, but might be related to the microstructure
of the anticodon loop.
Little is known about the functions of modified nucleotides outside the anticodon region. One of
the reasons might be that their effects on anticodon-codon interaction are minor and that the
methods employed to study other effects are not sensitive enough.
The tRNAs of a mutant (trmA) lacking m5U54 had a lower stability, increased error levels
and decreased A-site binding in vitro (Davanloo et al., 1979). Although m5U54 is not essential for
cellular growth, the gene (trmA) encoding the tRNA(m5U54)mehtyltransferase is essential
(Persson et al., 1992). This suggested that trmA has another function which is essential. A nuvA
mutant lacking s4U in the tRNA grew normally, but this modification was suggested to be a
sensor for near-UV light (Kramer et al., 1988; Thomas and Favre, 1980).
2.4.4 A to I editing in tRNAs
A variety of modified nucleotides are present in tRNAs, among them are inosine (I) and N1-
methylinosine (m1I) in eukaryotic tRNAAla (Curran, 1998; Holley et al., 1965). I is found at
position 34 (the wobble position of the anticodon) of seven yeast and eight tRNAs of higher
eukaryotes, whereas m1I is present exclusively in eukaryotic tRNAAla at position 37 (3’ adjacent
to the anticodon; (Sprinzl et al., 1998). These modifications proceed through hydrolytic
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deamination of A to I and subsequent methylation at position 37 (Fig. 2.7 A; Björk et al., 2001;
Grosjean et al., 1996b). Based on sequence homology, a Saccharomyces cerevisiae open reading
frame (ORF) with significant homology to the C-terminal part of ADARs was found. The
recombinant protein does not form I in GluR-B pre-mRNAs or extended dsRNA but specifically
converts A to I at position 37 in eukaryotic tRNAAla (Fig. 2.7 C; Gerber et al., 1998). The enzyme
was named scADAT1 (S. cerevisiae adenosine deaminase acting on tRNA 1) and its gene TAD1
(tRNA adenosine deaminase 1). The gene is not essential for cell viability and the function of
m1I37 is not known. However, in analogy to the function assigned to m1G37 found within several
tRNAs from the prokaryote Salmonella typhimurium, one possible function of m1I37 (a
modification similar to m1G37) could be the prevention of frameshifting and improvement of
translation fidelity (Björk et al., 1989; Qian and Björk, 1997). Recently, the human and
Drosophila melanogaster orthologues of scADAT1 were cloned and the recombinant enzymes
were shown to deaminate A to I at position 37 in tRNAAla (Keegan et al., 2000; Maas et al.,
1999). A majority of archaebacterial tRNAs contain m1I at position 57 (in the T loop). In contrast
to the formation of m1I37 in eukaryotes, the first enzymatic step in the in vitro formation of m1I57
in archael tRNAs was shown to be a methylation, followed by a deamination (reviewed in
Grosjean et al., 1996b). Neither I34 nor m1I37 have been identified in archael tRNAs.
In yeast, A34 is converted to I34 by the tRNA:adenosine 34 deaminase that is comprised of
Tad2p and Tad3p (scADAT2/scADAT3) which form a heterodimer (Gerber and Keller, 1999).
The C-terminal part of Tad3p is sequence related to Tad2p (Fig. 2.7 B). Interestingly, the two
proteins display a deaminase domain that resembles that of the cytidine deaminase (CDA)
superfamily, but in contrast to CDAs, Tad2p/Tad3p do not deaminate free cytidine or cytosine in
vitro  (Gerber and Keller, 1999). However, functionally Tad2p/Tad3p belong to the ADAR
family. The TAD2 and TAD3 genes are both essential for vegetative growth, underscoring the
biological importance of this editing event (Gerber and Keller, 1999). Crick (1966) postulated
that the first two bases of the codon pair are classical Watson-Crick basepairs. He predicted that
the third base of the anticodon (position 34) can basepair in a non-canonical way with different
nucleotides in the mRNA ("wobble hypothesis"). I34 was predicted to pair with the last position
of codons ending in C, U and A (Curran, 1995).
Database searches revealed a number of sequences with homology to Tad2p and Tad3p.
Prokaryotic genomes encode only polypeptides that are homologous to Tad2p (see chapter 3). In
order to characterize the tRNA:adenosine 34 deaminase from E. coli the Tad2 homologue was
cloned and the recombinant protein purified (see chapter 3).
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Figure 2.7  Deamination mechanism, protein domain structure of S. cerevisiae tRNA-specific adenosine
deaminases (Tads) and modifications in tRNAArg2 from E. coli and tRNAAla from S. cerevisiae.
A) Reaction mechansim of cytidine and adenosine deamination, respectively (from (Gerber and Keller, 2001). B)
The proteins contain a deaminase domain (green) with three Zn2+-chelating residues (asterisk) and Tad1p and Tad2p
contain a glutamate involved in proton transfer during catalysis. A putative nuclear localization signal in Tad2p is
shown in red.  C) Adenosine at position 34 is deaminated in both tRNAs (yellow box) whereas deamination at
position 37 by Tad1p and subsequent methylation is present only in eukaryotic tRNAAla (blue box). Modifications in
the two tRNAs are indicated.
2.5 Aims of this thesis
In S. cerevisiae the heterodimer catalyzing adenosine deamination at the wobble position of
tRNAs has been identified (Gerber and Keller, 1999). Although this enzymes has been partially
characterized, the isolation of bacterial and human tRNA-specific adenosine deaminases will
help to address several questions. (i) Does tRNA editing at the wobble position require
conserved proteins in E. coli? If yes, can the proteins from different organisms be exchanged?
(ii) E. coli has only one tRNA containing I34. Is the enzyme / are the enzymes catalyzing the
reaction essential? If yes, is the formation of I34 the essential process or could another reaction be
catalyzed by the same enzyme(s)? (iii) What determines substrate specificity and how do tRNA
editing enzymes recognize their substrates? What are the differences between eukaryotic and
prokaryotic tRNA recognition? (iv) How does I34 influence translational efficiency? (v) Where
does tRNA editing occur in eukaryotes?
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3.1 Abstract
We report the characterization of tadA, the first prokaryotic RNA editing enzyme to be
identified. E. coli tadA displays sequence similarity to the yeast tRNA deaminase subunit Tad2p.
Recombinant tadA protein forms homodimers and is sufficient for site-specific inosine formation
at the wobble position (position 34) of tRNAArg2, the only tRNA having this modification in
prokaryotes. With the exception of yeast tRNAArg no other eukaryotic tRNA substrates were
found to be modified by tadA. However, an artificial yeast tRNAAsp which carries the anticodon
loop of yeast tRNAArg is bound and modified by tadA. Moreover, a tRNAArg2 minisubstrate
containing the anticodon stem and loop is sufficient for specific deamination by tadA. We show
that nucleotides at positions 33 to 36 are sufficient for inosine formation in mutant Arg2
minisubstrates. The anticodon is thus a major determinant for tadA substrate specificity. Finally,
we show that tadA is an essential gene in E. coli, underscoring the critical function of inosine at
the wobble position in prokaryotes.
3.2 Introduction
The nucleotide inosine (I) has been observed in viral transcripts and eukaryotic mRNAs. In all
known cases, I is made by the deamination of adenosine, a process termed RNA editing. Because
I is read as guanosine by the translational machinery (Basilio et al., 1962), RNA editing can
change codon specificity and therefore the amino acid sequence of the encoded protein, resulting
in multiple protein products with different biological function from a single mRNA precursor. In
mammals for example, the messenger RNA precursors (pre-mRNAs) coding for subunits of
glutamate-gated ion channel receptors (GluRs) and the serotonin receptor subunit 5-HT2C are
edited (reviewed in Gerber and Keller, 2001; Gott and Emeson, 2000; Keegan et al., 2001; Maas
and Rich, 2000b; Seeburg et al., 1998). Editing was also detected in D. melanogaster, C. elegans
and in hepatitis delta virus (Hanrahan et al., 2000; Morse and Bass, 1999; Polson et al., 1996;
Semenov and Pak, 1999; Smith et al., 1996). RNA editing therefore represents an important
mechanism to increase the genetic diversity in eukaryotes. In all these cases, pre-mRNA editing
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requires double-stranded RNA (dsRNA) structures which are formed between exonic sequences
encompassing the editing site and downstream intronic sequences.
RNA editing of pre-mRNAs is catalyzed by adenosine deaminases acting on RNA
(ADARs; Bass et al., 1997). ADARs have a common modular organization consisting of two or
three double-stranded RNA binding domains (dsRBD) and a catalytic deaminase domain
containing three Zn2+-chelating residues and a proton-shuffling glutamate (reviewed in Bass et
al., 1997; Keller et al., 1999; Maas and Rich, 2000b).
Inosine is not only present in mRNAs but also in tRNAs. It was first found in tRNAAla
from yeast (Holley et al., 1965). Eukaryotic tRNAAla contains I at two positions, at the wobble
position of the anticodon (position 34) and as the derivative N1-methylinosine (m1I) at position
37, 3' adjacent to the anticodon (Holley et al., 1965; reviewed in Grosjean et al., 1996b). In
eukaryotes, seven to eight tRNAs contain I at position 34 whereas in prokaryotes and plant
chloroplasts only tRNAArg2 contains this modification. As in pre-mRNAs, I in tRNAs is the
product of hydrolytic deamination of genomically encoded adenosine (Auxilien et al., 1996). m1I
at position 37 is formed in a two-step reaction. First, A is deaminated to I which is further
methylated by a methyltransferase (Björk et al., 2001; Grosjean et al., 1996a). The genomes of S.
cerevisiae and prokaryotes do not encode classical ADAR proteins, but a yeast protein was
identified based on sequence homology to ADARs which contains a deaminase domain, but
lacks a known RNA-binding motif. This protein catalyzes the deamination of A at position 37 in
yeast tRNAAla and was therefore named adenosine deaminase acting on tRNA 1 and its gene
tRNA-specific adenosine deaminase 1 (scADAT1/TAD1; Gerber et al., 1998). Tad1p
specifically targets A37 in tRNAAla. Mutations affecting the three-dimensional structure of the
tRNA or the length of the anticodon loop abolish conversion of A to I in vitro (Gerber et al.,
1998). Whereas A37 is unmodified in a ∆tad1 strain, modification of A34 was unaffected in all
tRNAs tested, suggesting that I formation at these two positions is catalyzed by different
enzymes. Whereas I in the wobble position (I34) is crucial to allow the decoding of three codons
by a single tRNA (Crick, 1966), the function of m1I37 is less clear. It was postulated that this
modification may prevent translational frameshifts and improve translational fidelity (Björk et
al., 1989). ADAT1 proteins have also been cloned from human (Maas et al., 1999), mouse (Maas
et al., 2000a) and D. melanogaster (Keegan et al., 2000).
The tRNA adenosine deaminase which specifically deaminates A34 has been partially
purified from yeast extracts (Auxilien et al., 1996) and has been identified by homology to
Tad1p (Gerber and Keller, 1999). Activity depended on the correct tRNA structure as well as on
the length and the nucleotide sequence of the anticodon loop. The tRNA:A34 deaminase is a
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heterodimer of sequence-related subunits named scADAT2/Tad2p and scADAT3/Tad3p. Both
polypeptides contain a deaminase domain that resembles that of the cytidine deaminase (CDA)
superfamily (Gerber and Keller, 1999), although Tad2p/Tad3p deaminates adenosine. Most
cytidine/deoxycytidylate deaminases  catalyze deaminations of mononucleotides, but there are
also a few known cytidine deaminases that act on RNA (CDARs). One of the best studied
examples is APOBEC1 which catalyzes the deamination of a cytidine to uridine in the apoB
mRNA, resulting in a change of a glutamine codon to a stop codon (reviewed by Chester et al.,
2000). Interestingly, the deaminase domain of Tad3p lacks the glutamate which, in analogy to
CDAs and CDARs, is thought to be part of the active center. The lack of this glutamate suggests
that Tad3p is catalytically inactive and that Tad2p is the catalytic subunit of the complex.
Deamination of tRNA is not limited to eukaryotes but has also been detected in E. coli
extracts (Auxilien et al., 1996). In E. coli the only known A to I conversion in RNA is the
deamination of tRNAArg2 at position 34. Based on sequence homology, we identified an E. coli
protein homologous to Tad2p. Here, we report the identification and characterization of this
enzyme which is necessary and sufficient to catalyze this editing reaction. tadA/ecADAT2 shows
sequence homology to yeast Tad2p and Tad3p and is encoded by an essential gene, thus
underlining the vital function of I34. The identification of the first prokaryotic tRNA-specific
adenosine deaminase also provides further insight into the evolution of the deaminase family of
enzymes.
3.3 Results
tadA acts specifically on tRNAArg2
Database searches with the S. cerevisiae Tad2p sequence and the FASTA program (Pearson and
Lipman, 1988) revealed that the E. coli open reading frame (ORF) yfhC is 34% identical with
Tad2p (Fig. 3.1). To test whether yfhC indeed encodes an adenosine deaminase, the protein was
overexpressed in E. coli with an N-terminal GST tag and a C-terminal His6 tag and purified to
apparent homogeneity (Materials and methods; Fig. 3.2 A and B).
Peak fractions of the final gel filtration column were tested for adenosine deaminase activity on
in vitro transcribed and uniformally [a-33P]ATP-labelled tRNAArg2. The recombinant protein
indeed converted adenosine to inosine (Fig. 3.2 C). This activity stemmed from the recombinant
protein and not from an endogenous enzyme since GST purified from E. coli or eluates from Ni2+
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agarose incubated with extract from empty-vector transformed cells had no activity (results not
shown). 2 ng recombinant yfhC protein formed up to 0.5 mol I/mol tRNA (Fig. 3.2 C, fraction
12). No other protein was needed for activity since fraction 12 which lacks the contaminant
present in fractions six to eleven deaminated tRNAArg2 efficiently (Fig. 3.2 C, fraction 12). This is
in contrast to the yeast enzyme, which acts as a heterodimer composed of Tad2p and Tad3p
(Gerber and Keller, 1999).
E. coli   M R R A F I T G V F F L S E V E F S H E Y W M R H A L T L A K R A W D E R E V P V G A V L V H N N - - R V I G E G W N R  5 8
S. typhi   M P P A F I T G V T S L S D V E L D H E Y W M R H A L T L A K R A W D E R E V P V G A V L V H N H - - R V I G E G W N R  5 8
S. putrifaciens   M R V A M A M A E K A E A E G E V P V G A V L V K D G - - L Q I A T G Y N L  3 6
B. subtilis   M T Q D E L Y M K E A I K E A K K A E E K G E V P I G A V L V I N G - - E I I A R A H N L  4 3
H. influenza   M D A A K V R - - - - - - - S E F D - E K M M R Y A L E L A D K A E A L G E I P V G A V L V D D A R - N I I G E G W N L  5 1
C. crescentus   M G F R F L M R - - - T D E S E D Q D H R M M R L A L D A A R A A A E A G E T P V G A V I L D P S T G E V I A T A G N G  5 7
S. cerevisiae   M Q H I K H M R T A V R L A R Y A L D H D E T P V A C I F V H T P T G Q V M A Y G M N D  4 4
                         
* ◊ • ◊ ◊
E. coli   P I G R H D P T A H A E I M A L R Q G G L V M Q N - - - - Y R L I D A T L Y V T L E P C V M C A G A M I H S R I G R V V  1 1 4
S. typhi   P I G R H D P T A H A E I M A L R Q G G L V L Q N - - - - Y R L L D T T L Y V T L E P C V M C A G A M V H S R I G R V V  1 1 4
S. putrifaciens   S I S Q H D P C A H A E I L C L R A A G Q T V E N - - - - Y R L L D A T L Y V T L E P C A M C A G A M V H S R I A R V V  9 2
B. subtilis   R E T E Q R S I A H A E M L V I D E A C K A L G T - - - - W R L E G A T L Y V T L E P C P M C A G A V V L S R V E K V V  9 9
H. influenzae   S I V Q S D P T A H A E I I A L R N G A K N I Q N - - - - Y R L L N S T L Y V T L E P C T M C A G A I L H S R I K R L V  1 0 7
C. crescentus   P I A A H D P T A H A E I A A M R A A A A K L G N - - - - Y R L T D L T L V V T L E P C A M C A G A I S H A R I G R V V  1 1 3
S. cerevisiae   T N K S L T G V A H A E F M G I D Q I K A M L G S R G V V D V F K D I T L Y V T V E P C I M C A S A L K Q L D I G K V V  1 0 4
           
E. coli   F G A R D A K T G A A G S L M D V L H H - - - - - - - P G M N H R V E I T E G I L A D E C A A L L S D F F R M R R Q E I  1 6 7
S. typhi   F G A R D A K T G A A G S L I D V L H H - - - - - - - P G M N H R V E I I E G V L R D E C A T L L S D F F R M R R Q E I  1 6 7
S. putrifaciens   F G A R D E K T G A A G T V L N L L Q H - - - - - - - P A F N H Q V E V T S G V L A Q D C A D Q L S R F F K R R R E E K  1 4 5
B. subtilis   F G A F D P K G G C S G T L M N L L Q E - - - - - - - E R F N H Q A E V V S G V L E E E C G G M L S A F F R E L R K K K  1 5 2
H. influenzae   F G A S D Y K T G A I G S R F H F F D D - - - - - - - Y K M N H T L E V T S G V L A E E C S Q K L S T F F Q K R R E E K  1 6 0
C. crescentus   F G A D D P K G G A V V H G P K F F A Q - - - - - - - P T C H W R P E V T G G V L A D E S A D L L R G F F R A R R K A K  1 6 6
S. cerevisiae   F G C G N E R F G G N G T V L S V N H D T C T L V P K N N S A A G Y E S I P G I L R K E A I M L L R Y F Y V R Q N E R A  1 6 4
   
E. coli   K A Q K K A Q S S T D 1 7 8
S. typhi   K A L K K A D R A E G A G P A V 1 8 3
S. putrifaciens   K V L K Q A Q K V Q Q G 1 5 7
B. subitilis   K A A R K N L S E 1 6 1
H. influenzae   K I E K A L L K S L S D K 1 7 3
C. crescentus   I 1 6 7
S. cerevisiae   P K P R S K S D R V L D K N T F P P . . . 2 5 0
Figure 3.1  Bacterial genomes encode a protein (tadA) related to Tad2p of S. cerevisiae
Multiple sequence alignment of E. coli tadA, yeast Tad2p and putative tadA sequences from different bacteria.
Residues conserved in more than 83% of the proteins are shaded black, similar amino acids grey. The three putative
Zn2+-chelating residues (◊) and the glutamate thought to mediate proton transfer (•) are marked. The position of the
point mutation (D64E) in the tadA mutant NWL37 is indicated by an asterisk. The alignment was generated with the
ClustalW software at the European Bioinformatics Institute (Thompson et al., 1994).
To determine the site in tRNAArg2 that is modified by recombinant yfhC, in vitro modified
tRNA was amplified by RT-PCR and sequenced. Since I basepairs with C during reverse
transcription, A to I deamination changes the sequence from A to G. tRNAArg2 incubated with
recombinant yfhC contained a G at position 34, demonstrating that the template-encoded A at
this position was deaminated to I. tRNAArg2 incubated in the absence of protein carried A at
position 34 and therefore was not modified (Fig. 3.2 D). No other A in tRNAArg2 was modified by
the recombinant protein. These results showed that the yfhC gene encodes a protein which is
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sufficient to reconstitute A34:tRNA deaminase activity in vitro. Therefore, we renamed yfhC to
tadA (for tRNA adenosine deaminase A).
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Figure 3.2  tadA specifically deaminates A34 in tRNAArg2
SDS-polyacrylamide gel stained with silver (A), Western blot (B) and tRNA editing assay (C) of the final gel
filtration column of the purification of recombinant tadA.
20 µl aliquots of each fraction were separated on a 12% SDS-polyacrylamide gel (A) and transferred to a
nitrocellulose membrane for detection with antibodies (B). The Western blot was probed with a mouse a-GST
monoclonal antibody. Fraction numbers are indicated on the top, the molecular masses of the size standards in kDa
on the left.
C) 2 µl of the fractions indicated at the top were incubated with [33P]ATP-labelled tRNAArg2 for 30 min at 37˚C.
Reactions were treated with P1 nuclease and the products separated by one-dimensional TLC. The positions of
AMP,  IMP and the origin are indicated on the right. In the reaction indicated with -, tRNAArg2 was incubated with
buffer only.
D) Sequence analysis of in vitro modified tRNAArg2. The nucleotide sequence surrounding the anticodon is shown.
tRNA from reactions shown in (C) was amplified by RT-PCR and sequenced. The nucleotide at position 34 is
shaded grey,  the anticodon is underlined. Control: tRNAArg2 incubated with buffer only.
The substrate specificity of recombinant tadA was tested by comparing its activity on
various tRNA substrates (Fig. 3.3 A). In E. coli only one tRNA substrate is known which is
deaminated at position 34 (tRNAArg2) in contrast to S. cerevisiae where seven different tRNAs
are substrates for Tad2p/Tad3p (Auxilien et al., 1996; Gerber and Keller, 1999). Auxilien et al.
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(1996) showed that not only tRNAArg2, but also a variant of tRNAAsp from S. cerevisiae carrying
the anticodon loop of yeast tRNAArg is deaminated in vitro upon incubation with extracts from E.
coli. The latter observation could be reproduced with recombinant tadA which forms up to 0.8
mol I in this artificial tRNA, suggesting that the anticodon loop carries important recognition
signals for the enzyme (Fig. 3. 3A, lane 4). This hypothesis is supported by the result that tadA
deaminated yeast tRNAArg with the same efficiency as E. coli tRNAArg2 (Fig. 3.3 A, lanes 10 and
11). These two tRNAs have a conserved anticodon loop sequence (Fig. 3.3 B). However, parts of
the anticodon stem and the acceptor stem are also conserved between yeast and E. coli tRNAArg
and these nucleotides might also contribute to the recognition of the tRNA by tadA (Fig. 3.3 B).
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Figure 3.3  Substrate specificity of tadA
A) tRNA-editing assay with tadA and different tRNAs. tRNA substrates were incubated with either 2 ng
recombinant H6-tadA (lanes 2, 4, 6, 8, 10, 11), 20 ng recombinant scTad2p/scTad3p (lane 7) or 40 µg S. cerevisiae
total protein (lanes 1, 3, 5). 100 fmol tRNA-Ala from S. cerevisiae (lanes 1, 2), a tRNA-Asp mutant from S.
cerevisiae (lanes 3, 4), tRNA-Ala from B. mori (lanes 5, 6), human tRNA-Ala (lanes 7, 8), S. cerevisiae tRNA-Arg
(lanes 9, 10) and tRNA-Arg2 from E. coli (lane 11) were used. All reactions were incubated for 1 h at 30˚C and
processed as described in the legend to Figure 2 (see also materials and methods).
B) Cloverleaf structure of E. coli tRNAArg2, S. cerevisiae tRNAArg and S. cerevisiae tRNAAsp with the anticodon loop
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of tRNAArg. Completely conserved nucleotides and nucleotides conserved as purines or pyrimidines between tRNAs
from different species are shown in red (Klingler and Brutlag, 1993). Nucleotides that are conserved in addition
between the three tRNAs are depicted in blue.
C) UV-crosslinking experiments of recombinant tadA and different tRNAs. 400 ng GST-tadA (lanes 2-5) and 100
fmol [33P]ATP -labelled tRNA were irradiated and samples treated with RNaseA. Proteins were separated on a 12%
SDS polyacrylamide gel and gels exposed to a PhosphorImager screen.
E.c. – Escherichia coli, S.c. – Saccharomyces cerevisiae, B.m. – Bombyx mori, Arg2 – tRNAArg2, hAla – human
tRNAAla, B.m. Ala – B. mori tRNAAla, S.c. Ala – S. cerevisiae tRNAAla.
tRNAAla from S. cerevisiae, B. mori and H. sapiens are not deaminated by tadA, although
they are known to contain I34 in vivo (Fig. 3.3 A, lanes 2, 6 and 8). Notably, all these tRNAs are
substrates for yeast Tad2p/Tad3p (Fig. 3.3 A, lanes 1, 5 and 7; (Auxilien et al., 1996; Gerber and
Keller, 1999). In yeast and B. mori tRNAAla positions 34 and 37 are deaminated and 2 mol I/mol
tRNA are generated upon incubation with yeast extract (Fig. 3.3 A, lanes 1 and 5). The substrate
specificity of tadA could also be shown with UV-crosslinking experiments that indicate binding
of the protein to the tRNA substrate. Recombinant GST-tadA could be UV-crosslinked to its
natural substrate tRNAArg2 (Fig. 3.3 C, lane 2), but not to tRNAAla from H. sapiens, B. mori and S.
cerevisiae (Fig. 3.3 C, lanes 4, 5 and 6). GST alone could not be crosslinked to any of these
substrates (results not shown). In summary, we showed that recombinant tadA specifically
deaminates tRNAArg2 at position 34.
To determine whether the anticodon stem and loop is sufficient for deamination by tadA,
a tRNAArg2 minisubstrate containing only the anticodon stem and loop was tested in vitro (Fig.
3.4 A). This minisubstrate was deaminated as efficiently as full-length tRNAArg2 (Fig. 3.4 B, lane
1 and table III). Quantification revealed that 1.2-1.4 mol I/mol tRNA is formed with WT Arg2
minisubstrate in different experiments, suggesting that an additional A is deaminated. Although
the stem-loop of Arg2 serves as a substrate for tadA, there seem to be differences in site-
specificity between the full-length tRNAArg2 and mini Arg2. Sequences and structures outside the
anticodon arm might be important for deamination at the correct position. Interestingly, when A
at the wobble position was mutated to G the minisubstrate was not deaminated, indicating that
this nucleotide is essential for tadA recognition (Fig. 3.4 B, lane 2). In order to determine
nucleotides that are essential to specify these short RNAs as substrates for tadA, several mutant
minisubstrates were generated and tested in vitro. No I was formed with minisubstrates that have
mutations at position 35 or 36 in the anticodon (Figure 4B, lanes 3 and 4). This showed that
nucleotides in the anticodon were key determinants for tadA activity. The importance of the
anticodon loop size was investigated with a minisubstrate that has a 8 nt loop. This substrate was
still deaminated, but with a lower efficiency compared to the WT RNA (Figure 4B, lane 5 and
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table I) whereas a 3 nt loop was not sufficient for tadA activity (Figure 4B, lane 6). A
minisubstrate that has a random loop sequence but the correct anticodon was not deaminated,
showing that the anticodon is not the only determinant for tadA activity (Figure 4B, lane 7).
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Figure 3.4  RNA minisubstrates derived from E. coli tRNAArg2 and tRNAArg3 are sufficient for deamination by
tadA in vitro
A) Schematic drawing of Arg minisubstrates that were tested in vitro. Nucleotides shown in grey are mutated
compared to WT Arg2. A at the wobble position of the anticodon is shown in bold. Mutations in each minisubstrate
are indicated by arrows.
B) Editing assay with minisubstrates and tadA. 25-100 fmol minisubstrate, 100 ng recombinant Flag-tadA-H6 and
500 ng BSA were incubated in a total volume of 25 µl. WT Arg2 (lane 1), mutant 1 (lane 2), mutant 2 (lane 3),
mutant 3 (lane 4), mutant 4 (lane 5), mutant 5 (lane 6), mutant 6 (lane 7), mutant 7 (lane 8), mutant 8 (lane 9),
mutant 9 (lane 10), , WT Arg3 (lane 11) and mutant 10 (lane 12) were used. All reactions were incubated for 45 min
at room temperature and were processed as described in the legend to Figure 2 (see also material and methods).
Table III  tRNAArg2 minisubstrates
substrate mutations compared to WT mol I/mol RNA
Arg2 WT — 1.2-1.4
mut 1 A34G 0
mut 2 C35G 0.10
mut 3 G36C 0
mut 4 8 nt loop, U28G, A42C 0.50
mut 5 3 nt loop, 7 bp G-C stem 0
mut 6 U28G, C32U, U33C, A37C, A38U, A42C 0
mut 7 U28G, C32U, U33C, A37G, A38U, A42C 0
mut 8 U28G, C32U, A37C, A38U, A42C 0.26
mut 9 linear 0
Arg3 WT — 0
mut 10 C34A 1.39
When position 37 in mutant 6 was changed to G, I formation was not restored (Figure 4B,
lane 8). G at position 37 in the WT Arg2 minisubstrate did not affect tadA activity (results not
shown). However, reverting position 33 in mutant 6 to the wild-type U residue restored I
formation which was, however, not as efficient as with WT minisubstrate (Figure 4B, lane 9 and
table I). This suggests that U33 is an important determinant for tadA activity, but additional
nucleotides probably contribute to efficient deamination. To determine whether a stem-loop
structure in addition to the sequence is required for tadA activity, a linear minisubstrate was
analyzed (mutant 9, Figure 4A). Although mutant 9 contains the same essential nucleotides for
activity as mutant 7, the linear RNA was not deaminated (Figure 4B, lane 10), indicating that a
stem-loop structure is essential for tadA activity. As expected, the anticodon arm of E. coli
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tRNAArg3 was not a substrate for tadA (Figure 4B, lane 11) because this RNA does not contain A
at the wobble position (Figure 4A). However, I formation was detected in Arg3 when C34 was
mutated to A (Figure 4B, lane 12). This result provides further information about key nucleotides
for tadA activity. The anticodon stem of Arg3 differs from that of Arg2, indicating that
recognition of the stem by tadA is not sequence-specific (Figure 4A). In summary, a
minisubstrate with a stem-loop structure is deaminated at the wobble position of the anticodon if
the RNA has the sequence UACG within the loop. However, it cannot be excluded that other
regions of the tRNA are needed for efficient deamination. The results with the mutant
minisubstrates suggest that in addition to the correct sequence in the loop the structure and the
loop size but not the stem sequence are important for deamination by tadA.
A point mutation in tadA leads to an inactive enzyme in vitro
Next we asked whether tadA is responsible for inosine formation at position 34 of tRNAArg2 in
vivo and took advantage of a non-lethal point mutant described previously (Poulsen et al., 1992).
The mutant form of tadA carries a glutamic acid instead of an aspartic acid at position 64 (D64E;
Fig. 3.1). This amino acid is highly conserved in bacterial, but not in eukaryotic Tad2 proteins.
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Figure 3.5  The point mutation D64E abolishes
tadA activity in vitro.
Lane 1: no protein, lanes 2 to 4: 40 µg of total protein
of E. coli extract. All reactions were incubated 2 h at
37˚C and processed as described in the legend to
Figure 2 (see also materials and methods).
To determine whether deamination of A34 in tRNAArg2 is affected by this mutation in vivo,
total RNA was isolated from the mutant (NWL37) and the corresponding parental strain
(NWL32). After amplification of tRNAArg2 by RT-PCR with specific primers, the cDNAs were
subcloned and multiple clones of each strain were sequenced. As expected, all clones derived
from the wild-type strain contained G at position 34 (results not shown). Interestingly, 16 out of
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17 clones derived from NWL37 also had G at position 34, and only one clone contained A at this
position (results not shown). Therefore, this point mutant of tadA is almost fully active in vivo,
which is not suprising given that the mutant strain showed no growth defect even at 42˚C (results
not shown), although tadA is an essential gene.
Even so the mutant protein was functional in cells, its activity might be reduced in an in
vitro assay system. We therefore prepared extracts from mutant and parental strains and tested
equal amounts in a deamination assay. Whereas extracts from wild-type cells showed activity
(NWL32; Fig. 3.5, lane 2), no inosine formation could be detected with extracts from the mutant
strain (NWL37; Fig. 3.5, lane 3). However, activity could be restored by transforming the mutant
cells with a tadA expression construct (NWL37R; Fig. 3.5, lane 4). Thus, the mutation D64E
abolishes the enzymatic activity of tadA in vitro, although it does not detectably affect its
activity in cells.
tadA cannot substitute for yeast Tad2p in vivo and in vitro
Because tadA is 34% identical with yeast Tad2p and is functionally conserved, we attempted to
replace Tad2p with tadA in a ∆TAD2 yeast strain (Gerber and Keller, 1999). tadA was cloned
into the pGAL∆Trp-FLIS6 vector (Gerber et al., 1998) and transformed into a ∆tad2 yeast strain
carrying a copy of TAD2 on a plasmid with the URA3 marker (pFL38; Gerber and Keller, 1999).
Cells were then transferred to plates containing FOA and galactose to force the loss of the
URA3-marked TAD2 plasmid and induce the expression of tadA, respectively. No cells grew
showing that tadA cannot substitute for Tad2p in vivo.
Next we tested whether tadA could functionally replace Tad2p in an in vitro deaminase
assay. No activity was detected when tadA preincubated with yeast Tad3p was incubated with B.
mori tRNAAla, which is a substrate for the Tad2p/Tad3p heterodimer (Fig. 3.6 A, lanes 4 and 2).
Thus, tadA can neither replace yeast Tad2p in vivo nor in vitro.
tadA forms homodimers
Because yeast Tad2p functions as a heterodimer with Tad3p and E. coli does not encode a Tad3-
like protein, we wondered whether tadA might form homodimers instead. This hypothesis was
tested with three different approaches. We investigated the interaction of Flag-tadA and in vitro
translated 35S-methionine-labelled tadA in a Flag pull-down assay. The tagged tadA and labelled
translated tadA were preincubated, bound to anti-Flag agarose, washed and eluted by boiling the
matrix in SDS-gel loading buffer. The result is shown in Fig. 3.6 B (lane 2). Approximately 10%
of the tadA input was pulled-down by Flag-tadA. In a second experiment, recombinant Flag-
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tadA was chromatographed on a gel filtration column which separates proteins according to size
and fractions were tested for tadA activity. 50% of tadA eluted at a position corresponding to a
dimer and about 50% of tadA eluted as monomer (results not shown). This result suggests that
tadA may act as a homodimer. However, elution of tadA monomers indicates that tadA does not
interact as strongly with itself as does the yeast Tad2p with Tad3p (Gerber and Keller, 1999).
Formation of tadA monomers could occur by separation of tadA dimers on the gel filtration
column due to the experimental conditions.
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Figure 3.6  tadA forms homodimers and cannot replace yeast Tad2p in vitro
A) Recombinant yeast Tad2p, Tad3p  and E. coli tadA were preincubated as indicated at the top and tested for
activity in vitro with tRNAAla from B. mori. As a control the yeast Tad2p/Tad3p complex was used (lane 2).
B) Flag pull-down assay with in vitro translated tadA. 35S-labelled tadA was incubated with Flag-tagged tadA (lane
2) or buffer (lane 1) and subsequently bound to Flag agarose and eluted. 10% of the input is shown in lane 3.
Proteins were separated on a 12% SDS polyacrylamide gel. Molecular masses of the protein standards are indicated
in kDa on the left.
C) Chemical crosslinking of recombinant tadA. 300 ng tadA (lanes 2-4) were incubated in a reaction mixture
containing tris(2,2’-bipyridyl)dichlororuthenium(II)hexahydrate, APS and BSA (90 ng, 0.9 µg, 9 µg). tadA
incubated with buffer only is shown in lane 1. Reaction products were separated on a 12% SDS polyacrylamide gel
and blotted to a nitrocellulose membrane. tadA was detected with a mouse anti-Flag antibody. Molecular masses of
protein standards are indicated in kDa on the left.
To confirm dimerization, we carried out chemical cross-linking experiments and indeed
observed a complex corresponding in size to tadA homodimers (Fig. 3.6 C, lanes 2-4). Complex
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formation was strongly stimulated by the addition of BSA although a weak cross-link was also
detectable in some experiments in the absence of BSA (results not shown). The reason for this
stimulation is unclear, however BSA might have a stabilizing effect on the interaction of the
highly purified tadA subunits. tadA complex formation was specific and only involved tadA
subunits but not BSA. Complexes with BSA would have a higher molecular mass and can
therefore easily be distinguished from tadA homodimers by size. Dimerization was not complete
and could be observed with about 30% of tadA. This might be due to the experimental procedure
where tadA might have been crosslinked under suboptimal dimerization conditions. The addition
of E. coli total tRNA did not influence dimer formation in these assays, indicating that the
observed dimerization did not require substrate tRNA (results not shown). These experiments
suggest that tadA can form a homodimer in vitro, however it remains to be shown whether tadA
acts as a homodimer in vivo.
tadA is essential for cell viability
tadA has previously been reported to be a non-essential gene in E. coli (Poulsen et al., 1992).
tadA was deleted by inserting a chloramphenicol acetyltransferase (cat) gene into the SphI
restriction site of the ORF which removed the last 17 amino acids of the protein. We
reinvestigated whether tadA is essential for viability because recombinant tadA-∆C,
corresponding to the knock-out gene described by Poulsen et al. (1992) was active in a tRNA
editing assay (results not shown). The tadA gene was inactivated with the two-step sacB
counterselection technique (Reece and Phillips, 1995). For this purpose a plasmid-borne tadA
gene was produced which was disrupted by an interposon carrying a kanamycin-resistance
cassette (pJW30; Fig. 3.7 A). The disrupted tadA cassette was introduced at the chromosomal
tadA locus by homologous recombination. Thus, the first recombination event resulted in the
introduction of a kanamycin-disrupted tadA gene and plasmid sequences into the genome next to
wildtype tadA (Fig. 3.7 A). Subsequent growth of these strains on 5% sucrose selected for
excision of the sacB gene, which confers sucrose sensitivity, by a second recombination event.
Sucrose-resistant clones were then analyzed for kanamycin and plasmid encoded
chloramphenicol resistance. If the wild-type copy of tadA can be lost because the gene is not
essential, one expects to find similar numbers of WT tadA and ∆tadA clones (Fig. 3.7 A).
However, all of the 400 clones analyzed were KanS/CamS and thus wild-type cells, indicating
that the disrupted form of tadA was lost selectively and that tadA is an essential gene (Fig. 3.7
B).
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Figure 3.7  tadA is an essential gene
A) The sacB counterselection procedure. The wildtype chromosomal copy of tadA was exchanged via a two-step
homologous recombination reaction with a gene copy disrupted by the insertion of a kanamycin-resistance cassette.
After the second recombination step, colonies were analyzed by their antibiotic-resistance profile for the presence or
absence of the Kan-cassette in the tadA locus and for mutational inactivation of the sacB gene. The mutation in sacB
is indicated by an asterisk.
B) Summary of the clones obtained by the strategy described in A. The total number of sucrose-resistant colonies
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analyzed are indicated in the first column (Total clones). The number of isolated colonies with a disrupted tadA
(∆tadA) gene in the chromosome is shown in the second column, the number of colonies with a restored wildtype
tadA locus (WT) after the second recombination step is shown in the third column. Colonies that had acquired
sucrose-resistance through sacB inactivation are listed in the fourth column (sacB-). Plasmids pJW30 and pJW117
carry disrupted and wild-type copies of the tadA ORF, respectively.
C) PCR analysis of WT (lane 1) and ∆tadA (lane 2) genomic E. coli DNA. Primers are indicated by arrows and
anneal 500 bp upstream of the tadA ORF and at the 3’ end of the ORF, respectively. Sizes of standards (lane M) are
indicated in bp on the left.
To corroborate this, we repeated the tadA deletion experiment in the presence of a
functional copy of tadA under the control of the arabinose promoter (PBAD). In this case, about
equal numbers of KanR/CamS (e.g. ∆tadA, 47%) and KanS/CamS (e.g. WT, 49%) clones were
obtained (Fig. 3.7 B). The deletion of tadA was confirmed by PCR analysis of seven of the
KanR/CamS clones (Fig. 3.7 C). PCR analysis of genomic DNA from wild-type cells led to the
accumulation of a fragment of 1000 bp (Fig. 3.7 C, lane 1) corresponding to tadA+500 bp
upstream sequence. This product was not formed with genomic DNA from a ∆tadA strain.
Instead, a faint band was observed at ~ 2500 bp, which corresponds to tadA disrupted by the
kanamycin cassette and 500 bp upstream sequence (Fig. 3.7 C, lane 2). Note that the primers
used are specific for the amplification of the genomic tadA locus whereas the rescue copy of
tadA is not amplified. In addition, the deletion was confirmed by Southern blot analysis of three
individual clones (results not shown). These results indicate that disruption of the WT
chromosomal copy of tadA resulted in viable E. coli only when an additional plasmid-born tadA
gene was also present. The same results were obtained when these gene disruption experiments
were performed with Caulobacter crescentus (results not shown). Thus, we conclude that tadA is
essential for viability of eubacterial organisms.
3.4 Discussion
We describe the cloning and functional characterization of the E. coli enzyme tadA/ecADAT2.
Based on the following observations we conclude that tadA is an adenosine deaminase that
specifically converts A34 to I34 in bacterial tRNAArg2: (i) Recombinant tadA purified to
homogeneity specifically deaminates tRNAArg2 at the wobble position of the anticodon and does
not need a cofactor. (ii) The recombinant protein is highly specific for the wobble position of
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tRNAArg2. However, eukaryotic tRNAs are deaminated by tadA if they contain the anticodon
loop of tRNAArg from yeast or E. coli. (iii) Recombinant tadA forms homodimers. A to I
deamination at the wobble position of the anticodon is conserved from bacteria to mammals and
the enzymes catalyzing the reaction are also conserved not only in their sequence but probably
also in their property to act as dimers. Thus, the tadA homodimers may represent the ancestor of
the eukaryotic Tad2p/Tad3p heterodimer. (iv) tadA is encoded by an essential gene. The fact that
E. coli cells are not viable without tadA underscores the important role of I34 in tRNA. There are
two major differences between tRNA deamination in E. coli and S. cerevisiae. First, tRNAArg2 is
the only E. coli tRNA that has A at position 34 and is therefore the only tRNA target for tadA
whereas yeast has seven tRNAs containing A34. Second, tadA is sufficient to catalyze the
reaction in E. coli, whereas in yeast the Tad2p/Tad3p heterodimer is needed to modifiy A34 to I34
in tRNAs (Gerber and Keller, 1999).
The sequences of tadA and the yeast tRNA deaminase subunit Tad2p were compared to
predicted Tad2 proteins from other prokaryotic organisms (Fig. 3.1). Comparing these sequences
with those of cytidine deaminases revealed that they share conserved motifs which are typical for
cytidine nucleotide deaminases rather than adenosine deaminases (Gerber and Keller, 1999). On
the basis of these observations we propose that tadA is the ancestor of the eukaryotic Tad2/Tad3
proteins. Gerber and Keller (1999) suggested that Tad2 and Tad3 are paralogs that appeared by
gene duplication after the divergence of prokaryotes and eukaryotes. This hypothesis is now
further supported by the identification of tadA which acts as a single polypeptide. Prokaryotic
organisms encode only Tad2-like proteins, thus the appearance of Tad3 is a later event which
most probably happened after the divergence of prokaryotes and eukaryotes.
I-containing tRNAs are predicted to recognize codons ending in C, U and A. Inosine at
the wobble position allows a single tRNA to read three different codons (NNU, NNC, NNA)
which therefore must encode the same amino acid (Crick, 1966; Jukes, 1973). tRNAs with
inosine at the wobble position are present in all bacteria and eukarya for which representative
sets of tRNAs have been characterized (Sprinzl et al., 1998). However, Percudani (2001)
suggested that  I-containing tRNAs might not contribute significantly to the decoding of NNA
codons in higher eukaryotes because there is always a synonymous U-starting anticodon which
can read codons ending in A without wobbling. Because prokaryotes have fewer tRNA species, I
is also used to decode A. tRNAArg2 is the only tRNA which decodes the CGA arginine codon.
CGA is a very rare codon with a frequency of only 0.36 percent in E. coli
(http://www.kazusa.or.jp/codon/) and might be specifically avoided to encode arginine residues
because of its poor translational properties (Curran, 1995). The possibilities of codon-anticodon
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basepairing are greatly improved with inosine at the wobble position in tRNAs. Such advantages
might have been important for the survival of cells under selective conditions and might have
promoted the spreading of this modification and the responsible enzymes because the total
number of tRNA genes in an organism can be reduced with tRNAs containing I at position 34.
An E. coli strain has been described that has a point mutation in the tadA protein
(formerly designated yfhC; Poulsen et al., 1992). This mutation resulted in transient resistance to
the overexpression of the membrane protein gef which has a cell-killing function (reviewed in
Gerdes et al., 1990). It was speculated that the gef genes are involved in plasmid maintenance by
killing newborn plasmid-free cells (Gerdes et al., 1986). It is not known how the cells are killed
by the proteins of the gef gene family or why a mutation in tadA leads to resistance against the
gef proteins. We found that extracts from strain NWL32 showed I formation, whereas extracts
from the tadA mutant strain NWL37 had no deamination activity. Deamination activity could be
rescued by expressing tadA from a plasmid. The absence of activity in NWL37 extracts is
probably due to instability of the mutated tadA protein which might be inactivated during extract
preparation. tadA might also be stabilized by interactions with other tRNA modifying enzymes
and these interactions could be impaired in the mutant protein. This hypothesis is supported by
the observation that the mutated amino acid in NWL37 is highly conserved in bacterial tadA
sequences and therefore seems to have an important function (Fig. 3.1). NWL37 cells showed no
growth defect at 42˚C, indicating that the cells did not have a major disadvantage with the
mutation. In agreement with this proposal we could not detect a deficiency in tRNA deamination
in strain NWL37 in vivo. Consequently tadA is active despite the mutation and this explains the
presence of modified tRNAs in the mutant strain. This result also explains the wildtype growth
phenotype of the mutant strain since a tadA mutant with significantly reduced activity in vivo
would be expected to be lethal. It is not known why a mutation in the tadA gene makes the cells
resistant to gef, but Poulsen et al. (1992) suggest that there is a second mutation in the genome of
NWL37 because some E. coli  strains were only transiently resistant to gef when the mutated
tadA was introduced by P1 transduction. This other mutation has not been identified, but could
be responsible for the gef resistance.
In yeast seven different tRNAs contain I34. The Tad2p/Tad3p complex probably
deaminates all these tRNAs, however not all of them have been tested in vitro with recombinant
proteins. tadA is not able to replace yeast Tad2p neither in vitro nor in vivo. However, the yeast
Tad2p/Tad3p proteins are capable of deaminating tRNAArg2 from E. coli in vitro  (Auxilien et al.,
1996). tadA deaminates yeast tRNAArg and a hybrid tRNA which consists of the yeast tRNAAsp
with the yeast tRNAArg anticodon loop, indicating that this tRNA region is crucial for tadA to
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recognize and deaminate the substrate. The importance of the anticodon loop for recognition by
tadA was also shown with tRNAArg minisubstrates. Mutations in the anticodon of these
minisubstrates completely abolished tadA activity, whereas mutations in the stem or at position
37 (3’ adjacent to the anticodon) had no effect on I formation. Reduced loop size and increased
stem length resulted in less efficient deamination, which nevertheless still ocurred site-
specifically. In summary, the results suggest that the stem-loop structure of the anticodon arm
and nucleotides in the anticodon and at position 33 are key determinants for tadA activity.
Interestingly, it has been shown previously that tRNA modification or processing enzymes need
only few determinants in the tRNA sequence or structure to specifically catalyze a reaction.
Work with tRNA synthetases has shown that a variety of minisubstrates can be used for
aminoacylation (reviewed in Musier-Forsyth and Schimmel, 1993; Schimmel and Alexander,
1998). Synthetic substrates for specific aminoacylation can be as short as a tetraloop with a four
base pair stem and a CCA end. For alanyl-tRNA synthetase the critical determinant for
aminoacylation of tRNAAla was shown to be the G3:U70 base pair and this was also true for
specific aminoacylation of the minihelix (Francklyn and Schimmel, 1989). Furthermore, it has
been shown that RNase P, the enzyme that forms the mature 5’ ends of tRNAs by cleaving off
the leader sequence, can act on minisubstrates that consist only of a three basepair stem with
very short extensions at the 5’ and 3’ ends (reviewed in Altman and Kirsebom, 1999). Another
example is provided by the spliceosomal 15.5 kDa protein. This protein specifically interacts
with the 5’ stem-loop of U4 snRNA and plays an important role in the late stage of spliceosome
assembly (Nottrott et al., 1999). The crystal structure of the 15.5 kDa protein revealed that it
forms hydrogen bonds with only five bases of the U4 snRNA loop (Vidovic et al., 2000).
It is not known whether the 3D architecture of the tRNA is important for efficient I
formation by tadA. It cannot be excluded that other nucleotides in addition to the anticodon loop
of the tRNA are important for tadA binding. Further experiments will be required to show where
tadA binds to the tRNA and which nucleotides are contacted by the enzyme. It also remains to be
shown which sequences in Tad proteins are needed for tRNA binding since none of the enzymes
described so far contains a known RNA binding motif. The high substrate specificity of tadA
offers a potential explanation why only one polypeptide is required. A single protein might
suffice to modify tRNAArg2 in bacteria whereas the recognition of seven different tRNAs in yeast
might require a more elaborate mechanism.
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3.5 Materials and methods
Oligonucleotides
yfhC.1 5'-GGCGGATCCCGCCGCGCTTTTATAACCGG-3'
yfhC.2 5'-CCCAAGCTTAATCCGTCGAGGATTGCGC-3'
yfhC.3 5'-CCCACTAGTCATGCGCCGCGCTTTTATAACCGG-3'
yfhC.4 5'-GGGACTAGTGCATCCGTCGAGGATTGCGC-3'
yfhC.5 5'-CCCCATATGCGCCGCGCTTTTATAACCGG-3'
yfhC.6 5'-
CCCCATATGCTAGTGATGGTGATGGTGATGATCCGTCGAGGATTGCGC-
3'
yfhC.7 5'-CCCGCTAGCAGAGTAAAGCATAGCGTCCGT-3'
yfhC.8 5'-CCCCTCGAGTTAATCCGTCGAGGATTGCGC-3'
yfhC.9 5'-CTCCGGTTATAAAAGCGCGGV-3'
Arg1 5'-GACACGGTACCACACAACTGGTGCATCCGGGAGGATTCG-3'
Arg2 5'-GACACGGTACCACACAACTGG-3'
Arg3 5'-GCATCCGTAGCTCAGCTGG-3'
tadA.KO3 5'-CCCGCGGCCGCTCCAGAGGAGTATGGTTTGGC-3'
tadA.KO4 5'-CCCGCGGCCGCGCCGTCGATGCGGTACTGCCGC-3'
araC 5'-TTCATACTCCCGCCATTCAG-3'
Restriction sites are underlined and nucleotides encoding 6 histidine residues are double
underlined.
Bacterial strains and media
The strains used in this study are described in table IV. E. coli strains were grown at 37˚C or
24˚C in LB or 2xYT medium (Sambrook et al., 1989) supplemented with ampicillin (100 µg/µl),
kanamycin (30 µg/µl) or chloramphenicol (20 µg|µl) as necessary. C. crescentus strains were
grown in PYE medium (Ely, 1991), supplemented with nalidixic acid (20 µg/ml), kanamycin (20
µg/ml), tetracyclin (2 µg/ml), spectinomycin (50 µg/ml) or streptomycin (30 µg/ml) as needed.
Table IV  Plasmids and strains
Plasmid Description Reference
pGAL∆Trp-Flis6 Gal promoter, Trp-cassette removed, encodes Flag- and H6-tag Gerber et al. (1998)
pGDV1 pGEX derivative with TEV cleavage site, no thrombin site Dichtl and Keller (2001)
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pKO3 E. coli gene replacement vector Link et al. (1997)
pRDC15 pKO3 derivate allowing chromosomal replacement of araBAD genes Arigoni et al. (1998)
pJW24 tadA in GDV1 via NdeI-XhoI this work
pJW27 tadA in pQE9 via BamHI-HindIII (Qiagen) this work
pJW28 tadA in pTrc-FLIS6 via SpeI this work
pJW30 tadA with 700 nt overhangs, Kan-cassette inserted into tadA this work
pJW106 tadA in pBS-KS via BamHI/HindIII this work
pJW117 tadA in pRDC15 via NheI/XhoI this work
pJW118 tadA in pGAL∆Trp-Flis6 via SpeI this work
Strain Description Reference
MG1655 E. coli WT strain Neidhardt (1996)
JW9 MG1655, PBAD-tadA this work
JW33 MG1655, PBAD-tadA, ∆tadA this work
NWL32 gef-lacZ, ∆relF, CamR, KanR Poulsen et al. (1992)
NWL37 gef-lacZ, ∆relF, CamR, KanR Poulsen et al. (1992)
Cloning of the tadA gene
The ORF yfhC was amplified by PCR from 25 ng E. coli genomic DNA with primer pairs
yfhC.1/yfhC.2, yfhC.3/yfhC.4, yfhC.5/yfhC.6. The primers anneal at the 5' and the 3' end of the
tadA ORF, respectively. The ORF was cloned into pCR2.1 (Invitrogen) and several independent
clones were sequenced. tadA was then subcloned in the appropriate restriction sites of either
pQE9, pTrc-FLIS6 or pGDV1.
Expression of tadA in E. coli and purification of the recombinant protein
The procedure is described for the tadA-pGDV1 construct. The tadA-pGDV1 construct was
transformed into BL21 cells (Invitrogen). 2 liters of 2xYT medium supplemented with 100 µg/l
ampicillin and 10 µM ZnCl2 were inoculated with 28 ml of an overnight preculture. Cultures
were grown at 37˚C to an OD600 of 0.94 and then induced by adding IPTG to a final
concentration of 0.4 mM. Incubation was continued at 24˚C for 5 hours. Cells were harvested by
centrifugation and the pellet was resuspended in 40 ml lysis buffer (50 mM Tris-HCl pH 8.0, 200
mM KCl, 10% glycerol, 0.02% NP40, 2 mM ß-mercaptoethanol, 0.5 mM phenylmethylsulfonyl
fluoride, 0.5 µg/ml leupeptin, 0.7 µg/l pepstatin). Cells were lysed by sonication 3x3 min on ice.
After centrifugation, the cleared lysate was mixed with Ni2+-NTA agarose previously
equilibrated with lysis buffer. The mixture was stirred at 4˚C for 45 min and then loaded on the
column. The Ni2+-agarose was washed with 100 ml wash buffer (lysis buffer + 10 mM
tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli
51
imidazole) and bound proteins were eluted with 250 mM imidazole. Fractions 3-5 were applied
to glutathione sepharose (Amersham Pharmacia) equilibrated with buffer A (Tris-HCl pH 8.0,
130 mM KCl, 10% glycerol, 0.02% NP40, 1 mM DTT). Proteins were eluted with buffer B
(buffer A + 10 mM reduced glutathione). 50 µl of fraction 1 were loaded on a gel filtration
column (Superdex 200 PC3.2/30, Smart  System, Pharmacia) that had been equilibrated with
buffer A.
Construction of an E. coli tadA null mutant
The E. coli tadA gene was disrupted by the insertion of an omega cassette (Prentki and Krisch,
1984) via homologous recombination. A 1.9 kb NotI fragment containing 700 nt upstream and
downstream flanking regions of the tadA ORF was cloned into pCR2.1 (Invitrogen). The omega
cassette was then inserted in the unique EcoNI restriction site in the tadA ORF. pKO3 contains
two selection markers for the recombination step: a kanamycin resistance cassette and a sacB
gene conferring sucrose sensitivity. pJW30 was integrated into the chromosome of E. coli wild-
type strain MG1655 via homologous recombination. The resulting strain contained a wild-type
and a disrupted copy of tadA. To induce the second recombination event, colonies were serially
diluted in LB and plated on LB plates containing 5% sucrose. Colonies that were able to grow on
sucrose were tested for loss of the plasmid encoded chloramphenicol resistance and for presence
of the omega cassette encoding a kanamycin resistance. Clones that were sucrose- and
chloramphenicol-resistant had not lost the plasmid and were probably resistant to sucrose due to
a mutational inactivation of the sacB gene. Kanamycin- and chloramphenicol-sensitive clones
had lost the plasmid and recombination left a wild-type tadA in the chromosome. Null mutants
of tadA should be Kan-resistant and Cam-sensitive.
For the rescue construct for tadA null mutants, the tadA ORF + 26 nucleotides upstream
flanking sequence were amplified by PCR from E. coli genomic DNA with primers
yfhC.7/yfhC.8. The fragment was cloned into the NheI/XhoI restriction sites of pRDC15
generating construct pJW117. MG1655 cells were transformed with pJW117 and selected for the
integration of the plasmid at 43˚C. Integration at the correct locus was verified by PCR with
primers araC and yfhC.9. Then the same antibiotic resistance analysis as described above was
performed.
In vitro transcription of tRNAs and enzyme assays
In vitro transcription of tRNAs was performed essentially as described previously by Gerber et
al. (1998). For transcription of minisubstrates T7 primer and substrate primer were mixed in a
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1.2:1 ratio in 10 mM Tris pH 8 with a concentration of 20 pmol/µl substrate primer and 24
pmol/µl T7 primer. Primers were incubated 3 min at 95˚C and then quickly chilled on ice. 1 µl
primer mix was used for each reaction which was done as described (Gerber et al., 1998).
Minisubstrates were purified on a 20% urea gel. tadA activity was assayed in a reaction mixture
containing 50 mM Tris-HCl pH 8.0, 25 mM KCl, 2.5 mM MgSO4, 0.1 mM EDTA, 10%
glycerol, 2 mM DTT and 100-200 fmol 33P-labelled tRNA substrate in a 50 µl reaction as
described (Gerber et al., 1998). When purified tadA was used, the reaction was supplemented
with 1 µg BSA. Reactions were incubated at 37˚C for 15-90 min.
Sequence analysis of tRNAs
Sequence analysis of edited tRNA was done as described (Gerber et al., 1998). Analysis was
performed with in vitro edited tRNAs and with total RNA isolated from E. coli strains NWL32
and NWL37. Total RNA was isolated with the Total RNA Midi Kit (Qiagen) according to the
manufacturer's protocol. Arg1 primer was used for reverse transcription, Arg2 and Arg3 primers
were used for the subsequent PCR.
UV-crosslinking
10 µl reactions were carried out with 400 ng of recombinant tadA and 100 fmol of labelled
tRNA in 25 mM Tris-HCl pH 8.0, 2.5 mM MgSO4, 0.05 mM EDTA. The reactions were
incubated at room temperature for 6 min and then irradiated on ice in a UV Stratalinker at 500
mJ. tRNAs were digested with 500 ng RNaseA for 25 min at 37˚C. Proteins were separated on a
denaturing 12% SDS polyacrylamide gel and exposed on a PhosphorImager screen (Molecular
Dynamics).
Chemical crosslinking
The crosslinking was done according to a modified version of the procedure described by Fancy
and Kodadek (1999). Reactions were performed in microtiter plates in a total volume of 20 µl.
Reactions contained 1 x crosslinking buffer (0.1 x PBS, 2.5 mM MgSO4, 0.05 mM EDTA), 300
ng purified recombinant tadA and BSA from 90 ng to 9 µg. Proteins were dialyzed against 1x
PBS since Tris-buffer inhibits the crosslinking reaction. 1 x reaction buffer (15 mM Na-
p h o s p h a t e  p H  7 . 5 ,  1 5 0  m M  N a C l ,  0 . 1 2 5  m M  t r i s ( 2 , 2 ’ -
bipyridyl)dichlororuthenium(II)hexahydrate and APS to a final concentration of 2.5 mM were
added in the dark just before irradiation. Reactions were irradiated with a flashlight for 30
seconds and immediately afterwards quenched with 5 µl of 4 x Laemmli loading buffer. Proteins
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were denatured at 95˚C for 3 minutes, separated on a 15% SDS polyacrylamide gel and blotted
on a nitrocellulose membrane (Schleicher & Schuell).
Flag pull-down assay
tadA was in vitro transcribed/translated from construct pJW106 with the TNT® Coupled
Reticulocyte Lysate System by Promega according to the manufacturer's instructions. 500 µl
Flag-matrix slurry was washed twice with buffer TKG25 (50 mM Tris-HCl pH 8, 25 mM KCl,
10% glycerol, 0.1 mM EDTA, 0.01% NP40). The Flag-matrix was then blocked with 10 µg BSA
for 30 minutes at 4˚C and afterwards washed 4x with buffer TKG25. 1 µg of Flag-tagged
recombinant tadA that has been purified on Ni/NTA agarose, 3 µl of in vitro translated tadA and
100 ng BSA in buffer TKG25 in a total volume of 15 µl were incubated at room temperature for
1 hour. 2 x 250 µl of buffer TKG25 were added to the protein mixture and then transferred to a
tube containing the Flag-matrix and incubated at 4˚C for 45 minutes. The Flag-matrix was
washed with 3 x 1 ml buffer TKG25. 20 µl Laemmli loading buffer were added and the Flag-
matrix boiled at 95˚C for 3 minutes. The supernatant was loaded on a 12% SDS-polyacrylamide
gel.
Acknowledgments
We thank Dr. G. Church (Harvard Medical School, Boston) for providing plasmid pKO3, Dr. H.
Loferer (Genome Pharmaceuticals Corporation, Munich) for plasmid pRDC15 and Dr. S. Molin
(Technical University of Denmark, Lyngby) for E. coli strains NWL32, NWL37 and NWL43.
We are grateful to U. Jenal and members of his group for Caulobacter strains and helpful
discussions. We thank B. Dichtl, U. Rüegsegger and M. Schaub for critically reading the
manuscript. This work was supported by the University of Basel, the Swiss National Science
Foundation and the Louis-Jeantet-Foundation for Medicine.
tadA, an essential tRNA-specific adenosine deaminase from Escherichia coli
54
3.6 Supplement to chapter 3
3.6.1 Isolation of temperature-sensitive tadA mutants
A temperature-sensitive (ts) mutant of the yeast Tad2 protein has been described which contains
the two mutations C126S and L153P (Gerber and Keller, 1999). Another allele of Tad2p
carrying the mutation E86A was also found to be ts (A.G. and W.K., unpublished results). E86
and L153 are conserved between yeast and E. coli Tad2 whereas C126 is within a region of
Tad2p that is not present in bacterial sequences (Fig. 3.1). To test whether mutation of these
conserved amino acids would also generate ts alleles of tadA, the mutations E96A and L156P
were introduced by site-directed mutagenesis either as single or as a double mutations. The
resulting alleles were named tadA-1 (L156P), tadA-2 (E96A) and tadA-3 (E96A, L156P). The
mutant tadA alleles were expressed in E. coli and the recombinant proteins purified on a
Ni2+/NTA agarose and an a-Flag affinity column. The mutant proteins were expressed equally
well as WT tadA (Fig. 3.8 A).
To test tRNA-specific adenosine deaminase activity at high temperature, assay reactions
were either incubated at 43˚C or at room temperature as a control. Reactions were also
performed with mutant proteins that have been preincubated at 43˚C for 20 min. As can be seen
in Fig. 3.8 B WT tadA, tadA-1 and tadA-2 were active at room temperature whereas
recombinant tadA-3 did not form I in tRNAArg2 at 22˚C. tadA-3 could either not be folded
correctly due to the mutations or the structure of the mutant protein could be weakened and
therefore destroyed during purification. At 43˚C WT tadA was slightly more active than at room
temperature whereas tadA-1 was reduced in activiy (Fig. 3.8 B, compare lanes 1 and 5, 2 and 6
and C). Interestingly, tadA-2 had no deaminase activity at 43˚C, indicating that the mutation of
the conserved E96 leads to a ts allele also in E. coli. As expected tadA-3 was also not active at
high temperature (Fig. 3.8 B, lane 8). When the reactions were carried out without preincubation
of the recombinant protein, I formation could also be detected with tadA-2 (results not shown).
This is probably due to the fact that tadA-2 is active at room temperature and that the
deamination reaction proceeds very fast. Therefore the time until tadA-2 is inactivated is long
enough to allow deamination of the tRNA. tadA-2 deaminated tRNA when the protein was
preincubated at 43˚C for 15 min and then tested for activity at room temperature (results not
shown). This result showed that tadA-2 is not irreversibly inactivated at high temperature. At
37˚C tadA-1 and tadA-2 are almost as active as WT tadA, even after preincubation of the
proteins (results not shown).
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Figure 3.8  SDS-polyacrylamide gel analysis of the amount of purified tadA mutants and tRNA-specific
adenosine deaminase assay with different tadA mutants.
A) 10 µl of fraction 2 of each Flag-column were separated on a 12% SDS-PAA gel and stained with Coomassie. The
molecular masses of the size standards in kDa are indicated on the left.
B) E. coli tRNAArg2 was incubated with purified recombinant WT tadA (lanes 1 and 5), tadA-1 (lanes 2 and 6), tadA-
2 (lanes 3 and 7) or tadA-3 (lanes 4 and 8) at room temperature or at 43˚C for 30 min. Reactions were processed as
described in chapter 3.5.
C) Reaction products were quantified with the IPLab Gel Software (Signal Analytics). The numbers are calculated
as mol I/mol tRNA.
To test temperature sensitivity in vivo, the tadA-1, tadA-2 and tadA-3 alleles were
introduced into the E. coli genome under the control of the arabinose promoter via homologous
recombination (for details see chapter 3.3 and 3.5). For unknown reasons tadA-1 could not be
introduced stably into the genome and was not tested in vivo. tadA-3 could not rescue the ∆tadA
strain, indicating that this allele is not functional in vivo (results not shown). tadA-2 rescued the
∆tadA strain at room temperature (results not shown). However, the PBAD-tadA-2 strain grew as
efficiently as WT cells at 43˚C on LB plates, indicating that the mutant protein was stabilized
within the cells. Interestingly, when tadA-2 was encoded on a multi-copy expression plasmid and
was introduced into E. coli, the cells had a major growth defect (Fig. 3.9 A). This might be due
to the presence of the N-terminal Flag-tag and the C-terminal His6-tag which could prevent
correct folding at high temperature. The growth curve of two independent tadA-2 expression
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strains was determined. As can be seen in Fig. 3.9 B the mutant strains ceased growth two hours
after shift to 44˚C whereas the wild-type strain continued growth. It remains to be determined
whether tRNAArg2 in the mutant strains has an unmodified position 34.
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Figure 3.9  tadA-2 strains have a growth defect at high temperature
A) Growth of WT E. coli and tadA-2/pTrc-FLIS6 cells on LB plates. Plates were incubated overnight at 44°C.
B) Growth curve of wild-type and tadA-2 strains after shift to the non-permissive temperature. Cells were incubated
at 45˚C in a water bath and the optical density was measured at the indicated time points.
It has been predicted but never shown that I-containing tRNAs allow efficient decoding
of NNC, NNU and NNA codons (Crick, 1966; Jukes, 1973). It was speculated that I:A base pair
formation is inefficient and therefore NNA codons could be specifically avoided  (chapter 3.4
and Curran, 1995). Percudani (2001) suggested that I-containing tRNAs do not decode NNA
codons in eukaryotes with the exception of yeast tRNAs. However, this hypothesis was so far not
confirmed experimentally. Because S. cerevisiae has seven I-containing tRNA where the wobble
position is deaminated by a complex of two proteins,  analysis of translational efficiency would
be rather difficult. The identification of tadA offers new possibilities because in E. coli one
protein deaminates one tRNA substrate. With tadA ts mutants translational efficiency can be
determined in vivo with a reporter construct encoding several CGA arginine codons followed by
a reporter like luciferase which was engineered to contain no CGA, CGC and CGU arginine
codons. Upon shift to the non-permissive temperature luciferase activity can be measured in a
time-course experiment. At non-permissive temperature newly synthesized tRNAArg2 is not
deaminated anymore at the wobble position and with continued growth at high temperature the
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already existing modified tRNAArg2 is diluted due to cell division. Unmodified tRNAArg2 is
probably not able to base-pair with CGA codons. Base-pairing with CGU should not be affected
whereas base-pairing with CGC could be reduced. In summary cells will die because mRNAs
encoding for essential proteins are not translated efficiently and processes which they catalyze or
where they are involved do not occur efficiently enough. Translational efficiency can also be
monitored in vitro with the same reporter construct and E. coli translation extracts. tadA ts
mutants could also be used to monitor overall translation efficiency with pulse-chase
experiments. WT and ts strains grown at high temperature would be pulsed with 35S-methionine
and the resulting labelled proteins analyzed by 2-dimensional gel electrophoresis. This would
allow to see differences in the translation of specific proteins. Probably highly expressed genes
that contain many CGA and CGC codons will be affected most.
Materials and Methods
Generation of tadA ts alleles
tadA-1, tadA-2 and tadA–3 were generated by site-directed mutagenesis. For the tadA-1 allele
two fragments were amplified by PCR with primer pairs yfhC.3/yfhC.11 and yfhC.4/yfhC.10
introducing the mutations T467C and C468G with numbers referring to the tadA ORF. After gel
purification a mix of these two fragments was used as a template for amplification with primers
yfhC.3/yfhC.4 for cloning into pTrc-FLIS6 via SpeI. For in vivo replacement experiments two
fragments were amplified with primer pairs yfhC.7/yfhC.11 and yfhC.8/yfhC.10. A mix of these
fragments was used for amplification with primers yfhC.7/yfhC.8 for cloning into pRDC15 via
NheI/XhoI. Two fragments for tadA-2 and tadA-3 were amplified with primer pairs
yfhC.3/yfhC.11 and yfhC.4/yfhC.13 using either WT tadA (for tadA-2) or tadA-1 (for tadA-3) as
template. These reactions introduced the mutations A287C, A288C in tadA-2 and A287C,
A288C, T467C, C468G in tadA-3.
Name Sequence (5’ -> 3’) Restriction site
yfhC.10 GGCGTTGCCGAGTGACTTC -
yfhC.11 CCCCCCTTTCTGCGCTTTAATTTCC -
yfhC.13 TCACGCTTGCCCCATGTGTAA -
Preparation of E. coli extracts
20 ml LB supplemented with the appropriate antibiotic were inoculated with either E. coli WT or
ts strains and grown overnight at 30˚C. The next day cells were harvested by centrifugation and
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washed twice with buffer Q* (50 mM Tris pH 7.9, 50 mM KCl, 10% glycerol, 5 mM EDTA pH
8, 1 mM DTT, 0.5 mM PMSF, 0.5 µg/ml leupeptin, 0.7 µg/ml pepstatin). The pellet was
resuspended in 1 ml of buffer Q (same as buffer Q* but with 0.5 mM EDTA) and lysis was
performed by sonicating the cells 1 min on ice. The lysate was centrifuged 20 min at 4˚C with 14
krpm and the supernatant frozen in liquid nitrogen. The protein concentration of extracts was
determined by the Bradford method (Bradford, 1976).
3.6.2 tadA chelates Zn2+
All deaminases known to date contain Zn2+ in their active site (Chang et al., 1991; Moore et al.,
1993; Wilson et al., 1991; Yamanaka et al., 1994; Yang et al., 1992). Three amino acids that are
characteristic for Zn-chelating enzymes are also found in the deaminase domain of tadA (Fig.
3.1). To test for the presence of Zn2+ in tadA the protein was incubated with up to 5 mM o-
phenanthroline (OPA) which chelates divalent metal ions and then tested in an assay. Inhibition
of I formation could be observed, indicating that tadA contains zinc.
Expression of soluble recombinant tadA was enhanced several fold when 20 mM ZnCl2
was added to the medium. This has been observed previously with yeast Tad2p/Tad3p and also
with yeast Tad1p (Gerber et al., 1998; Gerber and Keller, 1999). The amount of active protein
was increased significantly when the expression was done in the presence of ZnCl2. The
importance of Zn2+ was also shown with inactive Tad2p mutants that could be re-activated when
the assay reaction was supplemented with ZnCl2 (M.S. and W.K., unpublished results). All these
results suggest that Tad proteins bind Zn2+ in their active site which is a prerequisite for
adenosine deamination.
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Figure 3.10  Inhibition of recombinant tadA by OPA (A) and NEM (B).
Final concentrations of the inhibitors are indicated at the bottom. The amount of I formation is indicated on the left.
Reactions were performed for 1 hour at 37˚C with 2 ng of Ni-NTA purified His6-tadA.
3.6.3 tadA is an essential gene in Caulobacter crescentus
To confirm the tadA deletion results obtained in E. coli, the tadA homologue in Caulobacter
crescentus was deleted with the sacB counterselection technique. Caulobacter tadA is 45%
identical to E. coli tadA and is highly conserved in the deaminase domain (Fig. 3.11 boxed
sequence). There was no other gene in the Caulobacter genome which displayed such a high
degree of homology.
Figure 3.11  Alignment of E. coli and Caulobacter crescentus tadA.
The E. coli tadA amino acid sequence is shown in the upper lane, the C. crescentus sequence in the lower lane. The
deaminase domain is boxed. Numbers above and below the sequences indicate amino acids.
The sacB counterselection technique is described in detail in chapter 3.3 (see also Fig. 3.7). The
results of the deletion are shown in Fig. 3.12. In summary, when tadA was deleted in C.
crescentus only wild-type and sacB- clones were obtained. However, ∆tadA clones were obtained
when a rescue copy of tadA was provided on a plasmid, thus confirming the deletion results with
E. coli.
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Figure 3.12  tadA is essential in C. crescentus.
The total number of sucrose-resistant colonies analyzed are indicated in the first column (Total clones). The number
of isolated colonies with a disrupted tadA (∆tadA) gene in the chromosome is shown in the second column, the
number of colonies with a restored wildtype tadA locus (WT) after the second recombination step is shown in the
third column. Colonies that had acquired sucrose-resistance through sacB inactivation are listed in the fourth column
(sacB-). Plasmids pJW72 carries a wild-type copy of the C. crescentus tadA ORF.
Methods
Table V  Plasmids, strains and primers Caulobacter tadA
Name Description Reference
pNPTS138 KanR derivative of pLITMUS28 cloning vector with sacB
and oriT
D. Alley
pMR20 RK2-based TetR broad host range vector R. Roberts + C. Moor
pJW57 ±500 bp Caulobacter tadA ORF in pNPTS138 (SpeI, AflII) this work
pJW58 pJW57 with Spec/Strep-cassette (BamHI) this work
pJW72 Caulobacter tadA ORF in pMR20 (NcoI, EcoRI) this work
pJW81 Caulobacter tadA ORF in pBF11 (NdeI, SpeI) this work
NA1000 Caulobacter WT strain Evinger and Agabian (1977)
JW30 Caulobacter ∆tadA, pJW72 this work
The strains and plasmids used for the deletion of Caulobacter tadA are described in table V. C.
crescentus strains were grown in PYE medium (Ely, 1991), supplemented with nalidixic acid (20
µg/ml), kanamycin (20 µg/ml), tetracyclin (2 µg/ml), spectinomycin (50 µg/ml) or streptomycin
(30 µg/ml) as needed.
The Caulobacter tadA gene was disrupted by the insertion of an omega cassette (Prentki and
Krisch, 1984) via homologous recombination. A 1 kb SpeI/AflII fragment containing 500 nt
upstream and downstream flanking regions of the tadA ORF was cloned into pNPTS138. The
omega cassette was then inserted in the unique BamHI restriction site between the upstream and
the downstream fragment generating construct pJW58. pNPTS138 contains two selection
markers for the recombination step: a kanamycin resistance cassette and a sacB gene conferring
sucrose sensitivity. pJW58 was integrated into the chromosome of C. crescentus wild-type strain
NA1000 via conjugation and homologous recombination. The resulting strain contained a wild-
type and a disrupted copy of tadA. To induce the second recombination event, colonies were
grown overnight at 30˚C in PYE and plated on PYE plates containing 3% sucrose. Colonies that
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were able to grow on sucrose were tested for loss of the plasmid encoded kanamycin resistance
and for presence of the omega cassette encoding a spectinomycin/streptomycin resistance.
Clones that were sucrose- and kanamycin-resistant had not lost the plasmid and were probably
resistant to sucrose due to a mutational inactivation of the sacB  gene.
Spectinomycin/streptomycin- and kanamycin-sensitive clones had lost the plasmid and
recombination left a wild-type tadA in the chromosome. Null mutants of tadA should be
spectinomycin/streptomycin-resistant and kanamycin-sensitive.
For the rescue construct for tadA null mutants, the tadA ORF was amplified by PCR from C.
crescentus genomic DNA with primers ccTad2.3/ccTad2.2. The fragment was cloned into the
NcoI/EcoRI restriction sites of pMR20 generating construct pJW72. pJW72 was inserted in
NA1000 via conjugation and correct clones identified by resistance to tetracyclin. A strain
containing pJW72 was then used to repeat the same procedure as described above.
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4.1 Introduction
tRNA is the most extensively modified nucleic acid in the cell and modified nucleotides which
are derivatives of the four standard nucleosides were found soon after the discovery of the
soluble (s)RNA, now called tRNA (Dunn, 1959; Smith and Dunn, 1959). All modifications with
the exception of queuosine (Q) are formed post-transcriptionally (reviewed in Björk, 1995;
Björk, 1996). To date, more than 80 different modifications have been characterized in tRNA
and some of them probably evolved early since they are conserved in Archaea, Bacteria and
Eucarya (Sprinzl et al., 1998). Some modified nucleotides are however specific for one of the
three phylogenetic domains and are likely to have evolved after the divergence of the three
kingdoms (Björk, 1984; Edmonds et al., 1991). Although modified nucleotides are found in
various positions in the tRNA, position 34 and 37 contain the largest variety of modifications
which influence codon reading patterns in several ways. Base modification contributes to reading
frame maintenance by improving the efficiency of the tRNA, influencing the fidelity of
translation, improving the recognition by elongation factors or aminoacyl-tRNA synthetases,
influencing codon choice, improving the efficiency of translation, decreasing the codon context
sensitivity and preventing frameshifting (reviewed in Björk, 1995; Björk, 1996; Curran, 1998). A
number of different modifications were predicted to prevent frameshifting (Urbonavicius et al.,
2001).
Eukaryotic tRNAAla contains inosine at two positions: at position 34 (the wobble position
of the anticodon) and at position 37 (3’ adjacent to the anticodon). Inosine at these positions is
generated by hydrolytic deamination of a genomically encoded adenosine (reviewed in Grosjean
et al., 1996a). The deamination of A37 to I34 is catalyzed by Tad1p (tRNA-specific adenosine
deaminase 1), an enzyme which is related to the pre-mRNA editing enzymes ADARs (Gerber et
al., 1998). In a second step I37 is further methylated to m1I37 by a recently identified
methyltransferase (Björk et al., 2001). Tad1p contains a deaminase domain with three Zn2+-
chelating residues and a glutamate involved in catalysis, however it does not contain a known
RNA binding domain. Tad1p is encoded by a non-essential gene in S. cerevisiae and the function
of m1I is not known (Gerber et al., 1998). It was suggested that this modification prevents
translational frameshifts.
In contrast to m1I37, I34 is present in seven or eight eukaryotic tRNA and also in tRNAArg2
from E. coli and plant chloroplasts. The deamination of A34 in yeast is catalyzed by a
heterodimer consisting of the two related subunits Tad2p and Tad3p (Gerber and Keller, 1999).
Both proteins are encoded by essential genes (Gerber and Keller, 1999). Interestingly, the two
proteins display a deaminase domain that resembles that of the cytidine deaminase (CDA)
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superfamily (reviewed in Gerber and Keller, 2001). Therefore it was postulated that Tad2p
evolved from a prokaryotic cytidine deaminase progenitor and that the appearance of Tad3p was
the result of a gene duplication event (Gerber and Keller, 1999). This hypothesis is supported by
tadA which is sufficient for bacterial tRNA:adenosine 34 deaminase activity and is likely
representing the origin of eukaryotic Tad proteins (Wolf et al., 2002).
Here, we report the characterization of the human tRNA:adenosine 34 deaminase which
consists of hTad2 and hTad3. The two proteins are homologous to the previously identified yeast
proteins Tad2p/Tad3p. The results of different experiments suggest that A34 deamination is a
nuclear process and I34 might thus contribute to efficient aminoacylation of the tRNA or increase
export efficiency.
4.2 Results
Two alternatively spliced hTad2 mRNAs are present in HeLa cells
Database searches with the yeast Tad2 sequence revealed a human EST which encoded part of a
homologous protein. The 5’ end of this EST T97494 was used to screen a HeLa cDNA library.
One of the positive clones identified contained a cDNA of 1514 bp coding for a 184 amino acid
protein. The clone had an in frame stop codon upstream of the first methionine, a short (52 bp) 5’
UTR and a long (910 bp) 3’ UTR. The sequence of the encoded protein was highly conserved in
the deaminase domain to yeast Tad2p and contained characteristic residues of deaminases
including the three Zn2+-chelating amino acids and a glutamate thought to be involved in proton
transfer during catalysis. However, the protein was encoded in two different reading frames.
Amino acids 26 to 184 were encoded in the –1 frame compared to the first methionine. It was
tried to isolate an in frame clone by PCR from HeLa and HEK cDNA, but all the amplified
fragments had the same –1 frameshift (results not shown). Therefore an in frame hTad2 clone
was generated by insertion of an additional nucleotide at the frameshift site. A second hTad2
clone was isolated that contained an alternative exon 1 and was therefore named hTad21b. hTad2
with the frameshift in its ORF was renamed hTad21a according to the order in which the two
isoforms were identified. hTad21b and hTad1a were identical except the first 25 aa of hTad1a and
32 aa of hTad21b (Fig. 4.1 D). However, the hTad21b protein was encoded in one frame.
Comparison of both hTad2 sequences with the genomic sequence revealed that the two different
exons 1 were present consecutively on chromosome 6 separated by 9100 bp (Fig. 4.1 A). The
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splice site consensus sequence was conserved between exon 1a and exon 2 which could explain
alternative splicing at this site and the isolation of hTad21a. hTad2 is encoded in six exons which
are separated by introns ranging in size from 106 to 11'867 bp (Fig. 4.1 A). Short repetitive
sequence elements were identified upstream of exon 1a and downstream of exon 6. The
repetitive sequence in the 5’ UTR and first exon belongs to the family of LTR/MaLR elements
(long terminal repeats/mammalian apparent LTR-retrotransposons) whereas the sequence in the
hTad21a 3’ UTR belongs to the LINE elements (long interspersed nucleotide elements). These
elements are inserted into the genome via reverse transcription of RNAs from active elements
and are thought to be of viral origin (Deininger et al., 1992). It is not known whether these
repetitive sequences have a function in the hTad2 mRNA.
To determine the ration between the hTad21a and hTad21b mRNAs in vivo, Northern blot
analysis was performed with HeLa poly(A)+ RNA. At least five different mRNAs could be
detected with a probe against the ORF of hTad2 (Fig. 4.1 C, lane 1). To distinguish between
hTad21a and hTad21b mRNAs, RNase H cleavage was applied. Poly(A)+ RNA was incubated
with oligonucleotide hTad2.2 that annealed at the 3’ end of the hTad2 ORF (Fig. 4.1 B). After
digestion with RNase H a single band was detected in the Northern (Fig. 4.1 C, lane 2)
suggesting that the various mRNAs detected in the undigested sample were due to differences in
the 3’ UTR. However, the single band in lane 2 could still be a mixture of hTad21a and hTad21b
transcripts. Therefore, the mRNA was either digested with oligonucleotides hTad2.2/N-term-1a
or hTad2.2/N-term-1b. Incubation with the hTad21a-specific primer did not change the band
pattern compared to lane 2 (Fig. 4.1 C, lane 3) whereas after incubation with a hTad21b-specific
primer a shorter transcript accumulated (Fig. 4.1 C, lane 4). This result showed that in vivo
hTad21b is the major form whereas hTad21a could not be detected with the Northern. However,
hTad21a mRNA can easily be detected by RT-PCR (results not shown).
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hTad2-1a  M S G - S F L R P - - - - - - S L E A D A D T I L L V Q S G E L A K E A L E N T E V P V G C L M V Y N N E V V G K G R N 53
hTad2-1b  M E A K A A P K P A A S G A C S V S A E E T E K W M E E A M H M A K E A L E N T E V P V G C L M V Y N N E V V G K G R N 60
bTad2  M E A K A G P T A A T D G A Y S V S A E E T E K W M E Q A M Q M A K D A L D N T E V P V G C L M V Y N N E V V G K G R N 60
pTad2  M E A K G E S T P A A D G E C S V S A E E T E K W M E Q A M Q M A K E A L E N T E V P V G C L M V Y N N E V V G K G R N 60
mTad2  M E E K V E S T T T P D G T C V V S V Q E T E K W M E E A M R M A K E A L E N I E V P V G C L M V Y N N E V V G K G R N 60
                       
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
hTad2-1a  E V N Q T K N A T R H A E M V A I D Q V L D W C R Q S G K S P S E V F E H T V L Y V T V E P C I M C A A A L R L M K I P 113
hTad2-1b  E V N Q T K N A T R H A E M V A I D Q V L D W C R Q S G K S P S E V F E H T V L Y V T V E P C I M C A A A L R L M K I P 120
bTad2  E V N Q T K N A T R H A E M V A I D Q A L D W C R R R G R S P S E V F E H T V L Y V T V E P C I M C A A A L R L M R I P 120
pTad2  E V N Q T K N A T R H A E M V A I D Q V L D W C R R G G K S P S E V F E R T V L Y V T V E P C I M C A A A L R L M K I P 120
mTad2  E V N Q T K N A T R H A E M V A I D Q V L D W C H Q H G Q S P S T V F E H T V L Y V T V E P C I M C A A A L R L M K I P 120
   
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
hTad2-1a  L V V Y G C Q N E R F G G C G S V L N I A S A D L P N T G R P F Q C I P G Y R A E E A V E M L K T F Y K Q E N P N A P K 173
hTad2-1b  L V V Y G C Q N E R F G G C G S V L N I A S A D L P N T G R P F Q C I P G Y R A E E A V E M L K T F Y K Q E N P N A P K 180
bTad2  L V V Y G C Q N E R F G G C G S V L D I A S A D L P S T . . .  148
pTad2  L V V Y G C Q N E R F G G C G S V L D I A S A D L P N T . . .  148
mTad2  L V V Y G C Q N E R . . .  137
  
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
hTad2-1a  S K V R K K D C Q K S  1 8 4
hTad2-1b  S K V R K K E C Q K S  1 9 1
bTad2  
pTad2  
mTad2
D
Figure 4.1  hTad2 mRNA is alternatively spliced
A) Schematic representation of the hTad2 genomic region on chromosome 6. Exons are shown as blue boxes and
are not drawn to scale. The sizes of the introns are indicated in base pairs. Dotted boxes correspond to repetitive
sequences. The cDNAs corresponding to the two alternatively spliced hTad2 mRNAs are shown with the –1
frameshifting site in hTad21a.
B) Schematic representation of the experiment shown in C. The hTad2.2 primer anneals to both hTad2 mRNAs, the
primers N-term 1a and N-term 1b are transcript-specific.
C) Northern blot analysis of HeLa poly(A)+ RNA that was RNase H cleaved with oligonucleotides as indicated on
top of each lane. Poly(A)+ RNA was separated on a 1.5% agarose/formaldehyde gel and blotted to a Hybond N+
membrane for detection with a hTad2 probe. Arrows indicate hTad2 mRNAs in the uncleaved sample.
D) Alignment of mammalian Tad2 sequences. Bovine (b), pig (p) and mouse (m) amino acid sequences were
predicted from ESTs. Highly conserved amino acids (≥80%) are shown in black, similar residues in grey. Three
Zn2+-chelating residues are depicted in yellow and the glutamate mediating proton transfer during catalysis in red.
hTad21a does not contain a site of programmed translational frameshifting
All the hTad21a mRNAs that were isolated and those found in the databases had exons 2 to 6 in
the –1 frame compared to exon 1. It was therefore investigated whether the hTad21a mRNA
contains a site of programmed translational frameshifting. Although errors that alter the reading
frame are extremely rare during translation, some genes have evolved sequences that efficiently
induce frameshifting. Frameshifting is conceptually a simple process. At a particular step in the
cycle of translational elongation the ribosome shifts its reading frame from the one it initiated
translation into a new reading frame. In some genes the frequency of frameshifting is very high,
aproaching 100%. These efficient frameshifts are termed programmed frameshifts since
conserved structural features of the mRNA template predispose the ribosome toward a shift at a
specific site. As a consequence, the protein is not directly encoded in the DNA as a single ORF,
but in two overlapping reading frames. Programmed translational frameshifting has been
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observed in diverse RNA viruses, E. coli, B. subtilis, yeast and mammals (reviewed in
Farabaugh, 1996; Gesteland and Atkins, 1996). Mechanisms underlying frameshifting are
diverse and in many cases unknown. The strength of the codon-anticodon pairing, low
availability of certain tRNAs and secondary RNA structures play a role in +1 and -1
frameshifting. In mammals and E. coli frameshifting regulates the levels of specific enzymes.
Viruses use frameshifting to translate gag-pro and gag-pro-pol proteins which are encoded in
overlapping reading frames (reviewed in Farabaugh, 1996; Gesteland and Atkins, 1996).
Programmed translational frameshifting of hTad21a was investigated in vitro by
translation with rabbit reticulocyte lysate in the presence of 35S-methionine. Two expression
constructs encoding hTad21a either with or without the –1 frameshifting site were in vitro
translated. Labelled protein was synthesized when the hTad2 ORF did not contain the
frameshifting site, however no hTad2 was detected with the –1 frameshift construct (results not
shown). To test whether programmed translational frameshifting occured in vivo, different
hTad21a expression constructs were transfected into HEK293 cells which have been used
previously to study recoding (Grentzmann et al., 1998). The first construct encoded the hTad21a
ORF, either with or without the –1 frameshifting site (Fig. 4.2 A). Extracts of transfected cells
were separated on polyacrylamide gels and blotted to nitrocellulose. hTad2 proteins were
detected with a-hTad2 antibodies and recombinant hTad2 was distinguished from endogenous
hTad2 by size. Tagged hTad2 could readily be detected when the protein was expressed from the
corrected clone (Fig. 4.2 A, lane 2), however no recombinant hTad2 was expressed from the
frameshifting construct (Fig. 4.2 A, lane 1).
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Figure 4.2  hTad21a does not contain a –1 frameshifting site.
A) Schematic drawing of the constructs used for transfection and Western blot analysis of extracts from transfected
HEK293 cells. The hTad21a ORF was cloned either in frame (lane 2) or with exons 2 to 6 in the –1 frame (lane 1).
The recombinant protein had a N-terminal Flag-tag and a C-terminal His6-tag and was detected with a a-hTad2
antibody. The arrow indicates the position of recombinant hTad2. The molecular masses of the size standards in kDa
is indicated on the left.
B) Same experiment as described in A) except that the hTad21a cDNA encoding a Flag-tag at the 5’ end of the ORF
either with (lane 3) or without (lane 4) the -1 frameshifting site was transfected.
C) HEK293 cells were transfected with a hTad21a cDNA containing intron 1 (lane 5) and as a control the hTad21a
cDNA without frameshift was used (lane 6).
It has been shown previously that secondary structures like pseudoknots stimulated translational
frameshifting by pausing the ribosome and thereby increasing the likeliness of alternative
decoding ( ten Dam et al., 1990; reviewed in Farabaugh, 1996; Gesteland and Atkins, 1996).
Such structures could be formed between sequences around the frameshifting site and sequences
further upstream or downstream, e.g. in the UTR. Therefore, a hTad2 expression construct
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containing the 5’ and 3’ UTR sequences was transfected into HEK293 cells (Fig. 4.2 B). Also
with these constructs expression of recombinant hTad2 could only be observed with the
corrected clone (Fig. 4.2 B, lanes 3 and 4). Because the frameshift site was present exactly at the
exon-exon junction, it was tested whether splicing at this site could determine framehifting.
Intron 1 was therefore reintroduced into the hTad21a cDNA and transfected into HEK293 cells.
Expression of recombinant hTad2 could not be observed with this construct (Fig. 4.2 C, lane 1).
Frameshifting was also investigated with dual-luciferase reporter constructs that encoded
the firefly luciferase gene the expression of which was coupled to short upstream frameshfting
sequences (pluc; Grentzmann et al., 1998). For normalization of the firefly luciferase activity the
activity of a second luciferase gene from Renilla reniformis was measured. Firefly luciferase
activity could only be measured when frameshifting occurred and was thus linearily coupled to
the frameshifting efficiency. The hTad2 coding region around the frameshifting site (33 nt
upstream sequence and 100 nt downstream sequence) was cloned into pluc and transfected into
HEK293 cells. Extracts of transfected cells were tested for both luciferase activities, however no
significant frameshifting was observed with hTad2 (results not shown). Although frameshifting
could not be detected in all these experiments it cannot be excluded that hTad2 is synthesized
from the hTad21a mRNA. Frameshifting might require different conditions or could be regulated
or hTad21a could be translated by a different mechanism.
Cloning of hTad3 and reconstitution of human tRNA:adenosine 34 deaminase activity with
recombinant proteins
hTad3 sequences were identified by homology to yeast Tad3p. The hTad3 ORF was amplified
from EST AI367911 and the recombinant protein expressed in E. coli CodonPlus cells. These
cells encode additional copies of rare E. coli tRNAs Arg(AGA and AGG) and Pro(CCC). The
hTad3 ORF has a G/C content of 73% and 21 CCC proline codons which is a very rare codon in
E. coli. hTad3 expression was increased several fold in BL21 CodonPlus cells compared to
BL21 cells (results not shown). hTad3 was purified on a Ni2+/NTA column (Fig. 4.3 A). To
reconstitute human tRNA:adenosine 34 deaminase activity in vitro recombinant hTad2 was
expressed in E. coli from the corrected hTad21a and from the hTad21b clone with an N-terminal
Flag-tag and a C-terminal His6-tag. The proteins were purified on a Ni2+/NTA and an a-Flag-
column (Fig. 4.3 A) and tested for adenosine deaminase activity with hTad3 on in vitro
transcribed B. mori tRNAAla (A37G) tRNA. Neither hTad2 alone nor hTad3 deaminated A to I
(Fig. 4.3 A, lanes 1 and 2). However, when the proteins were mixed, they converted A to I up to
0.8 mol I/mol tRNA (Fig. 4.3 A, lane 3). Thus, hTad2 and hTad3 are sufficient to reconstitute
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tRNA:adenosine 34 deaminase activity. Other eukaryotic-specific cofactors are not needed since
both recombinant proteins were expressed in E. coli. hTad2 and hTad3 are therefore the
sequence and also functional homologues of the previously described yeast proteins
Tad2p/Tad3p (Gerber and Keller, 1999). hTad2 and hTad3 could also be co-expressed in E. coli
with a N-terminal Flag-tag (hTad2) and a N-terminal His6-tag (hTad3). The complex was
purified on a Ni2+/NTA column and ana-Flag column (Fig. 4.3 B). Both complexes, containing
either hTad21a or hTad21b, were active in vitro (Fig. 4.3 B).
A
29
66
kDa
97
116
45
Flag-hTad21b-H6
29
45
66
97
116
kDa
H6-hTad3
29
97
45
66
116
kDa
Flag-hTad21b
H6-hTad345
66
116
kDa
29
97
Flag-hTad21a
H6-hTad3
B
1 2
321
origin
AMP
IMP
IMP
AMP
origin
hT
ad
2-
1b
hT
ad
3
hT
ad
2-
1b
 +
hT
ad
3
hT
ad
2-
1a
 +
hT
ad
3
hT
ad
2-
1b
 +
hT
ad
3
Figure 4.3  hTad2 and hTad3 are required for inosine formation at position 34.
A) Coomassie stained gels of the final purification step of hTad21b and hTad3. Approximately 20 ng of recombinant
hTad21b (lane 1), hTad3 (lane 2) or 20 ng of each protein were tested for tRNA:adenosine 34 deaminase activity
with B. mori tRNAAla (A37G). The reactions were incubated at 37˚C for 1 hour.
B) Coomassie stained polyacrylamide gel of the purification of the hTad2/hTad3 complex. Peak fractions of the
final Flag-column were separated on 15% polyacrylamide gels. The hTad21a/hTad3 complex (lane 1) and the
hTad21b/hTad3 complex (lane 2) were tested for tRNA deaminase activity with B. mori tRNAAla (A37G) for 1 hour
at 37˚C.
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Depletion of tRNA:adenosine 34 deaminase activity from HeLa extracts
Polyclonal antibodies were raised against aa 29-184 of hTad2 (∆N-hTad2). These antibodies
recognized the antigen (Fig. 4.4 A, lane 2), recombinant hTad2 (Fig. 4.4 A, lane 1) and similar
amounts of a single protein in HeLa cell cytoplasmic and nuclear extracts (Fig. 4.4 A, lanes 3
and 4). ∆N-hTad2 was shorter than the protein detected in HeLa cell extracts (Fig. 4.4 A,
compare lanes 2, 3 and 4), showing that the N-terminally deleted form did not correspond to the
endogenous hTad2. hTad2 could be depleted from HeLa cell extract whereas depletion with
preimmun hTad2 serum did not change the amount of hTad2 (Fig. 4.4 B, lanes 2 and 3). The
depleted extracts did not form I in B. mori tRNAAla (A37G) (Fig. 4.4 C, lane 3) whereas extracts
depleted with the preimmun a-hTad2 serum had the same tRNA adenosine deaminase activity as
untreated HeLa cell cytoplasmic extract (Fig. 4.4 C, compare lanes 1 and 2). Addition of
recombinant hTad2 to depleted extracts did not restore activity (Fig. 4.4 C, lane 4). However,
activity could be restored by adding hTad2 and hTad3 (Fig. 4.4 C, lane 6), indicating that the a-
hTad2 serum depleted the hTad2/hTad3 complex. This is not surprising because both proteins
are required for tRNA adenosine deaminase activity (Fig. 4.3 A) and hTad2 and hTad3 form a
heterodimer which is supported by the purification of the recombinant complex from E. coli
lysate (Fig. 4.3 B).
Figure 4.4  a-hTad2 antibodies deplete the hTad2/hTad3 complex from HeLa cell extracts.
A) Western blot analysis of Flag-hTad2-His6 (lane 1), ∆N-hTad2 (lane 2), HeLa cell cytoplasmic (lane 3) and
nuclear extract (lane 4). The proteins were separated on a 15% polyacrylamide gel and blotted to a nitrocellulose
membrane for detection with a-hTad2 antibodies.
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B) Western blot analysis of HeLa cell extracts depleted with a-hTad2 antibodies. Untreated HeLa cell cytoplasmic
extract (lane 1), extract depleted with preimmun hTad2 serum (lane 2) and extract depleted with a-hTad2 antibodies
were tested for the presence of hTad2.
C) tRNA-specific adenosine deaminase assay with depleted extracts. B. mori tRNAAla (A37G) was incubated with
10 µg total protein HeLa cell cytoplasmic extract (lane 1), extract depleted with preimmun serum (lane 2) or extract
depleted with a-hTad2 serum (lane 3). To reconstitute tRNA deaminase activity depleted extracts were
supplemented with recombinant hTad2 (lane 4), hTad3 (lane 5) or hTad2 and hTad3 (lane 6).
Substrate specificity of hTad2/hTad3
The substrate specificity of recombinant hTad2/hTad3 was tested with various eukaryotic and
prokaryotic tRNA substrates. Eight human tRNAs are known to contain I34 (Fig. 4.5 A). Site-
specificity of hTad2/hTad3 was tested with a mutant tRNAAla from B. mori that contained G
instead of A at position 34. This tRNA was not deaminated, indicating that adenosine
deamination is specific for position 34 (Fig. 4.5 B, lane 2). Yeast tRNAAla and human tRNAAla
were a substrate for hTad2/hTad3 (Fig. 4.5 B, lane 3 and results not shown). It has been shown
previously that tRNAArg2 from E. coli is a substrate for yeast Tad2p/Tad3p (Auxilien et al.,
1996). The result that hTad2/hTad3 also deaminated tRNAArg2 (Fig. 4.5 B, lane 4) confirmed that
eukaryotic tRNA:adenosine 34 deaminases recognize prokaryotic substrates. In summary,
eukaryotic tRNAs that contain A at the wobble position of the anticodon were deaminated
however the efficiency varied and was highest with human and B. mori tRNAs.
Because hTad2 and hTad3 are functionally conserved with yeast Tad2p/Tad3p (Gerber
and Keller, 1999) and also with E. coli tadA (Wolf et al., 2002), it was tried to exchange subunits
of the different complexes in vitro. Recombinant proteins were pre-incubated and tested for
activity with tRNAAla (A37G) from B. mori. In summary, the yeast proteins could not replace the
human proteins (Fig. 4.5 B, lanes 5 and 6) although the yeast enzyme is known to deaminate B.
mori tRNAAla (Fig. 4.5 B, lane 8; Gerber and Keller, 1999). tadA could also not replace hTad2 in
vitro (Fig. 4.5 B, lane 7). Interestingly, hTad2 and hTad3 could be replaced in vitro with
Drosophila Tad2 and Tad3, respectively (M.Schaub, pers. communication). To test replacement
of Tad2p with hTad2 in vivo, a pGal∆Trp-FLIS6-hTad2 expression construct was transformed
into the ∆tad2 yeast strain which carried a copy of TAD2 on a plasmid with the URA3 marker
(Gerber and Keller, 1999). Transformed cells were transferred to plates containing FOA and
galactose which forced the loss of the URA3-plasmid and induced hTad2 expression. Cells did
not grow on these plates, showing that hTad2 cannot replace Tad2p in vivo (results not shown).
The absence of activity in vitro with hybrid complexes could be due to several reasons. Either
the two mixed subunits did not interact or they did interact but could not recognize the substrate
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tRNA or they did not form a binding site for the tRNA. With Flag pull-down experiments it was
shown that the different subunits could interact. As a positive control hTad2 was shown to
interact with hTad3 (Fig. 4.5 C, lane 4). The human Tad2/Tad3 proteins also interacted with the
yeast Tad2/Tad3 proteins (M.S. and W.K., unpublished results) showing that a hybrid complex
could form but not deaminate tRNA. hTad2 also interacted with tadA (Fig. 4.5 C, lane 8) and
with itself (Fig. 4.5 C, lane 6). None of the labelled proteins bound to Flag-agarose (Fig. 4.5 C,
lanes 5, 7 and 9). Interestingly, it has been shown previously that tadA can form homodimers
(Wolf et al., 2002). Because tadA is likely to be the ancestor of the eukaryotic Tad2/Tad3
proteins, all eukaryotic Tad2 proteins could have the ability to form homodimers. With the
appearance of Tad3, which is suggested to be a duplication of Tad2, the complex was a
heterodimer, however Tad2 was still able to dimerize. This is also supported by the result that
hTad2 interacted with tadA. Thus, the different subunits did interact but could not deaminate
tRNA.
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Figure 4.5  hTad2 and hTad3 interact with other Tad2 proteins, but these complexes are noct active in vitro.
A) tRNAs from H. sapiens, S. cerevisiae and E. coli that contain I34. The anticodon sequence is boxed and position
34 is shown in yellow. The invariable U33 is boxed in blue. The consensus sequence of the human tRNAs is shown
at the bottom. The asterisk at position 35 indicates that there is a purine in all tRNAs except tRNAArg.
B) hTad2/hTad3 is specific for position 34 and none of the subunits can be exchanged with Tad2 or Tad3 proteins
from other organisms. hTad2/hTad3 was tested for deaminase activity with WT tRNAAla from B. mori (lane 1), B.
mori tRNAAla (A34G) (lane 2), S. cerevisiae tRNAAla (lane 3) or E. coli tRNAArg2. B. mori tRNAAla (A37G) was used
as a substrate to test adenosine deaminase activity of hTad2/yeast Tad3p (lane 5), hTad3/yeast Tad2p (lane 6),
hTad3/E. coli tadA (lane 7) or yeast Tad2p/yeast Tad3p (lane 8) as a positive control.
C) Flag pull-down assay with human and E. coli Tad2 and Tad3 proteins. 10% of the labelled protein input is shown
in lanes 1, 2 and 3. Asterisks indicate 35S-labelled proteins. Flag-hTad2 was tested for interaction with hTad3 (lane
4), with hTad2 (lane 6) or with tadA (lane 8). Flag-tadA interaction with hTad3 is shown in lane 10. Mock
incubation of labelled proteins with the Flag agarose was tested for hTad3 (lane 5), hTad2 (lane 7) and tadA (lane
9).
hTad2 contains a NLS and transports hTad3 into the nucleus
A putative NLS was identified in yeast Tad3p (Gerber and Keller, 1999). However, it has not
been shown experimentally that this motif really functions as a NLS. Therefore, hTad21a and
hTad21b were cloned into an expression plasmid adding either a N-terminal red fluorescent
protein tag (RFP) or a green fluorescent protein (GFP) tag. A N-terminal GFP-tag was added to
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hTad3. Expression and localization of the tagged proteins in HeLa monolayer cells was
monitored by confocal microscopy. GFP-hTad21a was observed mainly in the nucleus and was
excluded from the nucleolus (Fig. 4.6 A). A minor fraction of the recombinant protein localized
to the cytoplasm. Interestingly, GFP-hTad21b was detected exclusively in the nucleus and was
also excluded from the nucleolus (Fig. 4.6 A). Sequences which determine the different
localization of the hTad2 isoforms are most probably within the first exon since this is the only
difference between these two proteins (Fig. 4.1 D). GFP-hTad3 was detected in the cytoplasm
and was excluded from the nucleus (Fig. 4.6 A). The result that hTad2 and hTad3 localized to
different compartments when expressed independently raised the question how the complex
could form. The absence of co-localization could be due to the expression of only one subunit of
the complex. Therefore, hTad2 and hTad3 were co-expressed from two plasmids with different
fluorescent protein tags. For unknown reasons, RFP-hTad21a could not be co-expressed with
hTad3. When co-expressed with hTad21b hTad3 could also be detected in the nucleus (Fig. 4.6
B), suggesting that hTad3 is transported into the nucleus by forming a complex with hTad2. This
result further supports the idea that hTad2 and hTad3 form a tight complex. This was already
shown with the Flag pull-down experiments and the co-purification of the recombinant complex.
GFP-hTad21a GFP-hTad21b GFP-hTad3
GFP-hTad3 RFP-hTad21b
A
B
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Figure 4.6  hTad2 localizes to the nucleus and transports hTad3 into the nucleus.
A) HeLa cells were transfected with GFP-tagged hTad21a, hTad21b or hTad3 as indicated. Cells were analyzed two
days after transfection by confocal microscopy.
B) HeLa cells were co-transfected with GFP-hTad3 and RFP-hTad21b and analyzed by confocal microscopy two
days after transfection.
4.3 Discussion
This chapter describes the identification and characterization of human Tad2 and Tad3. These
two proteins are sufficient to reconstitute human tRNA:adenosine 34 deaminase activity in vitro.
The results in this chapter raise several questions and could help to answer questions that are still
open after the identification of the yeast Tad2p/Tad3p complex and E. coli tadA.
Two alternatively spliced hTad2 mRNAs were detected by RT-PCR. The two
recombinant proteins expressed from these cDNAs differed only in their N-terminal sequence.
hTad21a mRNA encoded the protein in two different reading frames, thus raising the possibility
of programmed translational frameshifting. However, frameshifting could not be detected with in
vitro translation and cell culture expression systems. There are two possible explanations for this
result. First, the hTad21a mRNA does not contain a site for programmed –1 frameshifting.
Second, hTad21a contains a site for programmed frameshifting which could however not be
detected with the methods that were used. If frameshifting occurs in hTad21a mRNA, it could be
a mechanism to regulate the expression and also adenosine deamination in tRNAs. It has been
shown previously that frameshifting can be regulated. Mammalian ornithine decarboxylase
antizyme requires +1 recoding. Antizyme plays a key role in polyamine biosynthesis by binding
to ornithine decarboxylase (ODC) which is the key enzyme in polyamine synthesis. This binding
targets ODC for degradation by proteasomes. Expression of antizyme is autoregulatory because
the required frameshift event is modulated by polyamines. High concentrations of polyamines
lead to greater frameshifting, giving more antizyme. Antizyme causes faster turnover of ODC
and synthesis of fewer polyamines, thereby completing the autoregulatory circuit ( Matsufuji et
al., 1995; Rom and Kahana, 1994; reviewed in Gesteland and Atkins, 1996). A similar
mechanism could also apply for hTad2 expression. However, because hTad21a mRNA was
underrepresented compared to hTad21b mRNA as shown by Northern blot, it is likely that the
protein detected in HeLa cell extracts corresponds to hTad21b. It is still possible that a minor
fraction of hTad2 is expressed from the hTad21a mRNA. However, this protein cannot be
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distinguished from hTad21b with the a-hTad2 antibodies. It was tried to isolate hTad2 from HeLa
cell extracts with a hTad2 antibody affinity column in order to sequence the N-terminus of the
protein. The amount of the isolated hTad2 was not sufficient for sequencing and a major
contaminant which had the same size as hTad2 complicated analysis. It is therefore still unclear
whether hTad21a is expressed. Because hTad21a and hTad21b have slightly different pI values,
HeLa extracts could be tested for hTad21a by 2-dimensional gel electrophoresis and Western
blotting. In case hTad21b is the only form of the protein, the question arises why the hTad21a
mRNA exists or why the pre-mRNA is spliced between exon 1a and exon 2. In addition, what
happens to hTad21a mRNA in the cells? Is it degraded by the nonsense-mediated decay (NMD)
pathway? Pre-mRNAs that contain premature stop codons are eliminated by NMD thereby
ensuring that these pre-mRNAs are removed as templates for translation. Translation of hTad21a
without frameshifting would lead to a 47 amino acid protein which could potentially be harmful
to the cells. NMD could prevent such an aberrant protein, but then the question remains why
splicing generates hTad21a. The splice site consensus sequence is conserved between exon 1a and
2 and a putative branch site was identified. These elements might be sufficient for splicing at this
site, but might generate a mRNA that is useless for the cell.
It was shown in chapter 4.2 that hTad2/hTad3 deaminated tRNAs from humans, B. mori,
S. cerevisiae and also from E. coli. In eukaryotes seven or eight different tRNAs contain I34,
therefore the anticodon sequence cannot be a determinant for deamination. An E. coli tRNAArg2
minisubstrate consisting of the anticodon arm was not deaminated by hTad2/hTad3. Recognition
of the tRNA by eukaryotic Tad2/Tad3 requires therefore sequences and structures outside the
anticodon arm. This is not surprising given the fact that the eukaryotic complex has to recognize
more tRNAs than E. coli tadA. What determines a eukaryotic tRNA as a substrate? Every
eukaryotic tRNA that contains A at the wobble position is deaminated, it is therefore possible
that Tad2/Tad3 recognizes only the overall tRNA structure and if this structure contains A34 it is
deaminated. Substrate tRNAs would therefore not be selected actively, but passively by
exclusion of the tRNAs that do not contain A34. This hypothesis could be tested with an
eukaryotic tRNA that is mutated to contain A34. Glycin is the only eukaryotic amino acid that is
encoded by a family box the codons of which are not read by an I34-containing tRNA. One of the
three tRNAGly could be mutated and tested for deamination in vitro with recombinant
hTad2/hTad3. If indeed the overall tRNA structure is the determinant for Tad2/Tad3, it is also
possible that adenosines in tRNA-like structures in mRNAs are deaminated. Tad2/Tad3 could
therefore also be involved in pre-mRNA editing and deaminate mRNAs that are not recognized
by ADARs. The identification of new editing substrates was a major goal of editing research
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during the last years. For ADAR2 it has been shown that the most important editing site is the
Q/R site in GluR-B. The other sites targeted by ADAR2 are either not essential or they are edited
by ADAR1 due to overlapping substrate specificity. It is possible that hTad2/hTad3 might also
contribute to redundancy in pre-mRNA editing by recognizing tRNA-like structures. New
editing substrates could be identified by comparing genomic DNA and cDNA sequences or by
searching for tRNA-like structures in pre-mRNAs.
4.4 Materials and methods
Table VI  hTad2 and hTad3 primers
Name Sequence (5’ -> 3’) restriction site
(underlined)
hTad2.1 GGCGGATCCCTCGAAAATACTGAAGTTCC BamHI
hTad2.2 CCCAAGCTTCAAGATTTCTGACAATCCTTTTTCCG HindIII
hTad2.5 CCCGGATCCATGAGCGGCAGCTTCCTGAGG BamHI
hTad2.7 CCCACTAGTCATGAGTGGAAGCTTCCTGAGG SpeI
hTad2.8 CCGACTAGTGATTTCTGACAATCCTTTTTCCG SpeI
hTad2.16 CCCACTAGTCATGGAGGCGAAGGCGGCA SpeI
hTad2.19 CCCCTCGAGCCATGAGTGGAAGCTTCCTG XhoI
hTad2.20 CCCCTCGAGCCATGGAGGCGAAGGCGGCA XhoI
92.SalI CCCGTCGACGGCTGATACCATACTTCTTGT SalI
225.SacI GGCGGAGCTCGGTTTGGTTAACTTCATTTCT SacI
hTad3.5 CCCGGATCCATGATCCTCTGCTCCCGTCTCTGT BamHI
hTad3.8 TATAAGCTTCAGGCTTGTGCGGAAGAAATCGAG HindIII
hTad3.9 CCCCTCGAGCCATGATCCTCTGCTCCCGTCTCT XhoI
Table VII  Plasmids and strains hTad2 and hTad3
Name Description Reference
E. coli BL21
codon plus
Stratagene
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codon plus
pCEP-Pu expression vector for cell culture Kohfeldt et al. (1997)
pEGFP cell culture expression vector with GFP tag Clontech
dsRed2 cell culture expression vector with RFP tag Clontech
p2luc expression and in vitro translation vector to study
programmed frameshifting
Grentzmann et al. (1998)
pET28 E. coli expression vector Novagen
pJW7 hTad21a/pTrc-FLIS6 (SpeI) this study
pJW9 ∆N-hTad21a/pQE9 (BamHI, HindIII) this study
pJW12 hTad3/pQE9 (BamHI, HindIII) this study
pJW13 hTad21a frameshift cDNA/pBS this study
pJW71 hTad21a frameshift/pCEP-Pu (KpnI, HindIII) this study
pJW75 hTad21a no frameshift/pCEP-Pu (KpnI, HindIII) this study
pJW93 hTad21a cDNA 92-225 frameshift/p2luc (SalI, SacI) this study
pJW94 hTad21a cDNA 92-225 no frameshift/p2luc this study
pJW114 hTad21a cDNA frameshift/pCEP-Pu (NotI, XhoI) this study
pJW115 hTad21a cDNA no frameshift/pCEP-Pu (NotI, XhoI) this study
pJW116 hTad21a cDNA + intron 1/pCEP-Pu (NotI, XhoI) this study
pJW120 hTad21b/pTrc-FLIS6 (SpeI) this study
pJW122 hTad3/pET28 (BamHI, HindIII) this study
pJW133 hTad21a/pTrc-Flag (SpeI, HindIII) this study
pJW134 hTad21b/pTrc-Flag (SpeI, HindIII) this study
pJW135 hTad21b/pEGFP (XhoI, HindIII) this study
pJW136 hTad3/pEGFP (XhoI, HindIII) this study
pJW139 hTad21a/pEGFP (XhoI, HindIII) this study
pJW159 hTad21a/dsRed2 (XhoI, HindIII) this study
pJW160 hTad21b/dsRed2 (XhoI, HindIII) this study
Cloning of hTad21a
A HeLa cDNA ZAP II library (Stratagene) was screened with a probe encompassing nucleotides
1-352 of Genbank EST T97494. Approximately 106 clones were screened in duplicates. Filters
were hybridized overnight in 5xSSC, 20 mM NaH2PO4, 1% SDS, 50% formamide, 100 µg/ml
salmon sperm DNA, 2x107 [g-32P]dATP-labelled hTad2. The following wash steps were done: 2
x 15 min at room temperature in 2xSSC, 0.1% SDS, 2 x 20 min at 65˚C in 0.1xSSC, 0.1% SDS,
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40 min at 68˚C in 0.1xSSC, 0.1% SDS. 3 positive clones were identified and the corresponding
plaques recovered. These clones were re-screened twice and afterwards sequenced. The insert of
clone 2 (1514 bp) was used to amplify the hTad2 ORF for expression with primer pairs
hTad2.5/hTad2.2, hTad2.7/hTad2.8 and cloned into the BamHI/HindIII and SpeI sites of pQE9
(Qiagen) and pTrc-FLIS6, respectively.
Cloning of hTad21b
The hTad2-1b ORF was amplified by PCR from HeLa cDNA with primers hTad2.16/hTad2.8
and subsequently cloned into the SpeI restriction site of pTrc-FLIS6.
Cloning of hTad3
The ORF of hTad3 with a 93 nt extension at the 3’ end was amplified by PCR from Genbank
EST AI367911 with the Expand Long Template kit (Boehringer) and primers hTad3.5/hTad3.8.
The PCR mix contained 0.38 mM deaza-dGTP and 0.125 mM dGTP to facilitate amplification
of G/C-rich sequences. The PCR product was cloned into the BamHI/HindIII restriction sites of
pQE9 (Qiagen) and transformed into BL21-CodonPlus™ E. coli cells (Stratagene).
GFP and RFP constructs
The ORFs of hTad21a, hTad21b and hTad3 were amplified by PCR with primer pairs
hTad2.19/hTad2.2, hTad2.20/hTad2.2 and hTad3.9/hTad3.8, respectively, and cloned into the
XhoI/HindIII sites of pEGFP-C1 (Clontech) adding a N-terminal GFP. For RFP constructs,
inserts from the pEGFP-C1 constructs were subcloned into the XhoI/HindIII sites of pDsRed2-
C1 (Clontech) adding a N-terminal red fluorescent protein (RFP).
hTad2 constructs for frameshifting experiments
hTad2 from nt 40-173 with and without the –1 frameshifting site was amplified with primers
92.SalI/225.SacI and cloned into the SalI/SacI site of pluc (Grentzmann et al., 1998) generating
constructs pJW93 and pJW94. hTad21a ORF with and without the –1 frameshifting site was
subcloned into pCEP-Pu (Reference) via KpnI/HindIII restriction sites generating constructs
pJW71 and JW75, respectively. hTad2 cDNA from the full-length hTad21a library clone was
subcloned into pCEP-Pu via NotI/XhoI generating constructs pJW114 and pJW115. hTad2
cDNA + intron 1 was generated by digesting a partial genomic hTad2 clone with HindIII,
followed by a partial digest with AccI. The correct fragment of ca. 3000 bp was subcloned into
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the HindIII/AccI sites of hTad2 cDNA/pBS. The hTad2 cDNA + intron 1 was then cloned into
the NotI/XhoI sites of pCEP-Pu generating construct pJW116.
Expression and purification of recombinant proteins
All proteins were expressed in BL21 E. coli cells and 2xYT medium. 1l cultures were inoculated
at an OD600 of 0.05-0.1 and grown at 37˚C. Induction was done at OD600 0.7-1.4 with 0.4 mM
isopropyl-ß-D-thiogalactopyranoside (IPTG) and growth was continued for 2-5h at 28˚C. Cells
were harvested and frozen at –70˚C. The next day cells were resuspended in buffer A (50 mM
Tris pH 7.9, 150 mM KCl, 10% glycerol, 0.02% NP40, 2 mM ß-mercaptoethanol, 0.5 mM
phenylmethylsulfonyl fluoride, 0.7 µg/ml pepstatin, 0.4 µg/ml leupeptin) and sonicated on ice.
After centrifugation lysates were mixed with 1 ml of Ni2+/NTA agarose (Qiagen) in buffer A,
stirred on ice 45 min and poured into a column. The column was washed with buffer A
containing 10 mM imidazole, buffer A with 300 mM KCl, buffer a with 25 mM KCl and the
recombinant protein eluted with buffer A containing 250 mM imidazole. Aliquots of each
fraction were analyzed by electrophoresis on a SDS-PAA gel and stained with Coomassie
Brilliant Blue R-250 (BioRad). Ni-fractions containing recombinant protein were further purified
on a anti M2-Flag affinity matrix (Kodak) and eluted with buffer B (50 mM Tris pH 7.9, 25 mM
KCl, 10% glycerol, 0.1 mM DTT, 100 µg/ml Flag peptide (Kodak). Flag-tagged proteins were
tested for activity with a tRNA-specific adenosine deaminase assay.
Generation of polyclonal antibodies against hTad2
The hTad2 ORF from nt 85-555 was amplified with primers hTad2.1/hTad2.2 and cloned into
the BamHI/HindIII restriction sites of the E. coli expression vector pQE9. Expression from this
constructs yielded a amino-terminal His6-tagged fusion protein. The recombinant protein was
expressed in BL21 E. coli cells. The culture (1l) was induced with 0.4 mM IPTG at OD600 1.34
and grown further for 2h at 37˚C. Cells were sonicated and the recombinant protein purified
under denaturing conditions on a Ni2+/NTA affinity column according to the manufacturer’s
instructions (Qiagen). Fraction 1 was further purified on a large 15% denaturing polyacrylamide
gel, stained with CuCl2 and H6-hTad2 cut out. The protein was eluted with 1x Tris-Glycin. A
rabbit was immunized 5x with 100 µg hTad2.
Depletion of HeLa extracts
ProteinA-sepharose beads were equilibrated in IPP buffer (10 mM Tris pH 7.9, 150 mM NaCl,
0.1% NP40). 20 µl packed beads were mixed with 20 µl a-hTad2 serum (terminal bleeding) or
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hTad2 pre-immun serum in a total volume of 500 µl IPP and were rotated overnight at 4˚C.
Beads were washed with 3x1 ml IPP buffer, 70 µl HeLa cytoplasmic extract was added and
rotated 2h at 4˚C.  Extracts were then tested for tRNA adenosine deaminase activity.
Northern analysis
Total RNA was isolated from HeLa cells with the RNeasy Kit (Qiagen) according to the
manufacturer’s instructions. Poly(A)+ RNA was subsequently isolated with an oligo(dT)
Sepharose column. For RNase H digestion 8 µg poly(A)+ RNA was mixed with different oligos
as indicated in H-buffer (100 mM KCl, 50 mM Tris pH 7.5, 5 mM MgCl2, 1 mM DTT) and
incubated at 70˚C for 15 min. The reaction mix was cooled to 37˚C and RNase H and RNAguard
added. Digestion was done at 37˚C for 1 h. The RNA was then phenol/chloroform extracted and
separated on a 1.5% agarose-formaldehyde gel. The gel was washed 10 min in water, 20 min in
75 mM NaOH, 2x15 min in 0.5 M Tris pH 7.9, 1.5 M NaCl, 20 min in 10x SSC. The RNA was
blotted to nitrocellulose with 10x SSC and crosslinked with a UV Stratalinker (Stratagene).
hTad2 mRNA was detected with a hTad2 ORF probe.
Flag pull-down assay
The Flag pull-down assays were done as described (chapter 3.5).
Transfection of HeLa monolayer cells
HeLa monolayer cells were cultured in Joklik’s modified Eagle medium (Sigma) supplemented
with 10% newborn calf serum at 37˚C in 5% CO2. For transfections 1x105-3x105 cells were
seeded on glass cover slips in 6-well plates. 1.5 µg plasmid DNA was transfected with PolyFect
Transfection Reagent (Qiagen) according to the manufacturer’s instructions. Cells were grown
for 1-2 more days and prepared for confocal microscopy by fixation in 3.7% paraformaldehyde
for 15 min, saturation in 50 mM NH4Cl for 15 min and permeabilization in 0.2% Triton for 15
min. Double-stranded nucleid acids were stained with TOTO-3 (Molecular Probes) diluted
1:1000 in PBS for 2 min. The cover slips were placed upside down on 5 µl Vecta Shield (Vector
Laboratories) on a microscope slide
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5 Conclusions and outlook
Since almost 40 years inosine is known to be present in tRNAs. However, the enzymes which
catalyze the deamination of the genomically encoded adenosine were identified only recently.
This work describes the characterization of E. coli tadA which catalyzes the formation of I34 in
tRNAArg2 and of hTad2/hTad3 which catalyze I34 formation in eight human tRNAs. The cloning
of Tad proteins allows to study the molecular mechanism of tRNA editing in detail. The
identification of tadA and hTad2/hTad3 could help to answer several questions: (i) How do tadA
and Tad proteins in general bind the tRNA substrate? (ii) Which amino acids in tadA are needed
for tRNA binding and which for catalysis? (iii) What is the role of I34? (iv) Is I34 formation linked
to other processes in the cell, e.g. tRNA export or aminoacylation? (v) Where does tRNA editing
occur?
Neither Tad1p nor Tad2p/Tad3p or tadA contain a known RNA binding motif. It has
been observed previously that the capacity to bind RNA does not go along with the presence of a
known RNA binding motif (e.g. 3’ end processing factors, aminoacyl-tRNA synthetases). This
suggests that there have to be RNA binding motifs that remain to be identified. Obviously, tadA
and hTad2/hTad3 have to bind tRNA to catalyze adenosine deamination. All Tad2 proteins
found so far are small proteins with a molecular weight between 20 and 28 kDa. The small size
should facilitate the identification of amino acids that are critical for tRNA binding. Such amino
acids could be identified by site-specific mutation and the generation and analysis of tadA
mutants would certainly give more insight into tRNA recognition and binding. Kinetic
parameters of mutant and wildtype tadA could be determined and tadA mutants could also be
analyzed in vivo. Mutation of highly conserved residues in Tad2p or Tad3p resulted in loss of
deaminase activity or the ability to form a heterodimer (A.G., M.S. and W.K., unpublished
results). C- and N-terminally deleted Tad2p and Tad3p also had no deaminase activity (M.S.,
A.G. and W.K., unpublished results). In vivo the mutants were lethal except for one mutation.
All these mutant proteins were tested for tRNA binding by UV-crosslinking. However, bandshift
experiments should also be done to investigate binding since this method allows to observe
differences in binding efficiency. Establishing the conditions for bandshifts with tadA (and other
Tad proteins) is difficult because these proteins do not bind stably to their substrates but release
the tRNA after catalysis. Efficiency of bandshifts could be improved with a tRNA substrate that
has a chemically modified nucleotide at position 34 which would trap the enzyme on the
substrate. For ADAR2 it has been shown that methylation of the 2’-hydroxyl group at the edited
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adenosine significantly decreased the rate of the deamination reaction (Yi-Brunozzi et al., 1999).
It might also be possible that tRNA binding of Tads cannot be attributed to a short amino acid
sequence but rather involves sequences throughout the protein. Different parts of tadA might
bind to different regions of the tRNA. This would be one explanation why no known RNA
binding motif is present. It has been shown for human ADAR1 that the NLS overlaps with the
third dsRNA binding domain which thus has a dual function. Likewise, the tRNA binding
domain of tadA might overlap with other domains, e.g. the deaminase domain and therefore it
might be difficult to assign certain functions to certain motifs. For the yeast Tad2p/Tad3p
complex it has been proposed that Tad2p catalyzes the deamination and Tad3p is responsible for
binding to the tRNA. Because E. coli only encodes a Tad2-like protein tRNA binding might be
different, also because tadA recognizes only one tRNA and not seven different tRNAs like the
yeast complex.
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Figure 5.1  Phylogenetic tree of deaminase domains from adenosine and cytidine deaminases.
The alignment was generated with the neighbour joining method. Amino acid sequences were used (with numbering
starting with the first methionine) of hADAR1 (908-1039), dADAR (326-452), hADAR2 (392-519), dADAT1 (76-
194), hADAT1 (85-302), scADAT1 (99-226), ecADAT2 (66-105), hADAT2 (69-114), scADAT2 (52-95),
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hADAT3 (237-314), scADAT3 (214-261), scDCTC (231-267), humdeoxdea (82-117), ECCDA (102-136), scCDD
(60-103), hCDA (63-106), rAPOBEC1 (59-100), hAPOBEC1 (59-100), hAID (54-94).
It has been shown in chapter 4.2 that Tad proteins from different organisms can interact.
This interaction could have its origin in bacteria where tadA is likely to act as a homodimer.
Bacterial tadA is proposed to be the ancestor of the eukaryotic Tad2p (Fig. 5.1; Gerber and
Keller, 1999; Gerber and Keller, 2001). Tad3 is suggested to have appeared through a genome
duplication in eukaryotes and its appearance probably enabled the eukaryotic tRNA:adenosine
34 deaminase to modify additional substrates. Since Tad2p can interact with itself it can also
interact with the related Tad3p and even with Tad2 proteins from human and E. coli. It was
proposed that a Tad2p-like enzyme might have evolved to Tad1p by establishing an additional
deaminase motif and changing site-specificity to position 37. Tad1p might then have evolved to
the metazoan ADARs by acquiring dsRNA binding domains (Fig. 5.1; Gerber et al., 1998;
Gerber and Keller, 1999). All Tads and ADARs are thought to be related and have a conserved
deaminase domain. Tad2 also interacts with Tad1, possibly because the two proteins have the
same origin and are related. This is supported by the presence of a conserved deaminase domain
in both proteins. Furthermore, D. melanogaster ADAR can also dimerize (Mary O’Connell, pers.
communication). E. coli cytidine deaminase and APOBEC1 form homodimers (Betts et al.,
1994; Lau et al., 1994b), so dimerization seems to be a general feature of cytidine deaminases
and adenosine deaminase that act on RNA and supports the idea that all these enzymes are
related (Fig. 5.1).
Why do all these enzmyes form homodimers? Is dimerization needed for catalysis? It has
been shown that APOBEC1 forms homodimers in which the active site residues in the
deaminase domain are involved in RNA binding. A structural model proposes that the deaminase
domain of one subunit targets C at the editing site, whereas the same domain in the other subunit
binds to a downstream U in the apoB mRNA (Navaratnam et al., 1998). However, despite
extensive mutagenesis, a specific U has not been identified as an essential requirement for apoB
editing. Probably, APOBEC1 binds to one of several downstream uridines and is thereby
searching for a editing site in a U or A/U-rich context. Mutational analysis confirmed that a
homodimeric structure of APOBEC1 is essential for its RNA binding and editing functions
(Navaratnam et al., 1998). Mutations that abolished dimerization also eliminated RNA binding
and RNA editing. Thus, for APOBEC1 and ECCDA is has clearly been shown that dimerization
is a prerequisite for activity and this could also prove correct for tadA. Such a result would
further support the hypothesis that tadA evolved from the E. coli cytidine deaminase that acts on
mononucleotides. It is likely that in eukaryotic tRNA:adenosine 34 deaminases Tad2 is the
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catalytic subunit of the complex and that binding and catalysis has been separated into two
different subunits. There are two possible explanations for ADAR dimerization to be important.
First, as for APOBEC1 dimerization of ADARs could also help the enzyme to find the target A
at the editing site and thus contribute to site specificity. Second, ADAR dimers could either be
the active or the inactive form of the enzyme. If dimerization inhibits ADARs, this could be a
mechanism to regulate pre-mRNA editing. In case of endogenous ADAR overexpression
hyperediting could be prevented by dimerization.
A minimal tRNA substrate for tadA has been identified using tRNAArg2 mutant
minisubstrates (chapter 3.3 and 3.4). tadA requires a stem-loop structure, the invariant U33 and
the correct anticodon sequence. Although deamination could be detected with such a substrate,
the efficiency was low compared to wild-type tRNA. A possible explanations for this result is
that tadA might require other tRNA structures or sequences than the anticodon arm for efficient
deamination. tadA could maybe not bind as efficiently to the minisubstrate as to full-length
tRNA or tadA could not efficiently dimerize on the minisubstrate. An interesting question is also
where site-specificity in the minisubstrates comes from. The minimal requirements U33-A34-C35-
G36 and stem-loop structure are probably also present in other RNAs. It is therefore likely that
additional tRNA sequences contribute to specificity which is supported by the result that more
than 1 mol inosine/mol WT minisubstrate is detected with tadA. Interestingly, hTad2/hTad3 is
not able to deaminate the arginine minisubstrate although this complex is known to deaminate
full-length tRNAArg2 (chapter 4.3). This result further supports the hypothesis that tRNA
recognition by Tads is different in bacteria and eukaryotes. It is very likely that hTad2/hTad3
need additional tRNA sequences and/or structures to deaminate A34 and this might explain why
the eukaryotic complex recognizes seven or eight different tRNAs. Nucleotides in human tRNAs
that are important for Tad2/Tad3 binding could be identified with footprint experiments.
Potential binding sites could then be verified by mutating specific nucleotides in the tRNA.
However, the best way to answer all these questions would be the crystal structure of a tRNA-
Tad protein complex. Such a structure would reveal the contacts between the protein and the
substrate and could to help to identify determinants for substrate- and site-specificity. Yeast
Tad2p/Tad3p could be successfully overexpressed in E. coli and purified as a complex, however
so far no crystals were obtained. Also for a co-crystal position 34 needs to be modified to trap
the enzyme on the substrate.
What is the function of I34 in tRNAs? One obvious function is alternative base pairing of these
tRNAs with several codons as suggested by Crick (1966). In E. coli tRNAArg2 decodes the codons
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CGC, CGU and CGA. The three base pairs with I have different structures. I:C is a Watson-
Crick base pair and I:U has the same geometry as a G:U pair. I:A is the only purine: purine pair
and has therefore a different conformation. Crick (1966) suggested a „long wobble“
conformation for the I:A pair and also predicted that A:G and A:A would not form during
translation. However, yeast mitochondria tRNAArg (ACG) and Mycoplasma tRNAThr (AGU) read
all four codons of their respective codon family boxes with unmodified A34. If A34 can base pair
with A, C, G and U at the wobble position of the codon, why then is A modified to I in tRNAs
that read codons of a four codon family box? By structural modelling it was confirmed that A
can base pair with all four nucleotides, however a significant propeller twist is required to read
C, G and A which will weaken the anticodon:codon complex (Lim, 1995). Interestingly, the
most severe problem occurs after translocation of the tRNA:mRNA complex to the P site of the
ribosome. The 6-amino group of A34 in all A:N pairs is predicted to interfere with reading the
next codon in the A site (Lim, 1995). Thus, the deamination of A34 relieves this steric hindrance.
However, this potential interference has not been shown experimentally. The A:I base pair is
predicted to be inefficient (Curran, 1995), the arginine codon CGA which is read by the I-
containing tRNAArg2 is therefore avoided in E. coli genes and especially in highly expressed
genes.
It is assumed that also S. cerevisiae uses I-containing tRNAs to read NNA codons.
However, the A-ending codons in four codon family boxes have two cognate isoacceptors, one
with inosine and one with a modified uridine which is capable of reading the NNA codon
without wobbling. Functional redundancy is avoided in decoding systems and this is supported
by the fact that the gene copy number of a certain tRNA is correlated with the abundance of the
respective codon and thus the translational need. This means that in the absence of such need due
to redundancy the gene number should be zero and this specific tRNA would not be present.
Genetic evidence against A:I base pairing in Schizosaccharomyces pombe was provided by
Munz et al. (1981). Mutation of the two tRNAs reading the serine codon UCA resulted in
lethality, suggesting that the remaining I-containing tRNA cannot read this codon. However, the
cells might not have survived because the UCA codon is abundant in yeast and translation was
not efficient enough with the I-containing tRNA. It was predicted that in S. cerevisiae only the
arginine codon CGA is read with I:A wobbling due to the higher number of tRNA genes
compared to bacteria (Percudani, 2001). This prediction could be tested with yeast tad2 or tad3
mutants in which the tRNAArg is overexpressed from a plasmid. tRNAArg containing adenosine at
position 34 would read codons ending in U and C. Arginine codons ending in A will neither be
read by the I34- nor by the C34-containing tRNA. Therefore, an artificial tRNAArg with U34 could
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be expressed in yeast cells. Such an artificial tRNA may rescue the tad2/tad3 mutants if tRNAArg
is indeed the only tRNA that forms an I:A base pair. However, this experiment includes several
critical steps. First, it is not clear whether the artificial tRNAArg would be recognized by arginyl-
tRNA synthetase and aminoacylated. Second, reading of arginine codons ending in C with
unmodified tRNAArg containing A34 could not be efficient enough for the cells to survive.
Efficiency depends largely on the abundance of this codon. The first base of the anticodon is not
necessarily required to form an „standard“ base pair with the third position of the codon when
the other two base pairs between the anticodon and the codon are G:C base pairs (Lagerkvist,
1978). Because this is the case for the CGN arginine codons, the A:C base pair is thought to be
formed. C. elegans has twice as many tRNA genes as yeast. Interestingly, four additional species
with different anticodons were found in the C. elegans genome which are complementary to the
four codons in yeast that are read through I:A and U:G wobbling. Thus, it is very likely that I:A
base pairing does not occur in higher eukaryotes and the higher number of tRNA genes in these
organisms can be explained by a more restricted use of wobbling. It has been shown previously
that a tRNA modification is not essential for all tRNAs it is part of. 1-methyladenosine at
position 58 (m1A58) is found in 18 yeast tRNAs and its formation is catalyzed by Gcd10p and
Gcd14p. The lethality of strains lacking Gcd10p could be complemented by genes encoding
tRNAMeti, indicating that modification of this tRNA is the only essential role of Gcd10p in yeast
cells (Anderson et al., 1998).
Conditional tadA mutants would be very helpful in elucidating functions of I34 in vivo. A
temperature-sensitive tadA mutant (tadA-2) was generated by mutation of a single amino acid
that is conserved in all Tad2 proteins and was previously shown to result in a ts phenotype in
yeast (M.S., A.G. and W.K., unpublished results). In E. coli the ts phenotype was more
pronounced when the mutant protein contained a Flag- and a His6-tag. The cells did not grow at
high temperature, however it remains to be determined whether tRNAArg2 was unmodified in this
strain. As discussed in chapter 3.6.1 tadA ts mutants are an excellent tool to study the effect of I34
in vivo. The expression of a reporter construct that is coupled to a series of arginine codons could
be analyzed. E. coli as a model organism is suited much better for these experiments than yeast
because in tad2/tad3 mutants seven tRNAs lack I34 and the resulting effects are thus more
difficult to analyze. It would be especially difficult to analyze the loss of I34 on translation with
tad2/tad3 mutants because most likely any reporter gene used (e.g. luciferase, CAT, ß-
galactosidase) would not be translated in this mutant since expression of the reporter also
depends on I-containing tRNAs. In E. coli tadA mutants the reporter gene could be mutated such
that it does not encode arginine residues read by tRNAArg2.
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It is not known whether the eight human tRNAs that are deaminated by hTad2/hTad3
contain I34 at all time. It could be possible that I34 formation is regulated developmentally, is
organ-specific or could be changed by metabolic stress. Hypomodified tRNAs might translate
less efficiently and this in turn might regulate gene expression. Hypomodification could also lead
to increased frameshifting or read-through and could thereby affect gene expression. Modified
nucleotides in tRNAs not only affect the translational efficiency but also the codon context
sensitivity and reading frame maintenance. tRNA modifying enzymes could also have other
functions in the cells. The modified nucleotides could act as sensors for environmental stress or
developmental signals. It is also not known whether hTad2/hTad3 could deaminate adenosines in
tRNA-like structures that are present in pre-mRNAs. tRNAs were integrated into the genome
through reverse transcription and are present in protein-coding genes and in short interspersed
repetitive elements (SINEs; Brosius, 1999).
Modified nucleotides at position 34 improve the decoding capacity of tRNAs, but
decrease the codon sensitivity. However, certain modifications also limit the decoding capacity
of the tRNA mainly when the codons read by these tRNAs encode two different amino acids.
Modification thus directs base pairing of tRNAs with mRNAs.
Could I34 formation be coupled to other processes in the cell, e.g. tRNA export or
aminoacylation? tRNAs undergo several maturation steps in the nucleus and are then exported to
the cytoplasm by the tRNA-specific export receptor exportin-t (Arts et al., 1998a; Kutay et al.,
1998). Mature tRNAs from HeLa cells bound exportin-t 10 times better than in vitro transcribed
tRNA lacking all modifications (Kutay et al., 1998). It was suggested that modifications and the
3’ CCA end of the tRNA contribute to binding specificity. tRNAs were only exported when they
had a mature 5’ and 3’ end, intron-containing tRNAs were exported in the presence of excess
exportin-t (Arts et al., 1998b; Lund and Dahlberg, 1998). Interestingly, in vitro transcribed
tRNAs were exported to the cytoplasm when injected into the nucleus of Xenopus oocytes. This
suggests that modifications in the tRNAs are not essential for tRNA export, but might increase
specificity and efficiency.
For a long time aminoacylation was believed to be restricted to the cytoplasm. However,
uncharged tRNAs became aminoacylated upon injection into the nucleus of Xenopus oocytes,
thus providing clear evidence for nuclear aminoacylation (Lund and Dahlberg, 1998). In S.
cerevisiae 15 cytoplasmic tRNA synthetases contain a classical nuclear localization signal
(Schimmel and Wang, 1999). Nuclear aminoacylation was suggested to be required for efficient
tRNA export and might provide a final check after synthesis and processing of the tRNA are
Conclusions and outlook
91
complete. Most modified nucleotides in tRNA are probably not essential for aminoacylation
(Björk, 1992). In vitro transcribed tRNAs could be aminoacylated with the cognate amino acid in
many cases. However, the kinetic characteristics of the reaction were different. Modified
nucleotides might affect recognition by the cognate aminoacyl-tRNA ligase either directly or
indirectly through conformational changes (Hall et al., 1989). The anticodon of tRNAArg2 is a
recognition motif for E. coli Arg-tRNA synthetase (Schulman and Pelka, 1989). Since the
tRNAArg isoacceptors have different nucleotides at the wobble position (C, I and mnm5U), this
position might not contribute significantly to recognition by the synthetase. An unmodified
tRNAArg with A34 or C34 instead of I34 has the same aminoacylation kinetics as mature tRNAArg2
(Tamura et al., 1992). Thus, I34 and mnm5U34 are not essential for aminoacylation of tRNAArg2.
Yeast has two tRNAIle, a major tRNA with the anticodon IAU and a minor tRNA with the
anticodon YAY. I34 and Y34 contribute significantly to the efficiency of aminoacylation (Senger
et al., 1997). Thus, in S. cerevisiae I34 is critical for correct aminoacylation and a lack of
TAD2/TAD3 not only affects translation by the decoding properties of A34, but also by the
absence of aminoacylation of certain tRNAs.
Where does I34 formation occur in human cells? Localization experiments with GFP-tagged
hTad2 and hTad3 revealed that hTad2 localizes to the nucleus and transports hTad3 into the
nucleus. hTad3 alone is detected in the cytoplasm. A putative NLS was identified in the hTad2
sequence which should be verified by mutation. GFP-hTad2 with a mutated NLS should not
localize to the nucleus and co-expression with hTad3 should also result in cytoplasmic
accumulation of both proteins. The nuclear localization of the hTad2/hTad3 complex suggests
that I34 formation occurs in the nucleus and it is likely that exported tRNAs all contain I34. By
Western blot analysis hTad2 was also detected in the cytoplasm (chapter 4.3). This result is in
contrast to the localization experiments with GPF-tagged proteins, however GFP-hTad2 might
accumulate exclusively in the nucleus due to the overexpression with the CMV promoter. The
endogenous hTad2 might also be found in the cytoplasm. This hypothesis could be verified by
immunofluorescence with the a -hTad2 antibodies. If hTad2 indeed is present in both
compartments, then the question arises where adenosine deamination occurs. To find an answer
to this question in vitro transcribed ATP-labelled tRNA could be injected into Xenopus oocytes.
Two hours later the oocytes are dissected into nuclear and cytoplasmic fraction and the
distribution of the tRNA could be analyzed by separating the fractions on denaturing
polyacrylamide gels. The tRNAs could also be analyzed for the presence of inosine by thin layer
chromatography and autoradiography. If I is detectable in the nuclear tRNA population, tRNA
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deamination is also a nuclear process. tRNA deaminase activity was already detected in vitro
with HeLa cell nuclear extracts which is thus consistent with the presence of hTad2 in the
nucleus as determined by Western blot. Since tRNAs seem to be deaminated already in the
nucleus, it might be possible that this modification contributes to tRNA quality control before
export to the cytoplasm. Although tRNAs are exported without any modified nucleotides, certain
modifications could improve the export efficiency, e.g. by increasing the binding efficiency of
the tRNA to the export receptor exportin-t. This would also be in agreement with the suggestion
that tRNA processing, modification and export are coupled. Due to interactions of the different
enzymes that are involved in these processes, such a coupling would „channel“ the tRNA from
its site of synthesis to its site of action thereby increasing the processing efficiency.
In summary, the identification and characterization of eukaryotic and prokaryotic
adenosine deaminases that act on tRNA allows to investigate different aspects of these enzymes.
There are conserved features, but clearly there are also differences, e.g. in tRNA binding. Future
research will provide new interesting insights into the formation of inosine in tRNAs.
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